syndrome	score	normalized_score
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	2.02235075	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	98.89481337497958
EMANUEL SYNDROME	1.26239828	62.42232115274761
OROFACIODIGITAL SYNDROME TYPE 2	1.1380690100000002	56.274561175898896
FAMILIAL MEDIAN CLEFT OF THE UPPER AND LOWER LIPS	1.1081731	54.79628595583629
OTOSCLEROSIS 7	1.05030887	51.93504984236784
DEAFNESS, AUTOSOMAL DOMINANT 1	1.04695826	51.769370867046675
MOWAT-WILSON SYNDROME; MOWS	1.0341709399999999	51.1370710545636
DEAFNESS, AUTOSOMAL DOMINANT 6	1.0232558	50.597345687932716
PSEUDOAMINOPTERIN SYNDROME	1.0195076200000002	50.41200790713481
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	1.0106383	49.97344303405332
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	1.00892857	49.888901319417506
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	1.00196464	49.544553040564296
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	1.00190476	49.54159212985185
MIDDLE EAR NEUROENDOCRINE TUMOR	1.00150376	49.52176371977017
HORNER SYNDROME, CONGENITAL	1.0	49.44740668748979
INCONTINENTIA PIGMENTI; IP	1.0	49.44740668748979
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	49.44740668748979
CHILDHOOD DISINTEGRATIVE DISORDER	0.98879085	48.89314328881871
CLEFT LIP/PALATE	0.9234251299999999	45.66097794855813
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.7537098099999999	37.268995499420654
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.65109284	32.19485245079272
LIMB-MAMMARY SYNDROME	0.64987104	32.13443760930194
NON-DISTAL MONOSOMY 20Q	0.60250657	29.79238739867453
OROFACIAL CLEFT 15	0.58432212	28.893213504136206
ADNP SYNDROME	0.54514245	26.955880427764566
DEAFNESS-HYPOGONADISM SYNDROME	0.53666649	26.53676618657767
POSTENCEPHALITIC PARKINSONISM	0.525641	25.991584298618818
OCULOPHARYNGODISTAL MYOPATHY	0.5232558	25.873642344187818
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.5208333	25.753856001487378
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5208333	25.753856001487378
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.51426644	25.429141804407568
17Q24.2 MICRODELETION SYNDROME	0.51296786	25.364930391031326
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.5106383	25.249739690308417
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.5106383	25.249739690308417
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.50816318	25.127351425068078
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.50613497	25.02706170035044
MULTIPLE SULFATASE DEFICIENCY	0.5058140999999999	25.011195510966626
INHERITED CREUTZFELDT-JAKOB DISEASE	0.50549451	24.995392614263373
48,XXXY SYNDROME	0.50451726	24.947070136078022
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.5044175499999999	24.94213973515721
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.50196464	24.8208496968194
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.50156495	24.801086062840483
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	24.723703343744894
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.5	24.723703343744894
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.5	24.723703343744894
DEAFNESS, UNILATERAL	0.5	24.723703343744894
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.5	24.723703343744894
ACATALASEMIA	0.5	24.723703343744894
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	0.5	24.723703343744894
ACITRETIN/ETRETINATE EMBRYOPATHY	0.49702329999999995	24.57651324825824
OROFACIAL CLEFT 10; OFC10	0.43333299999999997	21.427193082110012
BRANCHIOSKELETOGENITAL SYNDROME	0.40349734	19.95189706830034
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.385638	19.068799020150188
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.3645833	18.027698706567097
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.35	17.306592340621425
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.34946581	17.280178030443036
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.34156884	16.889693343254127
DEAFNESS AND MYOPIA; DFNMYP	0.33818737	16.722488420962584
ATELOSTEOGENESIS TYPE II	0.33432212	16.531361832263762
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	16.482452413361035
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.333333	16.482452413361035
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.333333	16.482452413361035
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.333333	16.482452413361035
PLACENTAL INSUFFICIENCY	0.333333	16.482452413361035
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	16.482452413361035
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.333333	16.482452413361035
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	16.482452413361035
HOLOPROSENCEPHALY	0.32763231000000004	16.20056807653173
CONGENITAL ENTEROVIRUS INFECTION	0.3269231	16.165499481234892
RING CHROMOSOME 7 SYNDROME	0.32405325999999995	16.023593335626867
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.32254094	15.948813033545242
MOHR-TRANEBJAERG SYNDROME	0.31799451	15.72400386035904
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.3125	15.45231458984056
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.30725047000000005	15.192738945012382
ALOPECIA AREATA 2; AA2	0.2981531	14.742897590835813
INSULINOMA	0.2857143	14.127831188531461
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.28571399999999997	14.127816354309456
MARCUS GUNN PHENOMENON	0.28571399999999997	14.127816354309456
ALOPECIA AREATA 1	0.2822801	13.958018904485286
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.2793044	13.810878256405324
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.26092455000000003	12.902042338600264
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.25991769000000003	12.8522557227029
MENINGIOMA	0.25854701	12.78447915130449
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.25789964	12.752468383637208
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.25665942	12.691142720915252
MOSAIC TRISOMY 1	0.25539307	12.628524997456548
8P INVERTED DUPLICATION/DELETION SYNDROME	0.25485852000000003	12.602092886211752
PGM3-CDG	0.25485437	12.601887679473997
ISOLATED CLEFT LIP	0.25485437	12.601887679473997
WEST SYNDROME	0.25431034	12.574986806813804
FRONTORHINY	0.25417745	12.568415740939104
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.25342843	12.531378644382038
HYPERTRICHOSIS CUBITI	0.25337	12.528489432409287
OTOMANDIBULAR SYNDROME	0.25312714	12.516480635221164
SCHIZOPHRENIA 1; SCZD1	0.25098912	12.410761090775177
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.25	12.361851671872447
HYPERPARATHYROIDISM 2	0.25	12.361851671872447
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.25	12.361851671872447
OSSICULAR MALFORMATIONS, FAMILIAL	0.25	12.361851671872447
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.25	12.361851671872447
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.361851671872447
NARCOLEPSY TYPE 1	0.25	12.361851671872447
DYSTONIA 6, TORSION	0.25	12.361851671872447
TETRAAMELIA SYNDROME 2; TETAMS2	0.25	12.361851671872447
AUTOSOMAL DOMINANT PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.25	12.361851671872447
SCHIZOPHRENIA	0.25	12.361851671872447
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.25	12.361851671872447
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.25	12.361851671872447
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	12.361851671872447
SEVERE COMBINED IMMUNODEFICIENCY DUE TO FOXN1 DEFICIENCY	0.25	12.361851671872447
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.20976105000000003	10.37213994654488
ALOPECIA UNIVERSALIS	0.20535699999999998	10.15437109512284
QUINQUAUD FOLLICULITIS DECALVANS	0.20202009999999998	9.989370043747355
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.20098912000000002	9.93839075640069
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.2	9.889481337497958
XQ25 MICRODUPLICATION SYNDROME	0.2	9.889481337497958
OTODENTAL SYNDROME	0.1899228	9.391189930826787
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.18953786	9.372155646096504
FRONTONASAL DYSPLASIA 1; FND1	0.18348007999999996	9.07261413481316
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.17826979999999998	8.814979300697466
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.1769231	8.748388478111425
ACROMELIC FRONTONASAL DYSPLASIA	0.17666106999999998	8.735431774137101
MYHRE SYNDROME	0.17642570000000002	8.723793338025068
AGEL AMYLOIDOSIS	0.17615041999999997	8.710181455912133
PFAPA SYNDROME	0.17543893000000002	8.675000120528054
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.17424240000000002	8.615834815004272
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.17399251	8.603478402547134
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.16973541	8.392975847537821
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.16956088	8.384345791648654
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.16862834999999998	8.338234601490369
GRANULOMATOSIS WITH POLYANGIITIS	0.16817076	8.31560796266424
PEMPHIGUS VULGARIS	0.166667	8.241250930383861
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	8.241250930383861
FECHTNER SYNDROME	0.166667	8.241250930383861
PITYRIASIS RUBRA PILARIS	0.166667	8.241250930383861
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	8.241250930383861
FRONTOTEMPORAL DEMENTIA; FTD	0.1666667	8.241236096161854
JERVELL AND LANGE-NIELSEN SYNDROME	0.16369029999999998	8.094060834897208
SANDHOFF DISEASE	0.16034095	7.928444163308466
FOCAL DERMAL HYPOPLASIA; FDH	0.15498463	7.66358802992013
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.1549052	7.659660422406943
HOLOPROSENCEPHALY 7	0.1547619	7.652574609028627
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.15332837	7.5816902681199085
NEUROFIBROMATOSIS TYPE 1	0.15318146000000002	7.57442594960345
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.15037961	7.435881733176106
PELGER-HUET ANOMALY; PHA	0.15001896	7.418048525954264
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.1495011	7.392441691927079
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.14914767	7.374965494981521
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.14896600000000002	7.365982384608605
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.14892465000000002	7.363937734342077
NASU-HAKOLA DISEASE	0.14849565	7.342724796873143
NORMAL PRESSURE HYDROCEPHALUS	0.14835151	7.335597447673208
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.14761581	7.299218990573221
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.14716733999999998	7.277043312096082
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.14633908999999998	7.236088497507169
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.14476176	7.158093619516791
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.14476176	7.158093619516791
UNILATERAL POLYMICROGYRIA	0.14476176	7.158093619516791
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.14473239000000002	7.156641349182381
PHACE SYNDROME	0.14442195	7.141290896250315
SCHINZEL-GIEDION SYNDROME	0.14384612	7.112817596057458
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.14333073999999998	7.087333391598858
HYDRANENCEPHALY	0.14285699999999998	7.063908177154728
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	7.063908177154728
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.14285699999999998	7.063908177154728
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.14285699999999998	7.063908177154728
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.14285699999999998	7.063908177154728
GANGLIONEUROMA	0.14285699999999998	7.063908177154728
BEHCET SYNDROME	0.14285699999999998	7.063908177154728
%109500 BASILAR IMPRESSION, PRIMARY	0.14285699999999998	7.063908177154728
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.14285699999999998	7.063908177154728
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.14285699999999998	7.063908177154728
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.14285699999999998	7.063908177154728
SYRINGOMYELIA, ISOLATED	0.14285699999999998	7.063908177154728
PTOSIS, HEREDITARY CONGENITAL 1	0.14285699999999998	7.063908177154728
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.14285699999999998	7.063908177154728
16P12.1P12.3 TRIPLICATION SYNDROME	0.14285699999999998	7.063908177154728
SARCOSINEMIA	0.14285699999999998	7.063908177154728
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.14285699999999998	7.063908177154728
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.14285699999999998	7.063908177154728
ARNOLD-CHIARI MALFORMATION TYPE I	0.14285699999999998	7.063908177154728
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.14285699999999998	7.063908177154728
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	7.063908177154728
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.14285699999999998	7.063908177154728
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.14285699999999998	7.063908177154728
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	7.063908177154728
UNCOMBABLE HAIR SYNDROME	0.14285699999999998	7.063908177154728
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.14285699999999998	7.063908177154728
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.14285699999999998	7.063908177154728
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.14285699999999998	7.063908177154728
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.14285699999999998	7.063908177154728
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.14285699999999998	7.063908177154728
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.14285699999999998	7.063908177154728
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	7.063908177154728
PHACE ASSOCIATION	0.14285699999999998	7.063908177154728
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.14127645000000003	6.985754078514818
NATIVE AMERICAN MYOPATHY	0.14122899	6.983407304593428
BIFID UVULA	0.13923157	6.884640065527703
DERMATOMYOSITIS	0.13861367000000002	6.8540865129355035
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.13727925000000002	6.7881029045035834
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.13670342000000002	6.759629604310727
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.13599680000000003	6.724689077797212
DISTAL MONOSOMY 12Q	0.13495981	6.673412611536351
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.13398246000000003	6.625085188610334
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.1319443	6.524303462196158
HYDROLETHALUS	0.13165587	6.510041346685287
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.12648863999999999	6.254535223427488
NIJMEGEN BREAKAGE SYNDROME	0.12577478	6.219236697689557
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.12514364	6.188028461432815
CARIBBEAN PARKINSONISM	0.125	6.180925835936224
YOUNG-ONSET PARKINSON DISEASE	0.125	6.180925835936224
MUCKLE-WELLS SYNDROME	0.12353830000000002	6.10864856158112
PAPILLARY TUMOR OF THE PINEAL REGION	0.12327570000000002	6.095663672584986
PINEOCYTOMA	0.12327570000000002	6.095663672584986
MONILETHRIX	0.12093347999999998	5.979846967693412
ALKAPTONURIA	0.11904760000000002	5.88659509236961
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.11852605000000001	5.860805797411749
SAGLIKER SYNDROME	0.11728383999999999	5.799381734350482
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.1143549	5.654553247007226
FRYNS MICROPHTHALMIA SYNDROME	0.11274510000000001	5.5749528117217055
DEAFNESS, X-LINKED 4	0.11261476	5.5685078367340575
PETTIGREW SYNDROME	0.11261476	5.5685078367340575
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.11112849999999999	5.495016134070709
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.11111099999999999	5.494150804453677
ALOPECIA, FAMILIAL FOCAL	0.11111099999999999	5.494150804453677
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.11111099999999999	5.494150804453677
CRONKHITE-CANADA SYNDROME	0.11111099999999999	5.494150804453677
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.11111099999999999	5.494150804453677
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.10980485	5.429565074208813
BARTSOCAS-PAPAS SYNDROME	0.10979648	5.429151199414839
LETHAL OMPHALOCELE-CLEFT PALATE SYNDROME	0.10892857	5.3862353006767
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.10730214	5.305812555017965
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.10658909999999999	5.2705545761535175
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.10653595	5.267926446488079
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.106109	5.246814876202854
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.10603616	5.243213127099738
DIPROSOPUS	0.10578998	5.231040164521411
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.10457714	5.171068371794556
HOLOPROSENCEPHALY 4	0.10424355	5.154573211397676
MONOSOMY 18Q	0.10330881000000001	5.108352742470613
HOLOPROSENCEPHALY 2; HPE2	0.10308447000000001	5.097259711254341
KBG SYNDROME	0.1026125	5.073922018720046
WIEDEMANN-STEINER SYNDROME	0.10207191	5.047191245138856
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.10190476000000001	5.038926111111042
SCHISIS ASSOCIATION	0.10162338	5.025012599817316
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.10162338	5.025012599817316
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.10151745000000001	5.019774636026911
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.10110254	4.999258412518204
PHENOBARBITAL EMBRYOPATHY	0.10098912	4.993650087651709
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.10056135	4.972497970493001
ZLOTOGORA-OGUR SYNDROME	0.10015450000000001	4.9523802930821965
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.10015065000000001	4.9521899205664495
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.1	4.944740668748979
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.1	4.944740668748979
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.1	4.944740668748979
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.1	4.944740668748979
SANDHOFF DISEASE	0.1	4.944740668748979
N SYNDROME	0.09775640000000001	4.833800467104927
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.09722458	4.807503347280386
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.09704407000000001	4.798577595899228
TAY-SACHS DISEASE	0.09673689	4.783388341512965
TAY-SACHS DISEASE; TSD	0.09640361	4.766908509812158
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.09640361	4.766908509812158
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.09542781	4.718657730366505
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.0954136	4.717955082717476
SMITH-FINEMAN-MYERS SYNDROME	0.09446331	4.670965706616421
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0944056	4.668112096776486
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0944056	4.668112096776486
PELIZAEUS-MERZBACHER DISEASE	0.09433131000000002	4.6644386489336735
TRICHOHEPATOENTERIC SYNDROME 1	0.09229548000000001	4.563772134977081
TRISOMY 8P	0.09169516000000001	4.5340878677944465
DDOST-CDG	0.09160508	4.529633645400037
CHRISTIANSON SYNDROME	0.09114014000000001	4.5066435681347565
LOCALIZED SCLERODERMA	0.0909091	4.495219239293678
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0909091	4.495219239293678
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0909091	4.495219239293678
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0909091	4.495219239293678
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.0909091	4.495219239293678
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.0909091	4.495219239293678
EROSIVE PUSTULAR DERMATOSIS OF THE SCALP	0.0909091	4.495219239293678
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.0909091	4.495219239293678
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0909091	4.495219239293678
HUNTINGTON DISEASE-LIKE 3	0.0909091	4.495219239293678
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.0909091	4.495219239293678
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.0909091	4.495219239293678
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.0909091	4.495219239293678
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.09085837000000001	4.492710772352422
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.09045265000000001	4.472648970511173
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.08912635000000001	4.407066875021556
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.08795031	4.3489147468608005
VAN MALDERGEM SYNDROME 1; VMLDS1	0.08779994	4.3414793403172025
VAN MALDERGEM SYNDROME 2; VMLDS2	0.08779994	4.3414793403172025
CLASSIC MYCOSIS FUNGOIDES	0.08756257	4.3297420093917935
BECKWITH-WIEDEMANN SYNDROME	0.08709349000000001	4.306547219862825
OROFACIODIGITAL SYNDROME TYPE 3	0.08684079	4.294051860192896
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.08677085000000001	4.290593508569174
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.08640201000000002	4.272355327086561
SCLEROSTEOSIS	0.08640201000000002	4.272355327086561
BARTSOCAS-PAPAS SYNDROME; BPS	0.08607155000000001	4.256014937072612
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08569503	4.237396999506638
POSTORGASMIC ILLNESS SYNDROME	0.08523806000000002	4.214801018072657
TETRASOMY 9P	0.08505610000000001	4.205803567951801
ERMINE PHENOTYPE	0.08483706000000002	4.194972607990973
CEREBROFACIOARTICULAR SYNDROME	0.08473123	4.189739588941236
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.08468145	4.187278097036332
DERMOODONTODYSPLASIA	0.08462302000000001	4.184388885063583
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08457552000000002	4.182040133245927
ANOPHTHALMIA PLUS SYNDROME	0.08432242000000001	4.169524994613323
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.08432242000000001	4.169524994613323
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.08377431	4.142422376533843
OROMANDIBULAR DYSTONIA	0.08333330000000001	4.120615575710594
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.08333330000000001	4.120615575710594
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	4.120615575710594
TELECANTHUS	0.08333330000000001	4.120615575710594
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0833333	4.120615575710593
MACS SYNDROME	0.08323265	4.115638694227497
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.08305807000000001	4.107006165967995
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.08275089000000001	4.091816911581732
RIN2 SYNDROME	0.08237779	4.07336808414663
184705 STEINFELD SYNDROME	0.08187462000000001	4.048487632523686
CLEFT VELUM	0.08177747	4.043683816963996
TUBEROUS SCLEROSIS COMPLEX	0.08166244	4.0379958817727335
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.08163695	4.036735467376269
CREE MENTAL RETARDATION SYNDROME	0.08128222	4.019194988802016
ETHYLMALONIC ENCEPHALOPATHY	0.08123344	4.016782944303801
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08057274	3.9841130427053764
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.07872815000000001	3.8929028508037
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07854648	3.883919740430783
MARSHALL-SMITH SYNDROME; MRSHSS	0.07844055000000001	3.8786817766403776
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.07727209	3.8209044598223127
ECTODERMAL DYSPLASIA SYNDROME	0.07712684	3.8137222240009554
CLEFT SOFT PALATE	0.07692310000000001	3.803647809362446
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	3.803647809362446
PEDIATRIC-ONSET GRAVES DISEASE	0.07692310000000001	3.803647809362446
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.07692310000000001	3.803647809362446
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	3.803647809362446
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.07692310000000001	3.803647809362446
OROFACIODIGITAL SYNDROME TYPE 10	0.07692310000000001	3.803647809362446
AMISH LETHAL MICROCEPHALY	0.07692310000000001	3.803647809362446
%613857 OROFACIAL CLEFT 13; OFC13	0.07692310000000001	3.803647809362446
FAMILIAL ANETODERMA	0.07692310000000001	3.803647809362446
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.07692310000000001	3.803647809362446
PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED	0.07692310000000001	3.803647809362446
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.07692310000000001	3.803647809362446
CRANIOSYNOSTOSIS 2	0.07692310000000001	3.803647809362446
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	3.803647809362446
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.07692310000000001	3.803647809362446
ALOPECIA-INTELLECTUAL DISABILITY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.07692310000000001	3.803647809362446
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.07692310000000001	3.803647809362446
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.07692310000000001	3.803647809362446
STEINERT MYOTONIC DYSTROPHY	0.07638890000000001	3.777233004709989
FLYNN-AIRD SYNDROME	0.07636931	3.776264330012981
TRICHOTHIODYSTROPHY	0.07557639000000001	3.7370564923023366
RETT SYNDROME; RTT	0.07480119	3.6987248626381946
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.07465575	3.6915332318095664
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0736111	3.6398779984134793
ARTERIAL TORTUOSITY SYNDROME	0.07241772	3.580868452220763
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.07241772	3.580868452220763
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.07226812	3.5734711201803147
KLEEFSTRA SYNDROME	0.07165067	3.542939818921124
PSEUDOTRISOMY 13 SYNDROME	0.07142860000000001	3.5319590333180337
HOLOPROSENCEPHALY 1; HPE1	0.07142860000000001	3.5319590333180337
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.07142860000000001	3.5319590333180337
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.07142860000000001	3.5319590333180337
DEAFNESS, AUTOSOMAL DOMINANT 50	0.07021406	3.4719031799998095
CLASSIC PHENYLKETONURIA	0.0694618	3.4347058738450786
FRONTOMETAPHYSEAL DYSPLASIA	0.06876257000000001	3.400130763666985
OROFACIODIGITAL SYNDROME TYPE 4	0.06874936000000001	3.399477563424644
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.0687103	3.3975461477194298
CHAR SYNDROME	0.06837657	3.3810440646856135
SATOYOSHI SYNDROME	0.0670045	3.313198761391909
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.0670045	3.313198761391909
GERMAN SYNDROME	0.06654950000000001	3.2907001913491025
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.06628780000000001	3.277759805018986
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.06606427	3.266706826202131
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.06534021000000001	3.2309039369159875
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.06511249999999999	3.2196442679391786
KRABBE DISEASE	0.06465129	3.1968386295008413
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.06431801	3.180358797800035
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.06406495	3.1678456370636985
OSTEOPETROSIS AND RELATED DISORDERS	0.06401745	3.1654968852460432
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.06348912	3.1393723368708417
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.06348912	3.1393723368708417
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.063328	3.1314053707053526
ANE SYNDROME	0.063328	3.1314053707053526
DISTAL TRISOMY 6P	0.06325552000000001	3.1278214226686445
AMISH INFANTILE EPILEPSY SYNDROME	0.0627294	3.1018061530622223
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0626959	3.1001496649381908
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.0625	3.090462917968112
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.0625	3.090462917968112
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.0625	3.090462917968112
COFFIN-SIRIS SYNDROME 10; CSS10	0.0625	3.090462917968112
DENTAL NONERUPTION	0.0625	3.090462917968112
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.0625	3.090462917968112
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.0625	3.090462917968112
SATOYOSHI SYNDROME	0.0625	3.090462917968112
%613930 ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3	0.0625	3.090462917968112
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.0625	3.090462917968112
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.0625	3.090462917968112
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.0625	3.090462917968112
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.0625	3.090462917968112
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.0625	3.090462917968112
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.0625	3.090462917968112
PYCNODYSOSTOSIS	0.0625	3.090462917968112
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.0625	3.090462917968112
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.0625	3.090462917968112
%203650 ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1;;AMR SYNDROME	0.0625	3.090462917968112
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.0625	3.090462917968112
INCONTINENTIA PIGMENTI	0.06238694000000001	3.0848723941680247
OROFACIODIGITAL SYNDROME TYPE 5	0.06200099	3.0657881675569874
NOONAN SYNDROME	0.061418480000000004	3.036984558687458
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.06121051	3.0267009815186605
RHIZOMELIC SYNDROME, URBACH TYPE	0.06082862	3.007817511378775
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.05994536	2.964142594947983
OCULODENTODIGITAL DYSPLASIA	0.05955017	2.9446014742991538
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	2.9319740900533695
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.0588235	2.908669527281556
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0588235	2.908669527281556
SPINOCEREBELLAR ATAXIA TYPE 4	0.0588235	2.908669527281556
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.057360650000000006	2.836335388408761
BAMFORTH-LAZARUS SYNDROME	0.057178980000000004	2.827352278035845
PACHYDERMOPERIOSTOSIS	0.057120550000000006	2.824463066063095
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.05704433999999999	2.8206946791994407
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.05704433999999999	2.8206946791994407
VELOCARDIOFACIAL SYNDROME	0.056878439999999995	2.8124913544299863
FRYNS SYNDROME	0.056660440000000006	2.8017118197721143
X-LINKED ADRENOLEUKODYSTROPHY	0.055688350000000005	2.753644490205272
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.05561726	2.7501292740638585
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.055555600000000004	2.747080346967508
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.055555600000000004	2.747080346967508
TRICHO-DENTO-OSSEOUS SYNDROME	0.055555600000000004	2.747080346967508
ELLIS VAN CREVELD SYNDROME	0.055555600000000004	2.747080346967508
ARGININOSUCCINIC ACIDURIA	0.055555600000000004	2.747080346967508
CHROMOSOME 1P36 DELETION SYNDROME	0.053988219999999996	2.6695774706736697
TRISOMY 13	0.05274663	2.6081840650045494
WAARDENBURG SYNDROME, TYPE 1; WS1	0.05272226000000001	2.6069790317035757
MCCUNE-ALBRIGHT SYNDROME	0.0526635	2.6040735020866186
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.052513960000000005	2.5966791368905713
PROGRESSIVE NON-FLUENT APHASIA	0.05230499999999999	2.586346606789153
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.05230499999999999	2.586346606789153
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.05225776	2.5840107112972364
TIETZ SYNDROME	0.0520833	2.5753841167265366
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0520833	2.5753841167265366
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.05175879	2.5593379387823796
PEROXISOME BIOGENESIS DISORDER 14B	0.05158947	2.5509655038820536
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.05043863	2.494059450369823
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0502451	2.4844898937535933
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.049959	2.4703429907003023
OROFACIODIGITAL SYNDROME TYPE 1	0.04978911	2.4619423707781647
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.04958361	2.4517809287038856
15Q OVERGROWTH SYNDROME	0.04940168	2.4427849620052307
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.04925377	2.435471196082084
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.049183950000000004	2.432018778147164
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.04913645	2.4296700263295072
COCKAYNE SYNDROME	0.04901966	2.4238950637024756
OROFACIAL CLEFT 11; OFC11	0.0488215	2.4140965655932827
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.048392340000000006	2.39287571653928
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.048279350000000006	2.3872886540576603
CHARGE SYNDROME	0.04823275000000001	2.3849844049060236
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.04795168000000001	2.371086222308371
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.04781341	2.364249129385691
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.047619	2.3546360590515762
PERIFOLLICULITIS CAPITIS ABSCEDENS ET SUFFODIENS, FAMILIAL	0.047619	2.3546360590515762
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS; EBSSH	0.047619	2.3546360590515762
ALOPECIA TOTALIS	0.047619	2.3546360590515762
LIPOID PROTEINOSIS	0.047619	2.3546360590515762
TRICHODYSPLASIA-AMELOGENESIS IMPERFECTA SYNDROME	0.047619	2.3546360590515762
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.047619	2.3546360590515762
ANONYCHIA WITH FLEXURAL PIGMENTATION	0.047619	2.3546360590515762
DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	0.047619	2.3546360590515762
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.047619	2.3546360590515762
AMYLOIDOSIS	0.047619	2.3546360590515762
ABLEPHARON-MACROSTOMIA SYNDROME	0.04749035000000001	2.348274650181231
PINEOBLASTOMA	0.047188030000000006	2.333325710191469
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.047161209999999995	2.33199953074411
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.04695826	2.3219641795568844
DEAFNESS, MID-TONE NEURAL	0.04695826	2.3219641795568844
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.046406039999999996	2.2946583326359185
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.04559286	2.254448690465786
PERRAULT SYNDROME 4	0.0454545	2.2476071472765047
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.0454545	2.2476071472765047
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.0454545	2.2476071472765047
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0454545	2.2476071472765047
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0454545	2.2476071472765047
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.0454545	2.2476071472765047
ACUTE MONOBLASTIC LEUKEMIA	0.0454545	2.2476071472765047
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.0454545	2.2476071472765047
MUCOPOLYSACCHARIDOSIS TYPE 2	0.04515025	2.232562773791836
TRIOPIA	0.0449736	2.223827889400491
OCULOMAXILLOFACIAL DYSOSTOSIS	0.044660500000000006	2.208345906366638
BRANCHIOOTORENAL SYNDROME 1	0.04464287	2.207474148586737
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.044396500000000005	2.1952917910011407
STURGE-WEBER SYNDROME	0.044261310000000005	2.188606996091059
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0440891	2.180091658185406
OROFACIODIGITAL SYNDROME I; OFD1	0.04365414000000001	2.1585840141726162
PALLISTER-HALL SYNDROME	0.04359069	2.1554465762182944
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.04351843	2.1518735066110564
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.043516990000000005	2.151802302345427
DISTAL MONOSOMY 10Q	0.04328717000000001	2.1404382993405076
JUVENILE MYOCLONIC EPILEPSY	0.043200840000000004	2.1361695047211766
PAI SYNDROME	0.04297274	2.12489055125576
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.04297274	2.12489055125576
WAARDENBURG SYNDROME TYPE 1	0.042938920000000005	2.1232182399615893
MUCOPOLYSACCHARIDOSIS TYPE IX	0.04276697	2.114715758381675
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.04169680000000001	2.0617986271669246
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.041666699999999994	2.0603102602256307
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.041666699999999994	2.0603102602256307
AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22	0.041666699999999994	2.0603102602256307
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.041666699999999994	2.0603102602256307
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.041666699999999994	2.0603102602256307
ADULT-ONSET DYSTONIA-PARKINSONISM	0.041666699999999994	2.0603102602256307
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.041666699999999994	2.0603102602256307
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.041666699999999994	2.0603102602256307
PERRY SYNDROME	0.041666699999999994	2.0603102602256307
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.04116769	2.0356355098145062
OROFACIODIGITAL SYNDROME V; OFD5	0.04116769	2.0356355098145062
MUCOLIPIDOSIS TYPE III	0.04098732000000001	2.0267166810702846
611426 TENTED EYEBROWS	0.0408333	2.019100791492277
INFANTILE MYOFIBROMATOSIS	0.0408333	2.019100791492277
FRONTONASAL DYSPLASIA	0.040681510000000004	2.0115951696311827
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0405229	2.00375231645648
SHPRINTZEN OMPHALOCELE SYNDROME	0.04042614	1.9989677853853984
LEPRECHAUNISM	0.04035306000000001	1.9953541689046772
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.04033851	1.9946347091373737
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040266550000000005	1.9910764737521423
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.040244020000000005	1.989962423679473
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.040236	1.9895658554778393
FIBROCHONDROGENESIS	0.04013185000000001	1.9844159080713377
RAINE SYNDROME	0.04013185000000001	1.9844159080713377
CONGENITAL HYPOTHYROIDISM	0.04003595	1.9796739017700067
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.04003534	1.9796437388519277
OROFACIODIGITAL SYNDROME IX; OFD9	0.04003534	1.9796437388519277
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.03989408999999999	1.972659292657319
FETAL HYDANTOIN SYNDROME	0.03989175000000001	1.9725435857256712
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.03983056000000001	1.9695178989104636
STICKLER SYNDROME, TYPE I	0.03963738	1.959965648886574
ACROCEPHALOPOLYDACTYLY	0.039450620000000006	1.9507308512136188
HOLOPROSENCEPHALY 3; HPE3	0.03923156999999999	1.9398993967787235
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.03908430000000001	1.9326172771958576
ZECHI-CEIDE SYNDROME	0.03874538999999999	1.9158590565953995
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.03871687	1.9144488165566729
MEHMO SYNDROME; MEHMO	0.03857048	1.907210210691691
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.03850847000000001	1.9041439770030006
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.03847488	1.9024830386123674
MAL DE MELEDA	0.0384615	1.9018214323108886
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	1.9018214323108886
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.9018214323108886
JUVENILE ABSENCE EPILEPSY	0.0384615	1.9018214323108886
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.9018214323108886
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.9018214323108886
BAZEX SYNDROME; BZX	0.0384615	1.9018214323108886
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.9018214323108886
LIP, HAMARTOMATOUS	0.0384615	1.9018214323108886
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.9018214323108886
CYCLIC NEUTROPENIA	0.0384615	1.9018214323108886
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.9018214323108886
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.9018214323108886
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.9018214323108886
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.9018214323108886
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.9018214323108886
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.8826951754041679
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.03796542000000001	1.8772915628013591
OCULOAURICULOFRONTONASAL SYNDROME	0.03776987	1.8676221224236198
BRANCHIO-OCULO-FACIAL SYNDROME	0.03776427	1.8673452169461702
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.03767894000000001	1.8631258697335271
ROSSELLI-GULIENETTI SYNDROME	0.03757113	1.8577949448185482
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.03757113	1.8577949448185482
FLYNN-AIRD SYNDROME	0.037565150000000005	1.8574992493265572
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.03751935000000001	1.8552345581002703
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.037511409999999995	1.854841945691171
WOODHOUSE-SAKATI SYNDROME	0.037386	1.8486407464184933
HYDROXYKYNURENINURIA	0.037384970000000003	1.8485898155896054
BRANCHIOGENIC DEAFNESS SYNDROME	0.037337680000000005	1.846251447727354
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.037337680000000005	1.846251447727354
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.03729953999999999	1.8443655236362926
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.03727925000000001	1.8433622357546042
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.03727925000000001	1.8433622357546042
WAGR SYNDROME	0.03727925000000001	1.8433622357546042
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.03727925000000001	1.8433622357546042
PEROXISOME BIOGENESIS DISORDER 11B	0.03723175000000001	1.841013483936948
WOLFRAM-LIKE SYNDROME	0.03674451	1.8169207295025354
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.03670342000000001	1.8148889355617468
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.03670342000000001	1.8148889355617468
FETAL ALCOHOL SYNDROME	0.036443199999999995	1.8020217313935276
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.036397589999999994	1.7997664351745113
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.036238	1.791875123541255
MENKES DISEASE	0.03616644	1.7883366671186982
HARLEQUIN ICHTHYOSIS	0.035714300000000004	1.7659795166590169
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.035714300000000004	1.7659795166590169
OTOFACIOCERVICAL SYNDROME 2	0.035714300000000004	1.7659795166590169
CROSSED POLYSYNDACTYLY	0.035714300000000004	1.7659795166590169
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.035714300000000004	1.7659795166590169
BENIGN SCHWANNOMA	0.035714300000000004	1.7659795166590169
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.035714300000000004	1.7659795166590169
OTOSCLEROSIS 4	0.035714300000000004	1.7659795166590169
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.03554677	1.7576955926166613
OROFACIODIGITAL SYNDROME XIV; OFD14	0.03542288	1.751569553402148
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.03477814	1.7196888324144561
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.034776709999999995	1.7196181226228928
OROFACIODIGITAL SYNDROME XVII	0.03467221	1.7144508686240505
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.03460093	1.710926257475366
JOUBERT SYNDROME 26	0.03448045	1.7049688339176572
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.03443295	1.7026200821000013
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.03437714	1.699860422332773
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.03403459	1.6829222131719734
ALSTROM SYNDROME; ALMS	0.03393314	1.6779057737635272
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.03391277	1.6768985300893033
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.033862500000000004	1.6744128089551231
OROFACIODIGITAL SYNDROME VIII; OFD8	0.033862500000000004	1.6744128089551231
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.033831139999999996	1.672862138281403
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.033831139999999996	1.672862138281403
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.033831139999999996	1.672862138281403
NEURONAL CEROID LIPOFUSCINOSIS	0.03367748	1.665264049769804
DESMOSTEROLOSIS	0.033460920000000005	1.6545557193775609
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.033447840000000006	1.6539089472980888
ESOPHAGEAL ATRESIA	0.03344383	1.6537106631972716
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.03343014	1.6530337281997198
MYOCLONIC EPILEPSY OF LAFORA	0.03327231	1.6452294440022335
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.03327231	1.6452294440022335
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.03327231	1.6452294440022335
HEART AND BRAIN MALFORMATION SYNDROME	0.033256759999999996	1.6444605368282426
CARDIOFACIOCUTANEOUS SYNDROME	0.033221389999999996	1.6427115820537062
MARDEN-WALKER SYNDROME	0.03322082	1.6426833970318946
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.03322082	1.6426833970318946
ROTHMUND-THOMSON SYNDROME	0.033215800000000004	1.6424351710503236
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.033181489999999994	1.6407386305268754
EAR-PATELLA-SHORT STATURE SYNDROME	0.033173320000000006	1.640334645214239
KOSAKI OVERGROWTH SYNDROME; KOGS	0.03311244	1.6373242870951044
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.033059580000000005	1.6347104971776039
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.03303655	1.6335717234015907
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.033001590000000004	1.6318430420637964
DUBOWITZ SYNDROME	0.03293379	1.628490507890384
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0329155	1.6275861148220703
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0329155	1.6275861148220703
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.0329155	1.6275861148220703
MICROPHTHALMIA, SYNDROMIC 1	0.03287619	1.625642337265185
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.03287338	1.6255033900523932
HYDROLETHALUS SYNDROME 1	0.03287338	1.6255033900523932
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0328128	1.622507866155265
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.03276819	1.6203020173429363
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.032767450000000004	1.6202654262619873
NEU-LAXOVA SYNDROME	0.032644990000000006	1.6142100968390374
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.032644990000000006	1.6142100968390374
GOLDENHAR SYNDROME	0.03252114	1.6080860355207913
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.03246445	1.6052828620356778
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.03226764	1.595551117925513
TEMPLE-BARAITSER SYNDROME	0.03209126	1.5868295843339735
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.03196587	1.5806293740094295
TRISOMY 20P	0.03194002	1.5793511585465576
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.03193167	1.578938272700717
HOLOPROSENCEPHALY 11	0.03192638	1.5786766959193403
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.03192638	1.5786766959193403
CHROMOSOME 15Q14 DELETION SYNDROME	0.03192638	1.5786766959193403
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.03192638	1.5786766959193403
WALKER-WARBURG SYNDROME	0.03165587	1.5653006779363074
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.03165587	1.5653006779363074
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.03165587	1.5653006779363074
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.03165587	1.5653006779363074
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.03165587	1.5653006779363074
AYMÉ-GRIPP SYNDROME	0.03156231	1.5606743785666262
1Q41Q42 MICRODELETION SYNDROME	0.03149923	1.5575552361527791
CRYPTOCOCCOSIS	0.03145843	1.5555377819599294
MUCOLIPIDOSIS IV; ML4	0.031274300000000005	1.5464330309665621
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.03125	1.545231458984056
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.03125	1.545231458984056
USHER SYNDROME, TYPE IIC	0.03125	1.545231458984056
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.03125	1.545231458984056
USHER SYNDROME, TYPE IF	0.03125	1.545231458984056
RETINITIS PUNCTATA ALBESCENS	0.03125	1.545231458984056
USHER SYNDROME, TYPE IE; USH1E	0.03125	1.545231458984056
MMEP SYNDROME	0.03125	1.545231458984056
OROFACIAL CLEFT 14	0.03125	1.545231458984056
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.03125	1.545231458984056
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.03125	1.545231458984056
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.03125	1.545231458984056
WILDERVANCK SYNDROME	0.03125	1.545231458984056
DEAFNESS-OLIGODONTIA SYNDROME	0.03125	1.545231458984056
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.03125	1.545231458984056
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.03125	1.545231458984056
DEAFNESS, X-LINKED 3	0.03125	1.545231458984056
USHER SYNDROME, TYPE IC	0.03125	1.545231458984056
USHER SYNDROME, TYPE IIA	0.03125	1.545231458984056
PERRAULT SYNDROME 3	0.03125	1.545231458984056
PENDRED SYNDROME	0.03125	1.545231458984056
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.031233510000000003	1.5444160712477795
BARAITSER-WINTER SYNDROME 1; BRWS1	0.031076919999999997	1.5366731018345852
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.03103518	1.5346091670794493
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.030976749999999997	1.5317199551066993
CRANIOFRONTONASAL DYSPLASIA	0.03095391	1.530590576337957
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.030915559999999998	1.5286942682914917
DISTAL MONOSOMY 6P	0.03090772	1.528306600623062
8Q22.1 MICRODELETION SYNDROME	0.030864779999999998	1.526183328979901
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.030499520000000002	1.5081221692132285
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.030400919999999998	1.503246654913842
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.030390300000000002	1.502721523454821
2Q23.1 MICRODUPLICATION SYNDROME	0.030380340000000006	1.5022290272842138
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.030302999999999997	1.4984047648510028
DOORS SYNDROME	0.030218140000000004	1.4942086579195029
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.030145500000000006	1.4906167982977236
SMITH-MAGENIS SYNDROME; SMS	0.03007819	1.4872884933535886
SPEECH-LANGUAGE DISORDER 1	0.02968256	1.467725615845817
WHITE-SUTTON SYNDROME; WHSUS	0.02960523	1.4639018478866732
15Q13.3 MICRODELETION SYNDROME	0.02958285	1.4627952149250074
FOUNTAIN SYNDROME	0.029554040000000004	1.4613706351383409
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.02954921	1.4611318041640402
BLAU SYNDROME	0.0294118	1.454337236011112
AREDYLD	0.0294118	1.454337236011112
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	1.454337236011112
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	1.454337236011112
OSSIFIED EAR CARTILAGES	0.0294118	1.454337236011112
EAR WAX, WET/DRY	0.0294118	1.454337236011112
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	1.454337236011112
DARWINIAN TUBERCLE OF PINNA	0.0294118	1.454337236011112
DARWINIAN POINT OF PINNA	0.0294118	1.454337236011112
EAR FOLDING	0.0294118	1.454337236011112
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	1.454337236011112
ALKAPTONURIA	0.0294118	1.454337236011112
OTOONYCHOPERONEAL SYNDROME	0.0294118	1.454337236011112
EAR WITHOUT HELIX	0.0294118	1.454337236011112
EAR MALFORMATION	0.0294118	1.454337236011112
HAIRY EARS, Y-LINKED	0.0294118	1.454337236011112
OSTEOMA OF MIDDLE EAR	0.0294118	1.454337236011112
MUSICAL PERFECT PITCH	0.0294118	1.454337236011112
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.02934275	1.450922892579341
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.02934275	1.450922892579341
HURLER SYNDROME	0.029295250000000002	1.4485741407616852
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.02928156	1.4478972057641335
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.02928156	1.4478972057641335
WAARDENBURG SYNDROME, TYPE IIB	0.02928156	1.4478972057641335
NAGER SYNDROME	0.029248889999999996	1.446281758987653
SNEDDON SYNDROME	0.02921508	1.4446099421675491
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0291161	1.4397156378536213
AGNATHIA-OTOCEPHALY COMPLEX	0.0291161	1.4397156378536213
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.029069430000000004	1.4374079273835165
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.028949810000000003	1.431493028595559
GAUCHER DISEASE, PERINATAL LETHAL	0.02876692	1.422449592386484
DISTAL MONOSOMY 10P	0.02873294	1.4207693695072428
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.02861335	1.4148559541414858
MICROPHTHALMIA, LENZ TYPE	0.02858296	1.4133532474522532
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	1.4019575981070544
DUBOWITZ SYNDROME	0.028161649999999996	1.3925205605407467
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.02815933	1.3924058425572319
DEAFNESS, X-LINKED 2	0.02811017	1.3899750080444748
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.02791896	1.38052016941176
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.373540173483754
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.373540173483754
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.373540173483754
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.373540173483754
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.373540173483754
GRISCELLI SYNDROME, TYPE 2; GS2	0.027777800000000002	1.373540173483754
NASAL BONES, ABSENCE OF	0.027777800000000002	1.373540173483754
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.027777800000000002	1.373540173483754
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.373540173483754
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.373540173483754
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.027777800000000002	1.373540173483754
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.373540173483754
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.027777800000000002	1.373540173483754
DIMPLES, FACIAL	0.027777800000000002	1.373540173483754
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.373540173483754
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.027777800000000002	1.373540173483754
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.027777800000000002	1.373540173483754
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.027777800000000002	1.373540173483754
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.373540173483754
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.027777800000000002	1.373540173483754
CYSTINOSIS, NEPHROPATHIC; CTNS	0.027777800000000002	1.373540173483754
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.027777800000000002	1.373540173483754
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.373540173483754
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.027777800000000002	1.373540173483754
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.027777800000000002	1.373540173483754
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.027777800000000002	1.373540173483754
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.373540173483754
DWARFISM, LEVI TYPE	0.027777800000000002	1.373540173483754
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	1.373540173483754
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.027777800000000002	1.373540173483754
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.373540173483754
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.373540173483754
MENKES DISEASE	0.027777800000000002	1.373540173483754
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.373540173483754
OROFACIAL CLEFT 3	0.027777800000000002	1.373540173483754
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.027777800000000002	1.373540173483754
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.373540173483754
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.027777800000000002	1.373540173483754
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.373540173483754
GAUCHER DISEASE, TYPE II	0.027777800000000002	1.373540173483754
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.373540173483754
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.027777800000000002	1.373540173483754
CLEFT CHIN	0.027777800000000002	1.373540173483754
REVESZ SYNDROME	0.027777800000000002	1.373540173483754
ALSTRÖM SYNDROME	0.0277603	1.372674843866723
MATERNAL PHENYLKETONURIA	0.027605640000000004	1.3650273079484359
311450 PALLISTER W SYNDROME;;W SYNDROME	0.027486109999999998	1.3591168594270797
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.02731105	1.350460596412368
GENITOPALATOCARDIAC SYNDROME	0.02721549	1.3457354022293115
PERMANENT NEONATAL DIABETES MELLITUS	0.027158450000000004	1.3429149221518573
TRANSIENT NEONATAL DIABETES MELLITUS	0.027158450000000004	1.3429149221518573
TRISOMY 18	0.02709544	1.3397992410564783
OCULOCEREBROCUTANEOUS SYNDROME	0.02709452	1.339753749442326
OSTEOGENESIS IMPERFECTA, TYPE V	0.027006139999999998	1.3353835876392854
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.02699997	1.3350784971400238
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.02699997	1.3350784971400238
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.02696827	1.3335110143480302
3Q29 MICRODELETION SYNDROME	0.026967650000000003	1.3334803569558842
WAARDENBURG SYNDROME	0.02690246	1.3302568805139265
CRANDALL SYNDROME	0.02684156	1.3272455334466584
ACROFRONTOFACIONASAL DYSOSTOSIS	0.026815799999999997	1.3259717682503886
HARTSFIELD SYNDROME	0.026815799999999997	1.3259717682503886
CORNELIA DE LANGE SYNDROME 1	0.0267591	1.3231681002912081
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.02667783	1.3191495095497157
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.02666432	1.3184814750853675
DEAFNESS-CRANIOFACIAL SYNDROME	0.02659044	1.314828300679296
SMITH-MAGENIS SYNDROME	0.026419230000000002	1.306362410180331
NEONATAL ADRENOLEUKODYSTROPHY	0.02629289	1.3001152248194334
XERODERMA PIGMENTOSUM	0.02627605	1.299282530490816
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02617284	1.2941790636466002
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02613497	1.292306490355345
FAMILIAL MELANOMA	0.02613497	1.292306490355345
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.02610632	1.2908898221537484
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.02593877	1.2826049091632594
OCULOFACIOCARDIODENTAL SYNDROME	0.025796009999999998	1.2755457973845534
XQ21 MICRODELETION SYNDROME	0.02568767	1.2701886653440309
VOCAL CORD PARALYSIS AND PTOSIS	0.025641000000000004	1.2678809548739258
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.025641000000000004	1.2678809548739258
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	0.025641000000000004	1.2678809548739258
DEND SYNDROME	0.025641000000000004	1.2678809548739258
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.025641000000000004	1.2678809548739258
MUNGAN SYNDROME	0.025641000000000004	1.2678809548739258
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.025641000000000004	1.2678809548739258
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.025641000000000004	1.2678809548739258
PURE MITOCHONDRIAL MYOPATHY	0.025641000000000004	1.2678809548739258
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.025641000000000004	1.2678809548739258
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.025641000000000004	1.2678809548739258
SCLERODERMA	0.0255452	1.2631438933132642
DE BARSY SYNDROME	0.02553223	1.2625025604485274
W SYNDROME	0.025521469999999997	1.26197050635257
RESTRICTIVE DERMOPATHY	0.025521469999999997	1.26197050635257
TRISOMY 8Q	0.02541044	1.2564803607880581
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.02541044	1.2564803607880581
PITT-HOPKINS SYNDROME	0.025185040000000002	1.2453349153206978
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.025177409999999997	1.244957631607672
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.02514364	1.2432877926838357
DILATED CARDIOMYOPATHY WITH ATAXIA	0.02514364	1.2432877926838357
RENPENNING SYNDROME 1; RENS1	0.02510547	1.2414003851705744
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.02508668	1.2404712683989163
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.025077699999999998	1.2400272306868627
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.02505445	1.2388775784813784
FRONTOFACIONASAL DYSPLASIA	0.025010749999999998	1.236716726809135
CORTICOBASAL SYNDROME	0.02490474	1.2314748072261945
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.02490474	1.2314748072261945
ABETA AMYLOIDOSIS, IOWA TYPE	0.02490474	1.2314748072261945
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.02487918	1.2302109315112622
HYPERTELORISM, TEEBI TYPE	0.02484226	1.2283853332563601
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.02482075	1.227321719538512
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.02482075	1.227321719538512
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.02477529	1.2250738404304988
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.02477325	1.2249729677208565
BRANCHIOOCULOFACIAL SYNDROME	0.02476182	1.2244077838624186
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.02475956	1.2242960327233048
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.02475956	1.2242960327233048
ALZHEIMER DISEASE 10	0.02467982	1.2203530965140443
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.02465347	1.219050157347829
CHROMOSOME 18Q DELETION SYNDROME	0.024616819999999998	1.2172379098927324
CHROMOSOME 17Q12 DELETION SYNDROME	0.024543109999999996	1.2135931415457972
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.024532349999999998	1.21306108744984
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.0245045	1.2116839771735934
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.024482939999999998	1.210617891085411
MEDULLOBLASTOMA	0.024482939999999998	1.210617891085411
3MC SYNDROME	0.02439507	1.2062729474597815
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.02435764	1.2044221310274688
COFFIN-LOWRY SYNDROME; CLS	0.024297930000000002	1.2014696263741589
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.02426173	1.1996796302520716
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.02419026	1.1961456240961168
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.02397413	1.1854585560887496
STICKLER SYNDROME, TYPE III	0.02396044	1.1847816210911977
GAPO SYNDROME	0.02396027	1.184773215032061
KOOLEN-DE VRIES SYNDROME; KDVS	0.02393685	1.1836151567674398
CHARLIE M SYNDROME	0.02378706	1.1762084297197208
INTELLECTUAL DISABILITY, WOLFF TYPE	0.02378706	1.1762084297197208
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.02378706	1.1762084297197208
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.02376821	1.1752763461036617
16P11.2P12.2 MICRODELETION SYNDROME	0.02374576	1.1741662518235276
DOUBLE OUTLET RIGHT VENTRICLE	0.02371642	1.1727154649113165
RESTRICTIVE DERMOPATHY, LETHAL	0.02371642	1.1727154649113165
TRISOMY 9P	0.023627469999999998	1.1683171180864642
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02358802	1.166366417892643
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02352959	1.1634772059198928
DISTAL TRISOMY 17Q	0.0234458	1.159334007713548
SHORT RIB-POLYDACTYLY SYNDROME	0.0234458	1.159334007713548
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0234458	1.159334007713548
RENAL AGENESIS, BILATERAL	0.0234458	1.159334007713548
TRIPLOIDY	0.0234458	1.159334007713548
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.02336852	1.1555127121247388
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.0233225	1.1532371424689805
JACOBSEN SYNDROME	0.023272960000000002	1.1507875179416824
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0232558	1.149939000442925
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.0232558	1.149939000442925
CINCA SYNDROME; CINCA	0.0232558	1.149939000442925
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.0232558	1.149939000442925
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.0232558	1.149939000442925
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.0232558	1.149939000442925
DEAFNESS, AUTOSOMAL DOMINANT 70	0.0232558	1.149939000442925
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.0232558	1.149939000442925
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.0232558	1.149939000442925
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.0232558	1.149939000442925
USHER SYNDROME, TYPE IV; USH4	0.0232558	1.149939000442925
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.0232558	1.149939000442925
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.0232558	1.149939000442925
PELIZAEUS-MERZBACHER DISEASE	0.02314673	1.1445457717955205
FAMILIAL TUMORAL CALCINOSIS	0.02312204	1.1433249153244065
HEART-HAND SYNDROME TYPE 2	0.02312204	1.1433249153244065
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.02279794	1.127299010816991
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.02279794	1.127299010816991
CHILDHOOD APRAXIA OF SPEECH	0.0227273	1.1238060460085866
BENCZE SYNDROME	0.0227273	1.1238060460085866
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.0227273	1.1238060460085866
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.0227273	1.1238060460085866
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.022686500000000002	1.121788591815737
SPINOCEREBELLAR ATAXIA 14	0.022686500000000002	1.121788591815737
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.022686500000000002	1.121788591815737
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.022686500000000002	1.121788591815737
BARAITSER-WINTER SYNDROME 2; BRWS2	0.022590020000000002	1.1170179060185284
CARTILAGE-HAIR HYPOPLASIA	0.02256348	1.1157055718450422
FREEMAN-SHELDON SYNDROME	0.02256106	1.1155859091208584
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02249288	1.1122145849329053
DISTAL MONOSOMY 7Q36	0.02245668	1.1104245888108182
PENTALOGY OF CANTRELL	0.02245668	1.1104245888108182
ANKYLOBLEPHARON FILIFORME ADNATUM-CLEFT PALATE SYNDROME	0.02245668	1.1104245888108182
VACTERL/VATER ASSOCIATION	0.02245668	1.1104245888108182
HEMIMELIA	0.02245668	1.1104245888108182
ANKYLOBLEPHARON FILIFORME ADNATUM-IMPERFORATE ANUS SYNDROME	0.02245668	1.1104245888108182
DYSRAPHISM-CLEFT LIP/PALATE-LIMB REDUCTION DEFECTS SYNDROME	0.02245668	1.1104245888108182
CONGENITAL LARYNGOMALACIA	0.02245668	1.1104245888108182
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.02245668	1.1104245888108182
CLEFT PALATE	0.02245668	1.1104245888108182
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.02245668	1.1104245888108182
ISOTRETINOIN-LIKE SYNDROME	0.02245668	1.1104245888108182
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.022398249999999998	1.107535376838068
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.02216814	1.0961570340852098
CADASIL	0.02194691	1.0852177843037365
CRI-DU-CHAT SYNDROME	0.02184893	1.0803729273964962
RAMOS-ARROYO SYNDROME	0.02182242	1.0790620766452108
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.02180357	1.078129993029152
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.02171723	1.073860703935754
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.0216333	1.069710583092473
METACHROMATIC LEUKODYSTROPHY	0.02162928	1.0695118045175893
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.0216009	1.0681084871157982
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.021587960000000003	1.0674686376732623
TRISOMY 4P	0.021587960000000003	1.0674686376732623
GYRATE ATROPHY OF CHOROID AND RETINA	0.02151745	1.063982101027727
SIMPSON-GOLABI-BEHMEL SYNDROME	0.021465150000000002	1.0613960016579715
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.02131499	1.053970979069778
CUTIS LAXA	0.021308320000000002	1.0536411648671724
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.021308320000000002	1.0536411648671724
%608572 BURN-MCKEOWN SYNDROME	0.02130801	1.0536258361710993
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.021192350000000002	1.0479067491136242
MYOCLONIC EPILEPSY OF INFANCY	0.021097880000000003	1.0432354526038572
MYOCLONIC-ASTASTIC EPILEPSY	0.021097880000000003	1.0432354526038572
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.021097880000000003	1.0432354526038572
ADIPOSIS DOLOROSA	0.02108361	1.0425298381104267
JUBERG-HAYWARD SYNDROME	0.02107257	1.0419839387405967
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.02102507	1.0396351869229408
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02098912	1.0378575526525258
MANITOBA OCULOTRICHOANAL SYNDROME	0.02098912	1.0378575526525258
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0208333	1.0301526577424809
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	1.0301526577424809
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	1.0301526577424809
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	1.0301526577424809
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	1.0301526577424809
PUPIL, EGG-SHAPED	0.0208333	1.0301526577424809
HYPERCALCEMIA, INFANTILE, 1	0.0208333	1.0301526577424809
DERMOIDS OF CORNEA	0.0208333	1.0301526577424809
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	1.0301526577424809
MYELINATED OPTIC NERVE FIBERS	0.0208333	1.0301526577424809
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	1.0301526577424809
CLEFT LIP-RETINOPATHY SYNDROME	0.0208333	1.0301526577424809
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0208333	1.0301526577424809
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0208333	1.0301526577424809
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	1.0301526577424809
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	1.0301526577424809
POLYARTERITIS NODOSA	0.0208333	1.0301526577424809
UNIQUE GREEN PHENOMENON	0.0208333	1.0301526577424809
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	1.0301526577424809
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	1.0301526577424809
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	1.0301526577424809
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	1.0301526577424809
AUTOSOMAL RECESSIVE AMELIA	0.0208333	1.0301526577424809
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	1.0301526577424809
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	1.0301526577424809
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.0208333	1.0301526577424809
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	1.0301526577424809
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	1.0301526577424809
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	1.0301526577424809
GAUCHER DISEASE, TYPE I	0.0208333	1.0301526577424809
PREPAPILLARY VASCULAR LOOPS	0.0208333	1.0301526577424809
IMINOGLYCINURIA	0.0208333	1.0301526577424809
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.0208333	1.0301526577424809
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	1.0301526577424809
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	1.0301526577424809
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	1.0301526577424809
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	1.0301526577424809
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	1.0301526577424809
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	1.0301526577424809
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	1.0301526577424809
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	1.0301526577424809
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.0208333	1.0301526577424809
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.020820130000000003	1.029501435396407
SPINOCEREBELLAR ATAXIA TYPE 17	0.020820130000000003	1.029501435396407
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.020820130000000003	1.029501435396407
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.02059884	1.0185592187705321
ENDOCARDIAL FIBROELASTOSIS	0.02059884	1.0185592187705321
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.020595210000000003	1.0183797246842567
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.02048826	1.0130913245390296
MONOSOMY 18P	0.02033416	1.0054714791684873
LATERAL MENINGOCELE SYNDROME	0.02032459	1.0049982674864881
ACRO-RENAL-MANDIBULAR SYNDROME	0.02032355	1.004946842183533
MONOSOMY 9Q22.3	0.02032355	1.004946842183533
TONNE-KALSCHEUER SYNDROME; TOKAS	0.02017484	0.9975935183350364
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.02009595	0.9936926124214605
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.02008345	0.9930745198378668
JOUBERT SYNDROME	0.02008345	0.9930745198378668
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.02004551	0.9911984852281434
FEINGOLD SYNDROME	0.02002226	0.9900488330226593
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02	0.9889481337497958
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.9889481337497958
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.9889481337497958
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02	0.9889481337497958
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.9889481337497958
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	0.9889481337497958
TRICHODENTOOSSEOUS SYNDROME	0.02	0.9889481337497958
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02	0.9889481337497958
HAIR WHORL	0.02	0.9889481337497958
NEVUS COMEDONICUS SYNDROME	0.02	0.9889481337497958
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02	0.9889481337497958
DARIER DISEASE	0.02	0.9889481337497958
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.9889481337497958
CATATRICHY	0.02	0.9889481337497958
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	0.9889481337497958
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	0.9889481337497958
DISSECTING CELLULITIS OF THE SCALP	0.02	0.9889481337497958
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.9889481337497958
VAN BOGAERT-HOZAY SYNDROME	0.02	0.9889481337497958
JUVENILE HYALINE FIBROMATOSIS	0.02	0.9889481337497958
KNOBLOCH SYNDROME	0.02	0.9889481337497958
HAIRY NOSE TIP	0.02	0.9889481337497958
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.9889481337497958
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.9889481337497958
WERNER SYNDROME; WRN	0.02	0.9889481337497958
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.9889481337497958
MIDPHALANGEAL HAIR	0.02	0.9889481337497958
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	0.9889481337497958
RINGED HAIR	0.02	0.9889481337497958
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.01990296	0.9841497574048418
HOLOPROSENCEPHALY 5; HPE5	0.01950762	0.9646012196450094
MCDONOUGH SYNDROME	0.019503270000000003	0.9643861234259192
JACKSON-WEISS SYNDROME	0.01950327	0.964386123425919
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.01945577	0.9620373716082632
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.01942725	0.960627131569536
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.01941023	0.9597855367077148
AICARDI SYNDROME; AIC	0.01927043	0.952872789252804
CRANIOFRONTONASAL SYNDROME; CFNS	0.01909098	0.9439994521227337
MELAS	0.019006469999999998	0.9398206517835739
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.01891384	0.935240338502112
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.01891384	0.935240338502112
RAYNAUD-CLAES SYNDROME; MRXSRC	0.01881282	0.9302451614785416
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.01875885	0.9275764849396179
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.01875425	0.9273490268688555
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0186271	0.9210617891085411
NEUROFERRITINOPATHY	0.01857678	0.9185735956040266
HUNTINGTON DISEASE	0.01857678	0.9185735956040266
SERKAL SYNDROME	0.0185185	0.9156918007422796
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.0185185	0.9156918007422796
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0185185	0.9156918007422796
INIENCEPHALY	0.0185185	0.9156918007422796
BOWEN-CONRADI SYNDROME	0.0185185	0.9156918007422796
KAPUR-TORIELLO SYNDROME	0.0185185	0.9156918007422796
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.0185185	0.9156918007422796
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.0185185	0.9156918007422796
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0185185	0.9156918007422796
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.0185185	0.9156918007422796
CAUDAL REGRESSION SEQUENCE	0.0185185	0.9156918007422796
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.0185185	0.9156918007422796
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01851415	0.9154767045231891
6P22 MICRODELETION SYNDROME	0.01846665	0.9131279527055334
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.01845296	0.9124510177079816
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.018263300000000003	0.9030728225556324
AARSKOG-SCOTT SYNDROME	0.01813273	0.8966164746644467
CORNELIA DE LANGE SYNDROME	0.01809347	0.8946751694778959
APERT SYNDROME	0.01808087	0.8940521321536334
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.01807702	0.8938617596378866
HUNTINGTON DISEASE-LIKE 1	0.01803757	0.8919110594440652
ACERULOPLASMINEMIA	0.01803757	0.8919110594440652
PROGRESSIVE SUPRANUCLEAR PALSY	0.01803757	0.8919110594440652
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.01801859	0.8909725476651367
MOEBIUS SYNDROME; MBS	0.01799529	0.8898204230893181
22Q11.2 MICRODUPLICATION SYNDROME	0.01795172	0.8876659995799443
DYSOSTOSIS, STANESCU TYPE	0.01793832	0.8870034043303319
WHITE FORELOCK WITH MALFORMATIONS	0.01793832	0.8870034043303319
TEMTAMY SYNDROME	0.01793832	0.8870034043303319
TREACHER-COLLINS SYNDROME	0.01777251	0.878804529827479
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.01765026	0.8727595843599336
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.01763657	0.8720826493623818
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.01763657	0.8720826493623818
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.01763657	0.8720826493623818
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.017630800000000002	0.8717973378257952
WIEDEMANN-STEINER SYNDROME; WDSTS	0.01757575	0.8690752580876487
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.01754773	0.8676897417522653
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.017542710000000003	0.8674415157706941
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.017542710000000003	0.8674415157706941
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.017542710000000003	0.8674415157706941
SHORT SYNDROME	0.017509030000000002	0.8657761271134594
ISOLATED CEREBELLAR AGENESIS	0.01731894	0.8563766695762344
HISTIDINEMIA	0.01731894	0.8563766695762344
ARGININEMIA	0.01731894	0.8563766695762344
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.01731894	0.8563766695762344
HISTIDINEMIA	0.01731894	0.8563766695762344
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.01728394	0.8546460103421724
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.0172824	0.8545698613358734
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.8525425176616865
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.8525425176616865
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.8525425176616865
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.8525425176616865
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.8525425176616865
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.8525425176616865
TRANSSEXUALITY	0.0172414	0.8525425176616865
MOTION SICKNESS	0.0172414	0.8525425176616865
PALMOMENTAL REFLEX	0.0172414	0.8525425176616865
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.8525425176616865
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.8525425176616865
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.8525425176616865
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.8525425176616865
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.8525425176616865
SICKLE CELL ANEMIA	0.0172414	0.8525425176616865
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.8525425176616865
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.8525425176616865
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.8525425176616865
JUMPING FRENCHMAN OF MAINE	0.0172414	0.8525425176616865
ERYTHERMALGIA, PRIMARY	0.0172414	0.8525425176616865
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.8525425176616865
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.8525425176616865
DIASTEMATOMYELIA	0.0172414	0.8525425176616865
CARDIAC ARRHYTHMIA	0.0172414	0.8525425176616865
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.8525425176616865
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.8525425176616865
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.8525425176616865
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.8525425176616865
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.8525425176616865
269800 SENILE PLAQUE FORMATION	0.0172414	0.8525425176616865
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.8525425176616865
THUMBS, CONGENITAL CLASPED	0.0172414	0.8525425176616865
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.8525425176616865
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.8525425176616865
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.8525425176616865
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.8525425176616865
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.8525425176616865
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.8525425176616865
RHEUMATOID ARTHRITIS	0.0172414	0.8525425176616865
CERVICAL RIB	0.0172414	0.8525425176616865
MOSAIC TRISOMY 15	0.0172414	0.8525425176616865
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.8525425176616865
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.8525425176616865
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.8525425176616865
MYOPATHY, CONGENITAL	0.0172414	0.8525425176616865
ALCOHOL DEPENDENCE	0.0172414	0.8525425176616865
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.8525425176616865
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.8525425176616865
WITTEVEEN-KOLK SYNDROME	0.017230699999999998	0.8520134304101302
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.01716091	0.8485624958974104
OPTICOCOCHLEODENTATE DEGENERATION	0.01706215	0.843679070012954
RING CHROMOSOME 8 SYNDROME	0.0169492	0.838093985427602
PEHO SYNDROME	0.0169492	0.838093985427602
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.0169492	0.838093985427602
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.0169492	0.838093985427602
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0169492	0.838093985427602
GRANT SYNDROME	0.0169492	0.838093985427602
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.0169492	0.838093985427602
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0169492	0.838093985427602
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.0169492	0.838093985427602
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0169492	0.838093985427602
GAMMA-HEAVY CHAIN DISEASE	0.0169492	0.838093985427602
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.016857800000000003	0.8335744924563656
RECOMBINANT 8 SYNDROME	0.016838739999999998	0.8326320248849017
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01681231	0.8313251299261516
LENNOX-GASTAUT SYNDROME	0.016787540000000004	0.8301003176625025
MYXEDEMA	0.01677327	0.8293947031690719
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.01672351	0.8269342002123025
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.01666025	0.8238061572652519
KNOBLOCH SYNDROME 1; KNO1	0.016552700000000004	0.8184880886760124
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.01650699	0.8162278477163271
SHORT SYNDROME	0.01648426	0.8151039081623205
KEIPERT SYNDROME	0.016479399999999998	0.8148635937658192
SOTOS SYNDROME	0.01642047	0.8119496580897254
ATAXIA WITH VITAMIN E DEFICIENCY	0.01635854	0.8088873801935693
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.01635854	0.8088873801935693
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.01635854	0.8088873801935693
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.01635854	0.8088873801935693
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.01635854	0.8088873801935693
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.0162373	0.8028923766067779
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.01615814	0.7989781198933963
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.01613281	0.7977256170820022
HUNTINGTON DISEASE-LIKE 2	0.01613281	0.7977256170820022
CREUTZFELDT-JAKOB DISEASE; CJD	0.01613281	0.7977256170820022
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.01613281	0.7977256170820022
ALZHEIMER DISEASE 3; AD	0.01613281	0.7977256170820022
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.01613281	0.7977256170820022
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.01613281	0.7977256170820022
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.01613281	0.7977256170820022
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.01613281	0.7977256170820022
ALZHEIMER DISEASE 4	0.01613281	0.7977256170820022
3MC SYNDROME 2	0.01600054	0.791185208599448
WOLF-HIRSCHHORN SYNDROME	0.01600054	0.791185208599448
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.015957449999999998	0.7890545198452839
LAMELLAR ICHTHYOSIS	0.015957449999999998	0.7890545198452839
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.01588037	0.7852431137378123
ZTTK SYNDROME; ZTTKS	0.01587625	0.7850393904222599
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.01580656	0.7815934006502088
BARATELA-SCOTT SYNDROME	0.0156877	0.7757160818913335
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.01562836	0.772781872778498
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0156156	0.7721509238691655
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0156156	0.7721509238691655
3MC SYNDROME 1	0.015567770000000002	0.769785854407303
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0155659	0.7696933877567974
AYME-GRIPP SYNDROME; AYGRP	0.01551781	0.7673154619691959
VAN DER WOUDE SYNDROME	0.015464519999999999	0.7646804096668195
BILATERAL POLYMICROGYRIA	0.015456720000000002	0.7642947198946572
SPINOCEREBELLAR ATAXIA TYPE 27	0.01537764	0.7603844189738105
CITRULLINEMIA TYPE II	0.01537764	0.7603844189738105
MANGANESE POISONING	0.01537764	0.7603844189738105
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.01535023	0.7590290655565064
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.015323509999999999	0.7577078308498165
PALLISTER-KILLIAN SYNDROME	0.01496473	0.7399670902784791
FAMILIAL COLORECTAL CANCER TYPE X	0.01494864	0.7391714815048773
BEHÇET DISEASE	0.01494864	0.7391714815048773
CHOREOACANTHOCYTOSIS	0.01494864	0.7391714815048773
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.01494864	0.7391714815048773
LYNCH SYNDROME	0.01494864	0.7391714815048773
3C SYNDROME	0.014929200000000002	0.7382102239188727
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.014870770000000002	0.7353210119461226
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.014809580000000001	0.7322953251309151
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0148038	0.7320095191202614
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.014794400000000001	0.7315447134973989
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.014760740000000001	0.7298803137882981
PYCNODYSOSTOSIS	0.014760740000000001	0.7298803137882981
RECESSIVE X-LINKED ICHTHYOSIS	0.01468198	0.7259858360375914
HEMIFACIAL MICROSOMIA	0.01451746	0.7178507486893655
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.01451746	0.7178507486893655
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.01449972	0.7169735516947295
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.014486510000000001	0.7163203514523877
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.01448309	0.7161512413215165
ACROCALLOSAL SYNDROME; ACLS	0.014435589999999998	0.7138024895038606
MENTAL RETARDATION, X-LINKED 102	0.014416120000000001	0.7128397484956553
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.01438326	0.7112149067119043
FRASER SYNDROME	0.014344079999999999	0.7092775573178884
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.014309350000000002	0.7075602488836321
ABETA AMYLOIDOSIS, DUTCH TYPE	0.014266440000000002	0.7054384606626719
ABETAL34V AMYLOIDOSIS	0.014266440000000002	0.7054384606626719
SPINOCEREBELLAR ATAXIA TYPE 12	0.014266440000000002	0.7054384606626719
ADULT POLYGLUCOSAN BODY DISEASE	0.014266440000000002	0.7054384606626719
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.014266440000000002	0.7054384606626719
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.014238240000000001	0.7040440437940847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.01422099	0.7031910760287254
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014218340000000001	0.7030600404010036
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.014212569999999999	0.7027747288644167
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0142099	0.7026427042885611
BRITTLE CORNEA SYNDROME	0.01415435	0.6998959008470711
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.01406486	0.6954708524226076
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.01406168	0.6953136096693414
CRIGLER-NAJJAR SYNDROME TYPE 1	0.01406051	0.6952557562035171
PRIMARY PROGRESSIVE FREEZING GAIT	0.014041520000000002	0.6943167499505217
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.014041520000000002	0.6943167499505217
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.014041520000000002	0.6943167499505217
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.014041520000000002	0.6943167499505217
ACROOSTEOLYSIS DOMINANT TYPE	0.01403461	0.6939750683703111
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.01400498	0.6925099417101608
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.01400282	0.6924031353117157
OROFACIODIGITAL SYNDROME VI	0.01400282	0.6924031353117157
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01400282	0.6924031353117157
PETERS PLUS SYNDROME	0.01400282	0.6924031353117157
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01399763	0.6921465032710078
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.013952960000000002	0.6899376876142777
15Q26 OVERGROWTH SYNDROME	0.013820460000000001	0.6833859062281852
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.01378294	0.6815306395292705
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.013780299999999999	0.6814000983756154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.01377219	0.6809990799073801
MONOSOMY X	0.01375974	0.6803834596941207
MOSAIC MONOSOMY X	0.01375974	0.6803834596941207
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.01375974	0.6803834596941207
TURNER SYNDROME	0.01375974	0.6803834596941207
WORSTER-DROUGHT SYNDROME	0.01370041	0.6774497450553519
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.01368738	0.676805445346214
ELSAHY-WATERS SYNDROME; ESWS	0.01368738	0.676805445346214
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.01368738	0.676805445346214
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.01367279	0.6760840076826435
POPLITEAL PTERYGIUM SYNDROME	0.01365384	0.6751469793259156
SIALURIA	0.01359206	0.6720921185407625
RICHARDS-RUNDLE SYNDROME	0.013565650000000002	0.6707862125301459
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.013565650000000002	0.6707862125301459
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.013565650000000002	0.6707862125301459
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013551960000000002	0.6701092775325942
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.013551960000000002	0.6701092775325942
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.013551960000000002	0.6701092775325942
DE SANCTIS-CACCHIONE SYNDROME	0.013551960000000002	0.6701092775325942
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0135353	0.6692854837371806
REFSUM DISEASE	0.013514020000000002	0.6682332429228708
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.01350571	0.6678223349732978
WEAVER SYNDROME	0.013470860000000001	0.6660990928502387
KLEEFSTRA SYNDROME	0.013461009999999999	0.6656120358943669
ASPARTYLGLUCOSAMINURIA	0.01340553	0.662868693771345
OTOFACIOCERVICAL SYNDROME	0.013401380000000001	0.662663487033592
ALOPECIA ANTIBODY DEFICIENCY	0.013401380000000001	0.662663487033592
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.01338088	0.6616498151964983
16P13.11 MICRODELETION SYNDROME	0.0133729	0.6612552248911322
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01333314	0.6592891960012376
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.013305820000000001	0.6579382928505354
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.013305820000000001	0.6579382928505354
LOEYS-DIETZ SYNDROME 5	0.013287690000000001	0.6570418113672913
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.01327643	0.6564850335679902
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.013257550000000002	0.6555514665297304
ZIMMERMANN-LABAND SYNDROME	0.0132265	0.6540161245520837
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01318326	0.6518780186869166
COCKAYNE SYNDROME A; CSA	0.013133240000000001	0.6494046594044085
3Q29 MICRODUPLICATION SYNDROME	0.013083359999999999	0.6469382227588363
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.01308227	0.646884325085547
SIMOSA CRANIOFACIAL SYNDROME	0.01307574	0.6465614335198777
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.01304678	0.645129436622208
GABRIELE-DE VRIES SYNDROME	0.01303934	0.6447615479164531
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.0130137	0.6434937164089859
KAPUR-TORIELLO SYNDROME	0.0130137	0.6434937164089859
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0130137	0.6434937164089859
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.01294689	0.6401901351681947
ROBERTS SYNDROME; RBS	0.01291814	0.6387685222259293
CHROMOSOME 10Q26 DELETION SYNDROME	0.01290667	0.6382013604712239
CEREBROTENDINOUS XANTHOMATOSIS	0.01285735	0.6357626143733969
COFFIN-LOWRY SYNDROME	0.012844940000000001	0.6351489720564051
COFFIN-SIRIS SYNDROME	0.012843259999999999	0.63506590041317
KABUKI SYNDROME 1	0.012843259999999999	0.63506590041317
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.012816939999999999	0.6337644446691554
22Q11.2 DELETION SYNDROME	0.012801510000000002	0.6330014711839675
JOHNSON NEUROECTODERMAL SYNDROME	0.012787300000000001	0.6322988235349383
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.012738639999999999	0.6298927127255249
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.012734480000000001	0.6296870115137051
SAY SYNDROME	0.012734480000000001	0.6296870115137051
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.01270879	0.6284167076359033
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.01268026	0.6270059731231092
PHELAN-MCDERMID SYNDROME	0.01268026	0.6270059731231092
POLYVALVULAR HEART DISEASE SYNDROME	0.012676050000000001	0.626797799540955
ADAMS-OLIVER SYNDROME 1; AOS1	0.01266383	0.6261935522312339
BOHRING-OPITZ SYNDROME	0.012630539999999999	0.6245474480626073
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.01262855	0.6244490477232992
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.01261486	0.6237721127257474
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.01261486	0.6237721127257474
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.01261486	0.6237721127257474
ADULT SYNDROME	0.01260411	0.6232405531038568
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.01259216	0.6226496565939414
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.01257821	0.621959865270651
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0125579	0.620955588440828
H SYNDROME	0.0125579	0.620955588440828
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01254618	0.6203760648344506
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.01254618	0.6203760648344506
MACHADO-JOSEPH DISEASE TYPE 3	0.01254306	0.6202217889255857
MACHADO-JOSEPH DISEASE TYPE 1	0.01254306	0.6202217889255857
MACHADO-JOSEPH DISEASE TYPE 2	0.01254306	0.6202217889255857
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.012520670000000001	0.6191146614898528
DISTAL MONOSOMY 19P13.3	0.01248601	0.6174008143740645
DESBUQUOIS DYSPLASIA 2; DBQD2	0.012456710000000001	0.615952005358121
21Q22.11Q22.12 MICRODELETION SYNDROME	0.012425640000000002	0.6144156744323407
SPINOCEREBELLAR ATAXIA TYPE 21	0.01242157	0.6142144234871225
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.01242157	0.6142144234871225
MONOAMINE OXIDASE A DEFICIENCY	0.01242157	0.6142144234871225
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012398880000000001	0.6130924618293835
ACROCRANIOFACIAL DYSOSTOSIS	0.012340630000000002	0.6102121503898372
MENTAL RETARDATION, X-LINKED 105; MRX105	0.01226843	0.6066420476270004
ANGELMAN SYNDROME	0.01226843	0.6066420476270004
MARSHALL SYNDROME	0.012253739999999999	0.6059156652227611
PETERS-PLUS SYNDROME; PTRPLS	0.012230850000000001	0.6047838140836845
3MC SYNDROME 3	0.012230850000000001	0.6047838140836845
CHARGE SYNDROME	0.01223085	0.6047838140836844
DISTAL MONOSOMY 15Q	0.01220755	0.6036316895078659
SPINOCEREBELLAR ATAXIA TYPE 28	0.01220325	0.6034190656591099
WERNICKE-KORSAKOFF SYNDROME	0.01220325	0.6034190656591099
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.01220325	0.6034190656591099
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01219665	0.6030927127749723
MUSCLE-EYE-BRAIN DISEASE	0.01219665	0.6030927127749723
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.01219665	0.6030927127749723
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.01219665	0.6030927127749723
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.01219479	0.6030007405985336
SEVERE COMBINED IMMUNODEFICIENCY	0.0121811	0.6023238056009819
ERYTHROKERATODERMIA VARIABILIS	0.01215692	0.6011281673072784
WALDENSTRÖM MACROGLOBULINEMIA	0.01215575	0.601070313841454
CRIGLER-NAJJAR SYNDROME	0.01215575	0.601070313841454
4Q21 MICRODELETION SYNDROME	0.01214912	0.6007424775351159
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.012135030000000002	0.6000457635748893
8Q21.11 MICRODELETION SYNDROME	0.01204941	0.5958120766143062
METACHROMATIC LEUKODYSTROPHY	0.012048200000000002	0.5957522452522146
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.012048200000000002	0.5957522452522146
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.012048200000000002	0.5957522452522146
LINEAR VERRUCOUS NEVUS SYNDROME	0.012048200000000002	0.5957522452522146
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.012048200000000002	0.5957522452522146
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.012048200000000002	0.5957522452522146
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.012048200000000002	0.5957522452522146
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.012048200000000002	0.5957522452522146
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.012048200000000002	0.5957522452522146
KURU, SUSCEPTIBILITY TO	0.012048200000000002	0.5957522452522146
MELANOSIS, NEUROCUTANEOUS; NCMS	0.012048200000000002	0.5957522452522146
SNEDDON SYNDROME	0.012048200000000002	0.5957522452522146
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.012048200000000002	0.5957522452522146
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.012048200000000002	0.5957522452522146
EARLY-ONSET LAFORA BODY DISEASE	0.012048200000000002	0.5957522452522146
ENCEPHALITIS LETHARGICA	0.012048200000000002	0.5957522452522146
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.012048200000000002	0.5957522452522146
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.012048200000000002	0.5957522452522146
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.012048200000000002	0.5957522452522146
SPINOCEREBELLAR ATAXIA TYPE 7	0.012048200000000002	0.5957522452522146
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.012048200000000002	0.5957522452522146
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.012048200000000002	0.5957522452522146
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.012048200000000002	0.5957522452522146
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.012048200000000002	0.5957522452522146
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012048200000000002	0.5957522452522146
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.012048200000000002	0.5957522452522146
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.012048200000000002	0.5957522452522146
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.012048200000000002	0.5957522452522146
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.012048200000000002	0.5957522452522146
SIALIDOSIS TYPE 1	0.01201541	0.5941308647869318
AURICULOCONDYLAR SYNDROME	0.012010970000000001	0.5939113183012392
AICARDI-GOUTIÈRES SYNDROME	0.01201026	0.5938762106424911
BARDET-BIEDL SYNDROME 1; BBS1	0.011969220000000001	0.5918468890720366
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.01188233	0.5875504039049606
CRANIOLENTICULOSUTURAL DYSPLASIA	0.01188233	0.5875504039049606
BARDET-BIEDL SYNDROME	0.011869510000000002	0.586916488151227
COHEN SYNDROME	0.011855820000000001	0.5862395531536753
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.011840640000000001	0.5854889415201592
DIGEORGE SYNDROME; DGS	0.01182245	0.5845894931925136
1P36 DELETION SYNDROME	0.01181927	0.5844322504392474
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01172569	0.5798049621214322
MEESTER-LOEYS SYNDROME; MRLS	0.01172274	0.5796590922717041
GAPO SYNDROME; GAPOS	0.01166646	0.5768761922233321
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.011615720000000001	0.5743672308080089
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.01154256	0.5707496585347521
LOEYS-DIETZ SYNDROME 3; LDS3	0.01154107	0.5706759818987878
ADRENOLEUKODYSTROPHY	0.01151646	0.5694590812202086
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.01150077	0.568683251409282
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.011472300000000001	0.5672754837408892
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.01140842	0.5641167834016924
ACROCRANIOFACIAL DYSOSTOSIS	0.011351510000000002	0.5613027314871073
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.011341180000000001	0.5607919397760255
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.01133771	0.56062035727482
WOLFRAM SYNDROME	0.01130861	0.5591814377402139
KOOLEN-DE VRIES SYNDROME	0.01128794	0.5581593598439836
KERATODERMA HEREDITARIUM MUTILANS	0.01128128	0.5578300401154448
20Q11.2 MICRODELETION SYNDROME	0.0112785	0.5576925763248536
COFFIN-SIRIS SYNDROME 1; CSS1	0.011250170000000002	0.556291731293397
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.011234290000000001	0.5555065064751997
NAIL-PATELLA SYNDROME	0.01122804	0.5551974601834029
ACROCARDIOFACIAL SYNDROME	0.011113089999999999	0.5495134807846759
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.011113089999999999	0.5495134807846759
FRYNS SYNDROME; FRNS	0.011113089999999999	0.5495134807846759
BOHRING-OPITZ SYNDROME	0.011113089999999999	0.5495134807846759
MOWAT-WILSON SYNDROME	0.011113089999999999	0.5495134807846759
BASAL CELL NEVUS SYNDROME	0.011113089999999999	0.5495134807846759
HYPOPLASMINOGENEMIA	0.0111111	0.5494150804453678
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	0.5494150804453678
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.5494150804453678
DERMAL RIDGES, PATTERNLESS	0.0111111	0.5494150804453678
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0111111	0.5494150804453678
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	0.5494150804453678
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.5494150804453678
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.5494150804453678
KYRLE DISEASE	0.0111111	0.5494150804453678
SYRINGOMAS, MULTIPLE	0.0111111	0.5494150804453678
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.5494150804453678
CURRY-JONES SYNDROME	0.0111111	0.5494150804453678
TRICHILEMMAL CYST 1	0.0111111	0.5494150804453678
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	0.5494150804453678
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	0.5494150804453678
PRENATAL BOWING	0.0111111	0.5494150804453678
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.5494150804453678
KERATOSIS, FAMILIAL ACTINIC	0.0111111	0.5494150804453678
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.5494150804453678
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.5494150804453678
GLOMUVENOUS MALFORMATIONS	0.0111111	0.5494150804453678
SCALP-EAR-NIPPLE SYNDROME	0.0111111	0.5494150804453678
131600 EPIDERMOID CYSTS	0.0111111	0.5494150804453678
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.5494150804453678
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	0.5494150804453678
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.5494150804453678
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.5494150804453678
FUTCHER LINE	0.0111111	0.5494150804453678
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.5494150804453678
ACROMIAL DIMPLES	0.0111111	0.5494150804453678
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.5494150804453678
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.5494150804453678
CAROTENEMIA, FAMILIAL	0.0111111	0.5494150804453678
CIRCUMVALLATE PLACENTA SYNDROME	0.0111111	0.5494150804453678
PILONIDAL SINUS	0.0111111	0.5494150804453678
MARFANOID HYPERMOBILITY SYNDROME	0.0111111	0.5494150804453678
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	0.5494150804453678
CAMOS SYNDROME	0.0111111	0.5494150804453678
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0111111	0.5494150804453678
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.5494150804453678
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.5494150804453678
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.5494150804453678
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	0.5494150804453678
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.5494150804453678
GM1 GANGLIOSIDOSIS	0.0111111	0.5494150804453678
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.5494150804453678
LENTIGINES	0.0111111	0.5494150804453678
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.5494150804453678
PSEUDOATROPHODERMA COLLI	0.0111111	0.5494150804453678
FASCIAL DYSTROPHY, CONGENITAL	0.0111111	0.5494150804453678
LICHEN PLANUS, FAMILIAL	0.0111111	0.5494150804453678
PIGMENTED PURPURIC ERUPTION	0.0111111	0.5494150804453678
PARANA HARD-SKIN SYNDROME	0.0111111	0.5494150804453678
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.5494150804453678
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.01103136	0.5454721442361075
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.01103136	0.5454721442361075
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.010996460000000001	0.543746429742714
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.01099517	0.5436826425880871
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.01098225	0.5430437820936848
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.01095444	0.5416686497137055
THOMAS SYNDROME	0.010953500000000001	0.5416221691514195
CHROMOSOME 15Q25 DELETION SYNDROME	0.010953500000000001	0.5416221691514195
DIAMOND-BLACKFAN ANEMIA 1	0.0109535	0.5416221691514194
CEREBROFACIOTHORACIC DYSPLASIA	0.0109535	0.5416221691514194
GIANT CELL ARTERITIS	0.01092382	0.5401545701209347
MECKEL SYNDROME 12; MKS12	0.01089321	0.5386409850022307
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.01089321	0.5386409850022307
19P13.12 MICRODELETION SYNDROME	0.01087539	0.5377598322150596
PHENYLKETONURIA	0.01087431	0.5377064290158371
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.01086263	0.5371288833057272
TEMPLE SYNDROME	0.01083333	0.5356800742897838
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.01083333	0.5356800742897838
TEMPLE SYNDROME	0.01083333	0.5356800742897838
KLEEFSTRA SYNDROME 2; KLEFS2	0.01083333	0.5356800742897838
GALLOWAY-MOWAT SYNDROME	0.010811600000000001	0.5346055821424647
TETRASOMY X	0.010811600000000001	0.5346055821424647
DISTAL MONOSOMY 9P	0.01074998	0.5315586329423815
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.010733620000000001	0.5307496733689742
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.01072872	0.5305073810762055
LATERAL MENINGOCELE SYNDROME	0.010717250000000001	0.5299402193215
VASCULAR EHLERS-DANLOS SYNDROME	0.01070821	0.529493214765045
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.01067734	0.5279667733206023
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.01067734	0.5279667733206023
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.01067734	0.5279667733206023
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01067669	0.5279346325062554
MENTAL RETARDATION, X-LINKED 90	0.01067669	0.5279346325062554
9Q33.3Q34.11 MICRODELETION SYNDROME	0.01067669	0.5279346325062554
LANDAU-KLEFFNER SYNDROME	0.01067669	0.5279346325062554
HOLMES-GANG SYNDROME	0.010658460000000002	0.5270332062823425
DESANTO-SHINAWI SYNDROME	0.01065443	0.5268339332333918
VICI SYNDROME; VICIS	0.010652209999999999	0.5267241599905456
STICKLER SYNDROME	0.010652209999999999	0.5267241599905456
ACRODERMATITIS ENTEROPATHICA	0.01063947	0.5260942000293469
TRICHODYSPLASIA-XERODERMA SYNDROME	0.01063947	0.5260942000293469
AUTOSOMAL RECESSIVE HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.01063947	0.5260942000293469
JUVENILE DERMATOMYOSITIS	0.01063947	0.5260942000293469
OMENN SYNDROME	0.01063947	0.5260942000293469
190360 TRICHODYSPLASIA-XERODERMA	0.01063947	0.5260942000293469
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.01063947	0.5260942000293469
TRANSGREDIENS ET PROGREDIENS PALMOPLANTAR KERATODERMA	0.01063947	0.5260942000293469
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.01063947	0.5260942000293469
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.01063947	0.5260942000293469
SÉZARY SYNDROME	0.01063947	0.5260942000293469
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.0106383	0.5260363465635226
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0106383	0.5260363465635226
OBESITY DUE TO SIM1 DEFICIENCY	0.0106383	0.5260363465635226
POSTERIOR CORTICAL ATROPHY	0.0106383	0.5260363465635226
SPASTIC PARAPLEGIA TYPE 7	0.0106383	0.5260363465635226
PITUICYTOMA	0.0106383	0.5260363465635226
SPINOCEREBELLAR ATAXIA TYPE 1	0.0106383	0.5260363465635226
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0106383	0.5260363465635226
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0106383	0.5260363465635226
GLIOBLASTOMA	0.0106383	0.5260363465635226
LYME DISEASE	0.0106383	0.5260363465635226
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0106383	0.5260363465635226
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.01059039	0.523667321309125
MONOSOMY 9P	0.01059039	0.523667321309125
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.010576980000000001	0.5230042315854457
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.010567130000000001	0.522517174629574
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.01055252	0.5217947480178697
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.010551950000000001	0.521766562996058
SAETHRE-CHOTZEN SYNDROME	0.010535580000000001	0.5209571089485837
FLOATING-HARBOR SYNDROME	0.01051165	0.5197738325065521
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.01048318	0.5183660648381592
RETT SYNDROME	0.01048318	0.5183660648381592
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.01048318	0.5183660648381592
CEDNIK SYNDROME	0.01047077	0.5177524225211675
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.01044602	0.5165285992056521
STICKLER SYNDROME, TYPE II	0.01043233	0.5158516642081004
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.01043233	0.5158516642081004
2Q33.1 DELETION SYNDROME	0.010395310000000001	0.5140211212125295
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.010395310000000001	0.5140211212125295
LOCKED-IN SYNDROME	0.01028938	0.5087831574221238
INFANTILE REFSUM DISEASE	0.01027569	0.508106222424572
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.01027569	0.508106222424572
HUNTINGTON DISEASE-LIKE 1	0.01023385	0.5060373429287673
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.01023385	0.5060373429287673
KUFOR-RAKEB SYNDROME	0.01023385	0.5060373429287673
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.01023385	0.5060373429287673
MENTAL RETARDATION, X-LINKED 104; MRX104	0.010200480000000001	0.5043872829676059
PITT-HOPKINS SYNDROME	0.010200480000000001	0.5043872829676059
LATHOSTEROLOSIS	0.01018901	0.5038201212129003
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.010187560000000002	0.5037484224732036
COFFIN-SIRIS SYNDROME 6; CSS6	0.010187560000000002	0.5037484224732036
MEIER-GORLIN SYNDROME 6; MGORS6	0.010187560000000002	0.5037484224732036
NEURALGIC AMYOTROPHY	0.010170390000000001	0.5028994105003793
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.010140600000000001	0.5014263722551591
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.010140600000000001	0.5014263722551591
CHROMOSOME 16P13.2 DELETION SYNDROME	0.010140600000000001	0.5014263722551591
ZECHI-CEIDE SYNDROME	0.01012397	0.500604061881946
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01012397	0.500604061881946
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.010111960000000001	0.5000101985276294
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.010111960000000001	0.5000101985276294
TRISOMY XQ28	0.010111960000000001	0.5000101985276294
GLASS SYNDROME	0.010072530000000001	0.49806048728194163
2Q32Q33 MICRODELETION SYNDROME	0.010072530000000001	0.49806048728194163
CAMURATI-ENGELMANN DISEASE	0.01006446	0.49766144670997353
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.01006446	0.49766144670997353
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.01006446	0.49766144670997353
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.01006446	0.49766144670997353
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.01006446	0.49766144670997353
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.01005077	0.4969845117124218
CONGENITAL RUBELLA SYNDROME	0.01005077	0.4969845117124218
VON HIPPEL-LINDAU DISEASE	0.01005077	0.4969845117124218
ALBINISM-DEAFNESS SYNDROME	0.01005077	0.4969845117124218
PENDRED SYNDROME	0.01005077	0.4969845117124218
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.01005077	0.4969845117124218
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01005077	0.4969845117124218
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.01004224	0.4965627253333774
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.010040890000000002	0.4964959713343494
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.010040890000000002	0.4964959713343494
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.01004089	0.4964959713343493
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0100388	0.4963926262543725
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.01001279	0.4951064992064309
IMMUNODEFICIENCY 23; IMD23	0.01000777	0.4948582732248597
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00999901	0.49442511394227723
OGDEN SYNDROME; OGDNS	0.00994253	0.4916323244125678
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.00991997	0.4905167909176981
OROFACIODIGITAL SYNDROME III	0.00991769	0.49040405083045063
LOEYS-DIETZ SYNDROME	0.00991769	0.49040405083045063
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00991769	0.49040405083045063
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00991769	0.49040405083045063
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00991769	0.49040405083045063
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00990643	0.48984727303114955
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00988265	0.4886714137001209
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00984775	0.4869456992067276
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00984775	0.4869456992067276
NON-DISTAL TRISOMY 13Q	0.00982248	0.4856961632397347
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00982248	0.4856961632397347
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.00980485	0.4848244054598343
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00980485	0.4848244054598343
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00980485	0.4848244054598343
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.0098044	0.4848021541268249
DK1-CDG	0.00978461	0.48382358994847946
PITT-HOPKINS-LIKE SYNDROME	0.009753290000000001	0.4822748971710274
16P13.2 MICRODELETION SYNDROME	0.009753290000000001	0.4822748971710274
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.009739600000000001	0.4815979621734756
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.009728130000000001	0.48103080041877017
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00972428	0.48084042790302317
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00972428	0.48084042790302317
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00972428	0.48084042790302317
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00972428	0.48084042790302317
15Q14 MICRODELETION SYNDROME	0.00970098	0.4796883033272047
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00967678	0.47849167608536747
HARDIKAR SYNDROME	0.00967678	0.47849167608536747
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00967678	0.47849167608536747
FOCAL DERMAL HYPOPLASIA	0.00967159	0.47823504404465944
MULTIPLE CARBOXYLASE DEFICIENCY	0.00967159	0.47823504404465944
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00967159	0.47823504404465944
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00966934	0.47812378737961253
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00966934	0.47812378737961253
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00966934	0.47812378737961253
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.009664559999999999	0.4778874287756463
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.009664559999999999	0.4778874287756463
CENTRAL CONGENITAL HYPOTHYROIDISM	0.009663109999999999	0.4778157300359494
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00966309	0.4778147410878157
DYSTONIA, JUVENILE-ONSET	0.00966309	0.4778147410878157
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00966309	0.4778147410878157
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.00963147	0.47625121408835724
PRIMROSE SYNDROME; PRIMS	0.009626790000000001	0.4760198002250599
14Q12 MICRODELETION SYNDROME	0.009611890000000001	0.4752830338654163
19Q13.11 MICRODELETION SYNDROME	0.00955718	0.47257776624554365
ABLEPHARON MACROSTOMIA SYNDROME	0.00955718	0.47257776624554365
KABUKI SYNDROME	0.009546460000000001	0.4720476900458539
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00954284	0.4718686904336451
FUMARASE DEFICIENCY; FMRD	0.00953613	0.471536898334772
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.00953266	0.4713653158335664
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.009524930000000001	0.47098308737987216
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.009524930000000001	0.47098308737987216
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.00948971	0.4692415497163387
CANAVAN DISEASE	0.00947743	0.46863433556221634
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00946374	0.4679574005646646
FABRY DISEASE	0.00946374	0.4679574005646646
SMITH-LEMLI-OPITZ SYNDROME	0.009450900000000002	0.46732249586279734
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00943827	0.46669797511633426
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00943827	0.46669797511633426
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00943827	0.46669797511633426
ZUNICH NEUROECTODERMAL SYNDROME	0.00943151	0.46636371064712684
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.009371790000000001	0.46341071151975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.009371790000000001	0.46341071151975
DISTAL MONOSOMY 3P	0.00934454	0.4620632696875159
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.00932429	0.4610619597020942
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00932429	0.4610619597020942
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.00932429	0.4610619597020942
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.009316479999999999	0.4606757754558648
CRANIOMETAPHYSEAL DYSPLASIA	0.00931189	0.46044881185916925
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00931189	0.46044881185916925
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0093106	0.46038502470454246
SALT-AND-PEPPER SYNDROME	0.0093106	0.46038502470454246
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.00926211	0.4579873199542661
EEC SYNDROME	0.00926211	0.4579873199542661
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00924155	0.45697068127277124
SHPRINTZEN-GOLDBERG SYNDROME	0.009213490000000001	0.4555831870411204
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.009213490000000001	0.4555831870411204
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00919817	0.454825652770668
DOWN SYNDROME	0.00916471	0.4531711425429045
FRONTOMETAPHYSEAL DYSPLASIA	0.0091523	0.45255750022591285
7Q11.23 MICRODUPLICATION SYNDROME	0.00915067	0.4524769009530122
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00914845	0.452367127710166
ROBERTS SYNDROME	0.009148449999999999	0.4523671277101659
HARTSFIELD SYNDROME; HRTFDS	0.009148449999999999	0.4523671277101659
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.009148449999999999	0.4523671277101659
MECKEL SYNDROME, TYPE 1; MKS1	0.009148449999999999	0.4523671277101659
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.009148449999999999	0.4523671277101659
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00914326	0.45211049566945793
VELO-FACIAL-SKELETAL SYNDROME	0.0091266	0.45128670187404435
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0091266	0.45128670187404435
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00909002	0.44947791573741597
SYNDROMIC DIARRHEA	0.00908873	0.4494141285827891
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.009049680000000001	0.4474832073516426
RING CHROMOSOME 1 SYNDROME	0.00898428	0.4442493469542808
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.008967010000000001	0.44339539024078783
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00892857	0.44149463192772076
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.00892857	0.44149463192772076
UVULA, BIFID	0.00892857	0.44149463192772076
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00892857	0.44149463192772076
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00892857	0.44149463192772076
CLEFT PALATE, X-LINKED	0.00892857	0.44149463192772076
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.00892857	0.44149463192772076
ACRO-RENAL-OCULAR SYNDROME	0.0089122	0.4406851778802465
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.00888957	0.4395661830669086
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.008795960000000002	0.4349374113268928
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.008795960000000002	0.4349374113268928
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.008795960000000002	0.4349374113268928
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.43374919014419233
BREATH-HOLDING SPELLS	0.00877193	0.43374919014419233
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.43374919014419233
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.00877193	0.43374919014419233
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.43374919014419233
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.43374919014419233
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.43374919014419233
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.43374919014419233
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.43374919014419233
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.43374919014419233
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.43374919014419233
LESCH-NYHAN SYNDROME	0.00877193	0.43374919014419233
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.00877193	0.43374919014419233
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.43374919014419233
CAFFEY DISEASE	0.00877193	0.43374919014419233
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00877193	0.43374919014419233
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00877193	0.43374919014419233
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.43374919014419233
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.00877193	0.43374919014419233
HEREDITARY FOLATE MALABSORPTION	0.00877193	0.43374919014419233
DIENCEPHALIC SYNDROME	0.00877193	0.43374919014419233
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.43374919014419233
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.43374919014419233
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.00877193	0.43374919014419233
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.43374919014419233
MILROY DISEASE	0.00877193	0.43374919014419233
RHEUMATIC FEVER	0.00877193	0.43374919014419233
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.43374919014419233
NANCE-HORAN SYNDROME	0.00877193	0.43374919014419233
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00877193	0.43374919014419233
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.43374919014419233
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.43374919014419233
FAMILIAL DYSAUTONOMIA	0.00877193	0.43374919014419233
HAMAMY SYNDROME; HMMS	0.00876786	0.4335479391989743
2P15P16.1 MICRODELETION SYNDROME	0.00875685	0.433003523251345
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00875685	0.433003523251345
CHAND SYNDROME	0.00874747	0.43253970657661633
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.008726910000000001	0.4315230678951215
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00867941	0.4291743160774657
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00866572	0.4284973810799141
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00866572	0.4284973810799141
BARBER-SAY SYNDROME; BBRSAY	0.00864154	0.42730174278621047
PROLIDASE DEFICIENCY	0.00864154	0.42730174278621047
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00860874	0.42567986784686085
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.00860197	0.42534510890358657
KEARNS-SAYRE SYNDROME; KSS	0.00856322	0.4234290218944463
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00856322	0.4234290218944463
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00856322	0.4234290218944463
TOLUENE EMBRYOPATHY	0.00854701	0.42262747943204215
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00854701	0.42262747943204215
FRAGILE X SYNDROME	0.00854701	0.42262747943204215
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00854701	0.42262747943204215
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00854701	0.42262747943204215
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.00854701	0.42262747943204215
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.00854701	0.42262747943204215
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.00854701	0.42262747943204215
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.00854701	0.42262747943204215
WHIM SYNDROME	0.00854701	0.42262747943204215
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00854701	0.42262747943204215
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00854701	0.42262747943204215
CENTRAL BILATERAL MACROGYRIA	0.00854701	0.42262747943204215
ATAXIA-PANCYTOPENIA SYNDROME	0.00854701	0.42262747943204215
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.00854701	0.42262747943204215
BETA-UREIDOPROPIONASE DEFICIENCY	0.00854701	0.42262747943204215
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00854701	0.42262747943204215
ISOLATED GLYCEROL KINASE DEFICIENCY	0.00854701	0.42262747943204215
TYROSINEMIA TYPE 2	0.00854701	0.42262747943204215
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.00854701	0.42262747943204215
PYRIDOXINE-DEPENDENT EPILEPSY	0.00854701	0.42262747943204215
PSYCHOGENIC MOVEMENT DISORDERS	0.00854701	0.42262747943204215
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00854701	0.42262747943204215
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.00854701	0.42262747943204215
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00854701	0.42262747943204215
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00854701	0.42262747943204215
TAKAYASU ARTERITIS	0.00854701	0.42262747943204215
FLOATING-HARBOR SYNDROME	0.00850401	0.42050124094448005
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00844915	0.41778855621360433
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00844915	0.41778855621360433
LUSCAN-LUMISH SYNDROME; LLS	0.00844915	0.41778855621360433
3P25.3 MICRODELETION SYNDROME	0.00842869	0.4167768622727784
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00838898	0.4148133057532181
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.008383950000000001	0.4145645852975801
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.008382510000000001	0.41449338103195005
CORNELIA DE LANGE SYNDROME 3	0.00835542	0.413153850784786
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.008348570000000001	0.4128151360489767
RETINITIS PIGMENTOSA	0.00832277	0.41153939295643943
TREACHER COLLINS SYNDROME 3; TCS3	0.0082828	0.40956298011114045
TREACHER COLLINS SYNDROME 2; TCS2	0.0082828	0.40956298011114045
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.008235840000000001	0.40724092989309596
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.008235840000000001	0.40724092989309596
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.008235840000000001	0.40724092989309596
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.008235840000000001	0.40724092989309596
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.008235840000000001	0.40724092989309596
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.008235840000000001	0.40724092989309596
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.008235840000000001	0.40724092989309596
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.008235840000000001	0.40724092989309596
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00822852	0.40687897487614344
COHEN-GIBSON SYNDROME; COGIS	0.00822852	0.40687897487614344
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00821431	0.4061763272271143
COFFIN-SIRIS SYNDROME 8; CSS8	0.00820905	0.4059162338679381
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008209049999999999	0.405916233867938
NOONAN SYNDROME 6; NS6	0.00816733	0.40385328806093596
ACROOTOOCULAR SYNDROME	0.00816318	0.4036480813231829
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.00815933	0.40345770880743603
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.00815933	0.40345770880743603
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00815933	0.40345770880743603
CATEL-MANZKE SYNDROME; CATMANS	0.00815933	0.40345770880743603
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.00815933	0.40345770880743603
NIJMEGEN BREAKAGE SYNDROME	0.00815933	0.40345770880743603
MECKEL SYNDROME, TYPE 6; MKS6	0.00815933	0.40345770880743603
PARIETAL FORAMINA	0.00815933	0.40345770880743603
KYPHOMELIC DYSPLASIA	0.00815933	0.40345770880743603
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00815933	0.40345770880743603
MECKEL SYNDROME, TYPE 5	0.00815933	0.40345770880743603
HOLZGREVE SYNDROME	0.00815933	0.40345770880743603
CULLER-JONES SYNDROME; CJS	0.00815933	0.40345770880743603
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00815933	0.40345770880743603
OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	0.00815933	0.40345770880743603
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.00815933	0.40345770880743603
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00815933	0.40345770880743603
%119530 OROFACIAL CLEFT 1; OFC1;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1;;OROFACIAL CLEFT, NONSYNDROMIC; OFC;;CLEFT LIP/PALATE, NONSYNDROMIC	0.00815933	0.40345770880743603
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00815933	0.40345770880743603
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00815933	0.40345770880743603
GENITOPALATOCARDIAC SYNDROME	0.00815933	0.40345770880743603
AICARDI SYNDROME	0.00815933	0.40345770880743603
VAN DER WOUDE SYNDROME	0.00815933	0.40345770880743603
ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE	0.00815933	0.40345770880743603
RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE	0.00815933	0.40345770880743603
THORACOABDOMINAL SYNDROME	0.00815933	0.40345770880743603
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00815933	0.40345770880743603
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.00815414	0.40320107676672806
PACHYONYCHIA CONGENITA	0.00815414	0.40320107676672806
HIDROTIC ECTODERMAL DYSPLASIA	0.00815414	0.40320107676672806
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008137479999999999	0.40237728297131437
SCLEROSTEOSIS 1; SOST1	0.00812085	0.4015549725981015
9P13 MICRODELETION SYNDROME	0.00809961	0.4005047096800592
JUNG SYNDROME	0.00809961	0.4005047096800592
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.008077599999999999	0.3994163722588675
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.00806097	0.3985940618856546
OKAMOTO SYNDROME	0.008046850000000001	0.3978958645032273
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00803973	0.3975437989676123
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00803973	0.3975437989676123
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00803973	0.3975437989676123
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.007999349999999999	0.39554711268557136
DEAFNESS-CRANIOFACIAL SYNDROME	0.00798659	0.3949161637762391
ABRUZZO-ERICKSON SYNDROME	0.00798151	0.39466497095026665
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00798151	0.39466497095026665
BRANCHIOOTIC SYNDROME	0.00798151	0.39466497095026665
CHROMOSOME 1P35 DELETION SYNDROME	0.007967710000000001	0.39398259673797936
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00795998	0.39360036828428496
DRAVET SYNDROME	0.00795998	0.39360036828428496
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00795998	0.39360036828428496
NIEMANN-PICK DISEASE TYPE C	0.00795998	0.39360036828428496
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00795998	0.39360036828428496
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007954020000000001	0.3933056617404276
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.007954020000000001	0.3933056617404276
HALLERMANN-STREIFF SYNDROME; HSS	0.00794002	0.39261339804680273
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00794002	0.39261339804680273
HUNTER-MACDONALD SYNDROME	0.00792308	0.3917757589775166
CODAS SYNDROME	0.00792308	0.3917757589775166
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00791302	0.39127831806624047
PIERPONT SYNDROME	0.007907830000000001	0.39102168602553244
OTOPALATODIGITAL SYNDROME TYPE 1	0.00789964	0.3906167117647618
OPITZ G/BBB SYNDROME	0.00788595	0.38993977676721003
6Q25 MICRODELETION SYNDROME	0.00788595	0.38993977676721003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00785562	0.38844003692237855
RUBINSTEIN-TAYBI SYNDROME	0.007841210000000001	0.3877274997920119
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.007827	0.3870248521429826
HENNEKAM SYNDROME	0.00780813	0.38609177957878965
AICARDI-GOUTIERES SYNDROME 7	0.007806840000000001	0.3860279924241628
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.007806840000000001	0.3860279924241628
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.007806840000000001	0.3860279924241628
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.007806840000000001	0.3860279924241628
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.007806840000000001	0.3860279924241628
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.007806840000000001	0.3860279924241628
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.007806840000000001	0.3860279924241628
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.007806840000000001	0.3860279924241628
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.007806840000000001	0.3860279924241628
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.007806840000000001	0.3860279924241628
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.007806840000000001	0.3860279924241628
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.007806840000000001	0.3860279924241628
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.007806840000000001	0.3860279924241628
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.0077962199999999995	0.38550286096514164
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.0077962199999999995	0.38550286096514164
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0077962199999999995	0.38550286096514164
WILLIAMS SYNDROME	0.00777874	0.38463852029624435
RICHARDS-RUNDLE SYNDROME; RRNS	0.00776055	0.38373907196859885
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00773779	0.3826136489923916
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00773255	0.3823545445813492
HSD10 DISEASE	0.00773255	0.3823545445813492
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.00771886	0.38167760958379743
POPOV-CHANG SYNDROME; POPCHAS	0.00769992	0.38074107570113636
BETA-THALASSEMIA MAJOR	0.00769029	0.3802648971747358
BUSCHKE-OLLENDORFF SYNDROME	0.00769029	0.3802648971747358
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00769029	0.3802648971747358
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00769029	0.3802648971747358
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00769029	0.3802648971747358
FUCOSIDOSIS	0.00769029	0.3802648971747358
JUVENILE PAGET DISEASE	0.00769029	0.3802648971747358
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00765242	0.37839232388348065
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00765242	0.37839232388348065
ALG11-CDG	0.00765242	0.37839232388348065
PLAGUE	0.00765242	0.37839232388348065
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00765242	0.37839232388348065
XFE PROGEROID SYNDROME; XFEPS	0.00765242	0.37839232388348065
FONTAINE PROGEROID SYNDROME; FPS	0.00764854	0.37820046794553314
BRESEK SYNDROME	0.00764533	0.3780417417700663
ALPORT SYNDROME	0.00763873	0.37771538888592887
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00763873	0.37771538888592887
SHEEHAN SYNDROME	0.00763873	0.37771538888592887
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00763873	0.37771538888592887
48,XYYY SYNDROME	0.00763322	0.3774429336750808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00763322	0.3774429336750808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00763322	0.3774429336750808
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00763322	0.3774429336750808
RENPENNING SYNDROME	0.007631639999999999	0.37736480677251455
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00757321	0.37447559479976456
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00752507	0.3720951966418288
TRISOMY 17P	0.00749995	0.37085307778583904
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00748626	0.37017614278828725
OROFACIODIGITAL SYNDROME TYPE 6	0.00746687	0.36921735757261687
BALLER-GEROLD SYNDROME	0.00746687	0.36921735757261687
LARSEN-LIKE SYNDROME	0.00746687	0.36921735757261687
LARSEN SYNDROME	0.00746687	0.36921735757261687
RING CHROMOSOME 13 SYNDROME	0.0074582599999999995	0.3687916154010376
FRONTONASAL DYSPLASIA 2; FND2	0.0074582599999999995	0.3687916154010376
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00741933	0.3668666278586936
CROUZON DISEASE	0.0074084400000000005	0.3663281455998669
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00739927	0.3658747128805426
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00739274	0.36555182131487324
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00739274	0.36555182131487324
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00739274	0.36555182131487324
MUENKE SYNDROME	0.00738033	0.3649381789978815
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00737905	0.3648748863173215
MEND SYNDROME	0.007351839999999999	0.3635294223813549
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00734725	0.36330245878465933
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0072661900000000005	0.35929425199857146
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0072394	0.35796955597341357
20Q11.2 MICRODUPLICATION SYNDROME	0.0072394	0.35796955597341357
HYPERTRYPTOPHANEMIA; HYPTRP	0.00723222	0.3576145235933974
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0071919	0.3556208041557578
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00717923	0.3549943055130273
NON-DISTAL MONOSOMY 10Q	0.00717923	0.3549943055130273
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00716196	0.3541403487995344
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00716196	0.3541403487995344
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00716196	0.3541403487995344
FOIX-CHAVANY-MARIE SYNDROME	0.0071461400000000005	0.3533580908257383
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00712409	0.3522677755082791
ZELLWEGER SYNDROME	0.00711804	0.3519686186978198
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00705946	0.34907198961406666
MACHADO-JOSEPH DISEASE; MJD	0.00705946	0.34907198961406666
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00705816	0.34900770798537295
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00701964	0.3471029938797708
NARP SYNDROME	0.00701196	0.3467232377964109
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.00701196	0.3467232377964109
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00701196	0.3467232377964109
DEMENTIA, FAMILIAL DANISH	0.00701196	0.3467232377964109
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00701196	0.3467232377964109
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00701196	0.3467232377964109
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00701196	0.3467232377964109
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.00699827	0.3460463027988592
MYOPATHY AND DIABETES MELLITUS	0.00699827	0.3460463027988592
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.0069649	0.34439624283769765
MONOSOMY 22Q13.3	0.0069518	0.34374848181009154
19P13.3 MICRODUPLICATION SYNDROME	0.00692493	0.34241982999239867
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00691052	0.34170729286203194
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.0068665	0.3395306180196486
TRISOMY 5P	0.0068644100000000005	0.33942727293967184
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0068384000000000006	0.3381411458917302
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0068384000000000006	0.3381411458917302
CRANIODIAPHYSEAL DYSPLASIA	0.00681901	0.3371823606760597
HENNEKAM-BEEMER SYNDROME	0.00681901	0.3371823606760597
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00681901	0.3371823606760597
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.006819	0.33718186620199286
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.006819	0.33718186620199286
DYSOSTEOSCLEROSIS	0.006816910000000001	0.3370785211220161
ISOLATED KLIPPEL-FEIL SYNDROME	0.00679047	0.33577113168919875
PRIMARY CILIARY DYSKINESIA	0.00675913	0.3342214499636129
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00673204	0.33288191971644876
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00673204	0.33288191971644876
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00671835	0.33220498471889703
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00671835	0.33220498471889703
COWCHOCK SYNDROME; COWCK	0.00667085	0.3298562329012412
AL KAISSI SYNDROME; ALKAS	0.00666357	0.3294962557805563
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.00666357	0.3294962557805563
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00666357	0.3294962557805563
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00665942	0.32929104904280326
PHAVER SYNDROME	0.00665942	0.32929104904280326
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00665942	0.32929104904280326
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00665942	0.32929104904280326
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00665942	0.32929104904280326
DUANE RETRACTION SYNDROME	0.0066567300000000005	0.32915803551881395
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.0066441	0.32853351477235093
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0066441	0.32853351477235093
HYPERPROLINEMIA, TYPE I	0.0066441	0.32853351477235093
ADENYLOSUCCINASE DEFICIENCY	0.0066441	0.32853351477235093
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.0066441	0.32853351477235093
CK SYNDROME	0.0066441	0.32853351477235093
11P15.4 MICRODUPLICATION SYNDROME	0.0066441	0.32853351477235093
FRAXE INTELLECTUAL DISABILITY	0.0066441	0.32853351477235093
1P21.3 MICRODELETION SYNDROME	0.0066441	0.32853351477235093
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.0066441	0.32853351477235093
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0066441	0.32853351477235093
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.0066441	0.32853351477235093
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0066441	0.32853351477235093
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0066441	0.32853351477235093
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.0066441	0.32853351477235093
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0066441	0.32853351477235093
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.0066441	0.32853351477235093
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00663733	0.3281987558290766
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00662364	0.32752182083152487
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00661054	0.3268740598039187
PONTINE TEGMENTAL CAP DYSPLASIA	0.00656521	0.3246326088587749
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00654439	0.3236031138515413
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00654439	0.3236031138515413
DUPLICATION/INVERSION 15Q11	0.00654439	0.3236031138515413
ALG13-CDG	0.006543520000000001	0.3235600946077232
NAXOS DISEASE	0.00653595	0.32318577773909885
PALLISTER-HALL SYNDROME	0.00653595	0.32318577773909885
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.00653595	0.32318577773909885
ELLIS-VAN CREVELD SYNDROME	0.00653595	0.32318577773909885
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00653595	0.32318577773909885
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00653595	0.32318577773909885
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00653595	0.32318577773909885
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00651083	0.3219436588831091
DIAMOND-BLACKFAN ANEMIA 10	0.00647775	0.320307938669887
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00647775	0.320307938669887
CEREBROCOSTOMANDIBULAR SYNDROME	0.00647775	0.320307938669887
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.00646914	0.31988219649830774
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00646914	0.31988219649830774
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.006450260000000001	0.3189486294600479
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.006450260000000001	0.3189486294600479
HALL-RIGGS SYNDROME	0.006450260000000001	0.3189486294600479
NOONAN SYNDROME 7; NS7	0.00644381	0.31862969368691363
NON-DISTAL TRISOMY 10Q	0.00644381	0.31862969368691363
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.006423470000000001	0.31762393343489004
RHYNS SYNDROME; RHYNS	0.00641932	0.31741872669713694
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00640926	0.3169212857858608
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00638219	0.3155827444868305
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00637182	0.3150699748794812
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00635813	0.31439303988192946
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00635813	0.31439303988192946
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.00635813	0.31439303988192946
RAMON SYNDROME	0.00635813	0.31439303988192946
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00632376	0.31269353251408044
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00632376	0.31269353251408044
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.00632376	0.31269353251408044
HYPERTELORISM, TEEBI TYPE; TBHS	0.00632376	0.31269353251408044
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00632376	0.31269353251408044
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00632376	0.31269353251408044
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.006322309999999999	0.3126218337743836
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.00630955	0.31199088486505117
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00630429	0.31173079150587496
JOUBERT SYNDROME 1	0.00630429	0.31173079150587496
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.006290670000000001	0.31105731782679147
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.006290670000000001	0.31105731782679147
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.006290670000000001	0.31105731782679147
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.006290670000000001	0.31105731782679147
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.006290670000000001	0.31105731782679147
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.006290670000000001	0.31105731782679147
15Q24 MICRODELETION SYNDROME	0.0062762600000000005	0.3103447806964247
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00626388	0.3097326218016336
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00626388	0.3097326218016336
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00626388	0.3097326218016336
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00626388	0.3097326218016336
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00626388	0.3097326218016336
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00626257	0.3096678456988729
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00626214	0.3096465833139973
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00625679	0.3093820396882192
FRIED SYNDROME	0.00625679	0.3093820396882192
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00625679	0.3093820396882192
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0062431	0.3087051046906675
CHROMOSOME 2Q37 DELETION SYNDROME	0.0062431	0.3087051046906675
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.00621638	0.30738386998397776
COFFIN-SIRIS SYNDROME 7; CSS7	0.00621638	0.30738386998397776
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.0062151	0.30732057730341783
RING CHROMOSOME 22 SYNDROME	0.0062151	0.30732057730341783
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.0062151	0.30732057730341783
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.0062151	0.30732057730341783
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0062151	0.30732057730341783
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.0062151	0.30732057730341783
ASPARTYLGLUCOSAMINURIA; AGU	0.0062151	0.30732057730341783
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.0062151	0.30732057730341783
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0062151	0.30732057730341783
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.0062151	0.30732057730341783
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.0062151	0.30732057730341783
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.0062151	0.30732057730341783
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.006202689999999999	0.306706934986426
FG SYNDROME TYPE 1	0.006202689999999999	0.306706934986426
ERYTHEMA OF ACRAL REGIONS	0.00617284	0.3052309298968045
PARAMOLAR TUBERCLE OF BOLK	0.00617284	0.3052309298968045
EPILEPSY-TELANGIECTASIA SYNDROME	0.00617284	0.3052309298968045
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00617284	0.3052309298968045
TEETH, ODD SHAPES OFLOBODONTIA, INCLUDED	0.00617284	0.3052309298968045
LEGG-CALVÉ-PERTHES DISEASE	0.00617284	0.3052309298968045
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00617284	0.3052309298968045
ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	0.00617284	0.3052309298968045
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00617284	0.3052309298968045
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00617284	0.3052309298968045
PRIMARY HYPEROXALURIA TYPE 1	0.00617284	0.3052309298968045
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00617284	0.3052309298968045
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00617284	0.3052309298968045
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.00617284	0.3052309298968045
IRIDOGONIODYSGENESIS, TYPE 2	0.00617284	0.3052309298968045
TEETH, FUSED	0.00617284	0.3052309298968045
DENS EVAGINATUS	0.00617284	0.3052309298968045
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00617284	0.3052309298968045
CORNEODERMATOOSSEOUS SYNDROME	0.00617284	0.3052309298968045
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.00617284	0.3052309298968045
BARDET-BIEDL SYNDROME 4; BBS4	0.00617284	0.3052309298968045
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00617284	0.3052309298968045
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00617284	0.3052309298968045
PREMATURE OVARIAN FAILURE 2B	0.00617284	0.3052309298968045
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00617284	0.3052309298968045
125300 DENS IN DENTE AND PALATAL INVAGINATIONS	0.00617284	0.3052309298968045
BANGSTAD SYNDROME	0.00617284	0.3052309298968045
MULTIPLE OSTEOCHONDROMAS	0.00617284	0.3052309298968045
CANINE TEETH, ABSENCE OF UPPER PERMANENT	0.00617284	0.3052309298968045
SPLIT LOWER LIP	0.00617284	0.3052309298968045
TOOTH SIZE	0.00617284	0.3052309298968045
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.00617284	0.3052309298968045
HYPOPHOSPHATASIA, INFANTILE	0.00617284	0.3052309298968045
17Q21.31 MICRODUPLICATION SYNDROME	0.00617284	0.3052309298968045
ISOLATED HEMIHYPERPLASIA	0.00617284	0.3052309298968045
CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH	0.00617284	0.3052309298968045
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.00617284	0.3052309298968045
STÜVE-WIEDEMANN SYNDROME	0.00617284	0.3052309298968045
MOLAR I REINCLUSION	0.00617284	0.3052309298968045
HYPOPHOSPHATASIA	0.00617284	0.3052309298968045
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.00617284	0.3052309298968045
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00617284	0.3052309298968045
JABERI-ELAHI SYNDROME; JABELS	0.00617284	0.3052309298968045
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00617284	0.3052309298968045
INCISORS, FUSED MANDIBULAR	0.00617284	0.3052309298968045
MOSAIC TRISOMY 14	0.00614209	0.30371042214116417
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00614209	0.30371042214116417
TEEBI-SHALTOUT SYNDROME; TBSH	0.00614209	0.30371042214116417
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.00613497	0.3033583566055492
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00613497	0.3033583566055492
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00613497	0.3033583566055492
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	0.00613497	0.3033583566055492
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00613497	0.3033583566055492
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00613497	0.3033583566055492
HELIX SYNDROME; HELIX	0.00613497	0.3033583566055492
PEELING SKIN SYNDROME	0.00613497	0.3033583566055492
TANGIER DISEASE	0.00613497	0.3033583566055492
CONGENITAL LETHAL ERYTHRODERMA	0.00613497	0.3033583566055492
RABSON-MENDENHALL SYNDROME	0.00613497	0.3033583566055492
HURIEZ SYNDROME	0.00613497	0.3033583566055492
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00613497	0.3033583566055492
KERATOSIS PILARIS ATROPHICANS	0.00613497	0.3033583566055492
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00613497	0.3033583566055492
NETHERTON SYNDROME	0.00613497	0.3033583566055492
SPINOCEREBELLAR ATAXIA TYPE 34	0.00613497	0.3033583566055492
DERMATITIS, ATOPIC	0.00613497	0.3033583566055492
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3	0.00613497	0.3033583566055492
ATOPIC KERATOCONJUNCTIVITIS	0.00613497	0.3033583566055492
DERMOODONTODYSPLASIA	0.00613497	0.3033583566055492
COMPLEX REGIONAL PAIN SYNDROME	0.00613497	0.3033583566055492
CRANIOECTODERMAL DYSPLASIA 3	0.00613497	0.3033583566055492
TOOTH AGENESIS, SELECTIVE, 4	0.00613497	0.3033583566055492
257960 OCULOTRICHODYSPLASIA; OTD	0.00613497	0.3033583566055492
IMMUNODEFICIENCY 55; IMD55	0.00613497	0.3033583566055492
XERODERMA PIGMENTOSUM VARIANT	0.00613497	0.3033583566055492
ANONYCHIA WITH FLEXURAL PIGMENTATION	0.00613497	0.3033583566055492
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00613497	0.3033583566055492
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00613497	0.3033583566055492
AMELO-ONYCHO-HYPOHIDROTIC SYNDROME	0.00613497	0.3033583566055492
TOOTH AGENESIS, SELECTIVE, 8; STHAG8	0.00613497	0.3033583566055492
ACUTE ADRENAL INSUFFICIENCY	0.00613497	0.3033583566055492
AICARDI-GOUTIERES SYNDROME 5	0.00613497	0.3033583566055492
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00613497	0.3033583566055492
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00613497	0.3033583566055492
SJÖGREN-LARSSON SYNDROME	0.00613497	0.3033583566055492
BLAU SYNDROME	0.00613497	0.3033583566055492
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00613497	0.3033583566055492
ADDISON DISEASE	0.00613497	0.3033583566055492
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00613497	0.3033583566055492
ORAL EROSIVE LICHEN	0.00613497	0.3033583566055492
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00613497	0.3033583566055492
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00613497	0.3033583566055492
TANGIER DISEASE; TGD	0.00613497	0.3033583566055492
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00613497	0.3033583566055492
ACQUIRED ICHTHYOSIS	0.00613497	0.3033583566055492
OCULOCEREBROCUTANEOUS SYNDROME	0.00612788	0.3030077744921349
PARC SYNDROME	0.00612788	0.3030077744921349
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.006109000000000001	0.30207420745387514
TARP SYNDROME	0.00609459	0.3013616703235084
SWEENEY-COX SYNDROME; SWCOS	0.00609459	0.3013616703235084
THYMOMA	0.00606945	0.3001185625193849
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00606945	0.3001185625193849
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.00606945	0.3001185625193849
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00605057	0.2991849954811251
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00605057	0.2991849954811251
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0060361600000000005	0.2984724583507584
MICROTRIPLICATION 11Q24.1	0.0060347099999999996	0.2984007596110615
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00602247	0.29779552335320664
BIOTINIDASE DEFICIENCY	0.00602195	0.29776981070172914
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.00602195	0.29776981070172914
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00602195	0.29776981070172914
DYSKERATOSIS CONGENITA	0.00602195	0.29776981070172914
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00602195	0.29776981070172914
KEUTEL SYNDROME	0.00602195	0.29776981070172914
PILI TORTI	0.00602195	0.29776981070172914
KID SYNDROME	0.00600826	0.29709287570417736
JOHANSON-BLIZZARD SYNDROME	0.00600826	0.29709287570417736
BJÖRNSTAD SYNDROME	0.00600826	0.29709287570417736
MOYNAHAN SYNDROME	0.00600826	0.29709287570417736
WOODHOUSE-SAKATI SYNDROME	0.00600826	0.29709287570417736
CHANARIN-DORFMAN SYNDROME	0.00600826	0.29709287570417736
RELAPSING POLYCHONDRITIS	0.00600826	0.29709287570417736
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00600826	0.29709287570417736
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.00600826	0.29709287570417736
X-LINKED AGAMMAGLOBULINEMIA	0.00600826	0.29709287570417736
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00600826	0.29709287570417736
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.00600826	0.29709287570417736
2Q31.1 MICRODELETION SYNDROME	0.0059825	0.29581911050790766
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0059825	0.29581911050790766
OTOPALATODIGITAL SYNDROME TYPE 2	0.005935	0.2934703586902519
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.005935	0.2934703586902519
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00593372	0.2934070660096919
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.00593372	0.2934070660096919
14Q22Q23 MICRODELETION SYNDROME	0.00587657	0.29058114671750185
CENANI-LENZ SYNDROME	0.00587657	0.29058114671750185
ALEXANDER DISEASE	0.00587529	0.2905178540369419
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.00587529	0.2905178540369419
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00587529	0.2905178540369419
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00587529	0.2905178540369419
NOONAN SYNDROME 11; NS11	0.00586288	0.2899042117199502
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00584349	0.2889454265042797
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00584349	0.2889454265042797
CROUZON SYNDROME	0.00584349	0.2889454265042797
MARSHALL-SMITH SYNDROME	0.00584349	0.2889454265042797
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00584349	0.2889454265042797
DYSOSTEOSCLEROSIS	0.00582779	0.28816910221928616
ATYPICAL RETT SYNDROME	0.00582779	0.28816910221928616
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00582779	0.28816910221928616
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00582779	0.28816910221928616
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00582779	0.28816910221928616
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00582779	0.28816910221928616
GAUCHER DISEASE	0.00582779	0.28816910221928616
CANAVAN DISEASE	0.00582779	0.28816910221928616
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00582779	0.28816910221928616
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00582779	0.28816910221928616
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.0058141	0.2874921672217344
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0058141	0.2874921672217344
NORRIE DISEASE	0.0058141	0.2874921672217344
TRIPLE A SYNDROME	0.0058141	0.2874921672217344
MUCOPOLYSACCHARIDOSIS TYPE 1	0.0058141	0.2874921672217344
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0057284599999999995	0.28325749131301775
FANCONI ANEMIA	0.0056949	0.2815980363445856
CHIME SYNDROME	0.0056949	0.2815980363445856
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0056949	0.2815980363445856
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0056949	0.2815980363445856
LAMB-SHAFFER SYNDROME	0.00567445	0.28058683687782643
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00567445	0.28058683687782643
CLASSICAL EHLERS-DANLOS SYNDROME	0.00561428	0.27761158641744016
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.0055544	0.2746506757049933
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0055544	0.2746506757049933
SPINOCEREBELLAR ATAXIA TYPE 29	0.0055544	0.2746506757049933
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0055544	0.2746506757049933
DYSTONIA 16; DYT16	0.0055544	0.2746506757049933
HYPERLYSINEMIA, TYPE I	0.0055544	0.2746506757049933
DUCHENNE MUSCULAR DYSTROPHY	0.0055544	0.2746506757049933
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.0055544	0.2746506757049933
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0055544	0.2746506757049933
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.0055544	0.2746506757049933
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0055544	0.2746506757049933
PERRY SYNDROME	0.00549451	0.2716892705184795
AREGENERATIVE ANEMIA	0.00549451	0.2716892705184795
SEMANTIC DEMENTIA	0.00549451	0.2716892705184795
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.00549451	0.2716892705184795
MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	0.00549451	0.2716892705184795
PARKINSONIAN-PYRAMIDAL SYNDROME	0.00549451	0.2716892705184795
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00549451	0.2716892705184795
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00549451	0.2716892705184795
HUNTINGTON DISEASE-LIKE 2	0.00549451	0.2716892705184795
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00549451	0.2716892705184795
WAISMAN SYNDROME; WSMN	0.00549451	0.2716892705184795
MAST SYNDROME	0.00549451	0.2716892705184795
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00549451	0.2716892705184795
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00549451	0.2716892705184795
HUNTINGTON DISEASE; HD	0.00549451	0.2716892705184795
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00549451	0.2716892705184795
PRESENILE DEMENTIA, KRAEPELIN TYPE	0.00549451	0.2716892705184795
GAUCHER DISEASE TYPE 3	0.00549451	0.2716892705184795
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.00549451	0.2716892705184795
AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA	0.00549451	0.2716892705184795
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.00549451	0.2716892705184795
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00549451	0.2716892705184795
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.00549451	0.2716892705184795
GANGLIOCYTOMA	0.00549451	0.2716892705184795
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00549451	0.2716892705184795
NIEMANN-PICK DISEASE, TYPE C2	0.00549451	0.2716892705184795
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.00549451	0.2716892705184795
SPINOCEREBELLAR ATAXIA TYPE 2	0.00549451	0.2716892705184795
LEBER OPTIC ATROPHY AND DYSTONIA	0.00549451	0.2716892705184795
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00549451	0.2716892705184795
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00549451	0.2716892705184795
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00549451	0.2716892705184795
ACERULOPLASMINEMIA	0.00549451	0.2716892705184795
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.00549451	0.2716892705184795
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.00549451	0.2716892705184795
HYDROCEPHALUS, NORMAL-PRESSURE	0.00549451	0.2716892705184795
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00549451	0.2716892705184795
PARKINSON DISEASE, LATE-ONSET; PD	0.00549451	0.2716892705184795
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.00549451	0.2716892705184795
INTERNAL CAROTID ARTERIES, HYPOPLASIA OF	0.00549451	0.2716892705184795
ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL	0.00549451	0.2716892705184795
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.00549451	0.2716892705184795
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.00549451	0.2716892705184795
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00549451	0.2716892705184795
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00549451	0.2716892705184795
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.00549451	0.2716892705184795
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00549451	0.2716892705184795
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.00549451	0.2716892705184795
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00549451	0.2716892705184795
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.00549451	0.2716892705184795
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00549451	0.2716892705184795
DEMENTIA, LEWY BODY; DLB	0.00549451	0.2716892705184795
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00549451	0.2716892705184795
PRIMARY DYSTONIA, DYT4 TYPE	0.00549451	0.2716892705184795
KUFOR-RAKEB SYNDROME	0.00549451	0.2716892705184795
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.00549451	0.2716892705184795
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.00549451	0.2716892705184795
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00549451	0.2716892705184795
UNVERRICHT-LUNDBORG DISEASE	0.00549451	0.2716892705184795
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.00549451	0.2716892705184795
MEGALOBLASTIC ANEMIA 1	0.00549451	0.2716892705184795
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00549451	0.2716892705184795
WILSON DISEASE	0.00549451	0.2716892705184795
AMYLOIDOSIS VI	0.00549451	0.2716892705184795
ALZHEIMER DISEASE 2	0.00549451	0.2716892705184795
ALZHEIMER DISEASE	0.00549451	0.2716892705184795
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00549451	0.2716892705184795
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00549451	0.2716892705184795
GM2-GANGLIOSIDOSIS, AB VARIANT	0.00549451	0.2716892705184795
EARLY-ONSET ALZHEIMER DISEASE WITH CEREBRAL AMYLOID ANGIOPATHY	0.00549451	0.2716892705184795
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.00549451	0.2716892705184795
SPINOCEREBELLAR ATAXIA 12	0.00549451	0.2716892705184795
LAFORA DISEASE	0.00549451	0.2716892705184795
DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	0.00549451	0.2716892705184795
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.00549451	0.2716892705184795
JUVENILE HUNTINGTON DISEASE	0.00549451	0.2716892705184795
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.005493619999999999	0.2716452623265276
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.005493619999999999	0.2716452623265276
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.005461140000000001	0.270039210557318
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.005461140000000001	0.270039210557318
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.005461140000000001	0.270039210557318
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.005461140000000001	0.270039210557318
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.005461140000000001	0.270039210557318
SECKEL SYNDROME	0.00545469	0.2697202747841837
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00543435	0.2687145145321601
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00543435	0.2687145145321601
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005401260000000001	0.26707829984487114
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00538685	0.2663657627145044
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00538685	0.2663657627145044
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00538685	0.2663657627145044
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.00537316	0.2656888277169527
COG5-CDG	0.00537316	0.2656888277169527
HELSMOORTEL-VAN DER AA SYNDROME	0.00533464	0.2637841136113505
SCARF SYNDROME	0.00533464	0.2637841136113505
GOLDBERG-SHPRINTZEN SYNDROME	0.00533464	0.2637841136113505
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00533319	0.26371241487165364
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00527476	0.26082320289890365
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00527476	0.26082320289890365
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00527302	0.26073716441126743
ISOTRETINOIN SYNDROME	0.00527302	0.26073716441126743
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00527302	0.26073716441126743
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00521459	0.2578479524385174
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00521459	0.2578479524385174
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00521459	0.2578479524385174
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.00521459	0.2578479524385174
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00521459	0.2578479524385174
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00521459	0.2578479524385174
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00516709	0.2554992006208616
DISTAL TRISOMY 14Q	0.00516709	0.2554992006208616
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00516709	0.2554992006208616
CYCLIC VOMITING SYNDROME	0.00516709	0.2554992006208616
COWDEN SYNDROME	0.00516709	0.2554992006208616
CONGENITAL TOXOPLASMOSIS	0.00516709	0.2554992006208616
THANATOPHORIC DYSPLASIA TYPE 2	0.00516709	0.2554992006208616
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00516709	0.2554992006208616
BARDET-BIEDL SYNDROME 16; BBS16	0.00516709	0.2554992006208616
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0051534	0.2548222656233099
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.0051534	0.2548222656233099
USHER SYNDROME	0.0051534	0.2548222656233099
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.0051534	0.2548222656233099
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.0051534	0.2548222656233099
SUSAC SYNDROME	0.0051534	0.2548222656233099
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.0051534	0.2548222656233099
MERRF	0.0051534	0.2548222656233099
VOGT-KOYANAGI-HARADA DISEASE	0.0051534	0.2548222656233099
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.0051534	0.2548222656233099
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.0051534	0.2548222656233099
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00511988	0.25316478855114527
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00510547	0.2524522514207785
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00510547	0.2524522514207785
ALLAN-HERNDON-DUDLEY SYNDROME	0.00506145	0.2502755765783952
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.00506145	0.2502755765783952
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.00506145	0.2502755765783952
COFFIN-SIRIS SYNDROME 5	0.00506145	0.2502755765783952
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.00506145	0.2502755765783952
HADZISELIMOVIC SYNDROME	0.00506145	0.2502755765783952
OHDO SYNDROME	0.00504704	0.2495630394480285
DEAFNESS, X-LINKED 7; DFNX7	0.00504704	0.2495630394480285
EMANUEL SYNDROME	0.00504559	0.2494913407083316
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0050139500000000005	0.24792682476073943
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0050139500000000005	0.24792682476073943
TRANSKETOLASE DEFICIENCY	0.0050139500000000005	0.24792682476073943
YOU-HOOVER-FONG SYNDROME; YHFS	0.0050139500000000005	0.24792682476073943
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0050139500000000005	0.24792682476073943
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0050139500000000005	0.24792682476073943
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0050139500000000005	0.24792682476073943
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0050139500000000005	0.24792682476073943
OPTIC ATROPHY 11; OPA11	0.0050139500000000005	0.24792682476073943
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.00500026	0.24724988976318768
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00500026	0.24724988976318768
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.00500026	0.24724988976318768
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00500026	0.24724988976318768
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00500026	0.24724988976318768
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.00500026	0.24724988976318768
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.00500026	0.24724988976318768
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00500026	0.24724988976318768
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00500026	0.24724988976318768
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00500026	0.24724988976318768
CAREY-FINEMAN-ZITER SYNDROME	0.00499338	0.24690969160517778
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00499338	0.24690969160517778
AU-KLINE SYNDROME; AUKS	0.00499338	0.24690969160517778
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00498716	0.2466021287355816
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00497347	0.24592519373802985
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.00494588	0.24456093978752197
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00493219	0.24388400478997027
MESOMELIA-SYNOSTOSES SYNDROME	0.00488745	0.24167172781477197
LATHOSTEROLOSIS	0.00488745	0.24167172781477197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00485852	0.24024121433930287
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.00485852	0.24024121433930287
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.00485852	0.24024121433930287
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00485852	0.24024121433930287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.00485852	0.24024121433930287
49,XXXYY SYNDROME	0.00485852	0.24024121433930287
CHROMOSOME 9P DELETION SYNDROME	0.00485852	0.24024121433930287
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00485852	0.24024121433930287
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00485437	0.2400360076015498
PARAGANGLIOMAS 1	0.00485437	0.2400360076015498
OTOSCLEROSIS	0.00485437	0.2400360076015498
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.00485437	0.2400360076015498
ACHONDROPLASIA	0.00485437	0.2400360076015498
PIGMENTED VILLONODULAR SYNOVITIS	0.00485437	0.2400360076015498
NON-FUNCTIONING PARAGANGLIOMA	0.00485437	0.2400360076015498
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00485437	0.2400360076015498
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00485437	0.2400360076015498
OTOFACIOCERVICAL SYNDROME	0.00485437	0.2400360076015498
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00485437	0.2400360076015498
COOPER-JABS SYNDROME	0.00485437	0.2400360076015498
FAMILIAL EXPANSILE OSTEOLYSIS	0.00485437	0.2400360076015498
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.00485437	0.2400360076015498
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00485437	0.2400360076015498
2Q37 MICRODELETION SYNDROME	0.00485437	0.2400360076015498
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00485437	0.2400360076015498
TURNPENNY-FRY SYNDROME; TPFS	0.00485437	0.2400360076015498
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.00485437	0.2400360076015498
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.00485437	0.2400360076015498
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00485437	0.2400360076015498
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00485437	0.2400360076015498
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00485437	0.2400360076015498
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00485437	0.2400360076015498
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00485437	0.2400360076015498
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00485437	0.2400360076015498
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00485437	0.2400360076015498
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00485437	0.2400360076015498
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.00485437	0.2400360076015498
CILIARY DYSKINESIA, PRIMARY, 33	0.00485437	0.2400360076015498
MULTIPLE SYNOSTOSES SYNDROME	0.00485437	0.2400360076015498
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00485437	0.2400360076015498
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00482626	0.23864604099956446
RING CHROMOSOME 10 SYNDROME	0.0047588100000000005	0.2353108134184933
MAN1B1-CDG	0.0047588100000000005	0.2353108134184933
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.0047588100000000005	0.2353108134184933
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0047588100000000005	0.2353108134184933
FRANK-TER HAAR SYNDROME	0.0047588100000000005	0.2353108134184933
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0047588100000000005	0.2353108134184933
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0047588100000000005	0.2353108134184933
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.0047588100000000005	0.2353108134184933
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.0047588100000000005	0.2353108134184933
MONOSOMY 5P	0.0047588100000000005	0.2353108134184933
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0047588100000000005	0.2353108134184933
COG1-CDG	0.0047588100000000005	0.2353108134184933
20P12.3 MICRODELETION SYNDROME	0.0047588100000000005	0.2353108134184933
HEREDITARY OROTIC ACIDURIA	0.0047588100000000005	0.2353108134184933
CRANIOFACIAL DYSSYNOSTOSIS	0.0047588100000000005	0.2353108134184933
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.0047588100000000005	0.2353108134184933
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.0047588100000000005	0.2353108134184933
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.0047588100000000005	0.2353108134184933
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00473934	0.23434807241028785
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.00473934	0.23434807241028785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.23434807241028785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00473934	0.23434807241028785
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00473934	0.23434807241028785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.00473934	0.23434807241028785
SPINOCEREBELLAR ATAXIA TYPE 10	0.00473934	0.23434807241028785
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.23434807241028785
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00473934	0.23434807241028785
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00473934	0.23434807241028785
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.23434807241028785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.00473934	0.23434807241028785
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.00473934	0.23434807241028785
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.23434807241028785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.00473934	0.23434807241028785
16P13.11 MICRODUPLICATION SYNDROME	0.00473934	0.23434807241028785
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00473934	0.23434807241028785
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.00473934	0.23434807241028785
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00473934	0.23434807241028785
BRUNNER SYNDROME; BRNRS	0.00473934	0.23434807241028785
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00473934	0.23434807241028785
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.00473934	0.23434807241028785
JAWAD SYNDROME	0.00473934	0.23434807241028785
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00473934	0.23434807241028785
MENTAL RETARDATION, X-LINKED 99	0.00473934	0.23434807241028785
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00473934	0.23434807241028785
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00473934	0.23434807241028785
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.23434807241028785
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.00473934	0.23434807241028785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00473934	0.23434807241028785
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00473934	0.23434807241028785
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.00473934	0.23434807241028785
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.00473934	0.23434807241028785
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00473934	0.23434807241028785
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00473934	0.23434807241028785
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00473934	0.23434807241028785
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00473934	0.23434807241028785
WILSON DISEASE	0.00473934	0.23434807241028785
GLYCINE ENCEPHALOPATHY; GCE	0.00473934	0.23434807241028785
KNIEST DYSPLASIA	0.00470578	0.23268861744185568
MOEBIUS SYNDROME	0.00470578	0.23268861744185568
20Q13.33 MICRODELETION SYNDROME	0.00469893	0.23234990270604639
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00469893	0.23234990270604639
20P13 MICRODELETION SYNDROME	0.00469893	0.23234990270604639
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00469893	0.23234990270604639
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00469893	0.23234990270604639
SHUKLA-VERNON SYNDROME; SHUVER	0.00469893	0.23234990270604639
DISTAL TRISOMY 5Q	0.00469893	0.23234990270604639
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00469893	0.23234990270604639
WRINKLY SKIN SYNDROME	0.00469893	0.23234990270604639
CDAGS SYNDROME	0.00469209	0.232011682444304
KALLMANN SYNDROME	0.00469209	0.232011682444304
DISTAL MONOSOMY 13Q	0.0046387600000000005	0.22937465224566017
TRISOMY X	0.0046387600000000005	0.22937465224566017
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00457714	0.22632770304557703
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.00457714	0.22632770304557703
TARP SYNDROME; TARPS	0.00457714	0.22632770304557703
FACIOCARDIORENAL SYNDROME	0.00457714	0.22632770304557703
STROMME SYNDROME; STROMS	0.00457714	0.22632770304557703
TRISOMY 12P	0.00457714	0.22632770304557703
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00457714	0.22632770304557703
MONOSOMY 13Q14	0.0045187100000000004	0.223438491072827
PFEIFFER SYNDROME	0.0045187100000000004	0.223438491072827
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.00451726	0.22336679233313014
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.0045172599999999995	0.22336679233313012
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1	0.0045045	0.22273584342379776
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.0045045	0.22273584342379776
CUTANEOUS MASTOCYTOSIS	0.0045045	0.22273584342379776
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0045045	0.22273584342379776
CHRONIC GRAFT VERSUS HOST DISEASE	0.0045045	0.22273584342379776
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0045045	0.22273584342379776
ALOPECIA, ANDROGENETIC, 1	0.0045045	0.22273584342379776
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0045045	0.22273584342379776
ADAMS-OLIVER SYNDROME	0.0045045	0.22273584342379776
KERION CELSI	0.0045045	0.22273584342379776
MARIE UNNA HEREDITARY HYPOTRICHOSIS	0.0045045	0.22273584342379776
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.0045045	0.22273584342379776
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0045045	0.22273584342379776
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.0045045	0.22273584342379776
PORPHYRIA CUTANEA TARDA	0.0045045	0.22273584342379776
SARCOIDOSIS	0.0045045	0.22273584342379776
HYPOTRICHOSIS SIMPLEX	0.0045045	0.22273584342379776
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.0045045	0.22273584342379776
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.0045045	0.22273584342379776
ATYPICAL WERNER SYNDROME	0.0045045	0.22273584342379776
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.0045045	0.22273584342379776
LICHEN PLANOPILARIS	0.0045045	0.22273584342379776
HYPOGONADISM, PRIMARY, AND PARTIAL ALOPECIA	0.0045045	0.22273584342379776
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.0045045	0.22273584342379776
LETHAL ACANTHOLYTIC EPIDERMOLYSIS BULLOSA	0.0045045	0.22273584342379776
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.0045045	0.22273584342379776
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.0045045	0.22273584342379776
HEMOCHROMATOSIS, TYPE 1	0.0045045	0.22273584342379776
THUMB DEFORMITY AND ALOPECIA	0.0045045	0.22273584342379776
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.0045045	0.22273584342379776
SCHÖPF-SCHULZ-PASSARGE SYNDROME	0.0045045	0.22273584342379776
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0045045	0.22273584342379776
MONILETHRIX; MNLIX	0.0045045	0.22273584342379776
KIKUCHI-FUJIMOTO DISEASE	0.0045045	0.22273584342379776
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.0045045	0.22273584342379776
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.0045045	0.22273584342379776
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.0045045	0.22273584342379776
MARIE UNNA HEREDITARY HYPOTRICHOSIS 1	0.0045045	0.22273584342379776
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.0045045	0.22273584342379776
GRAHAM LITTLE-PICCARDI-LASSUEUR SYNDROME	0.0045045	0.22273584342379776
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0045045	0.22273584342379776
MIXED CONNECTIVE TISSUE DISEASE	0.0045045	0.22273584342379776
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.0045045	0.22273584342379776
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0045045	0.22273584342379776
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0045045	0.22273584342379776
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	0.0045045	0.22273584342379776
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0045045	0.22273584342379776
MANDIBULOACRAL DYSPLASIA	0.0045045	0.22273584342379776
T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY	0.0045045	0.22273584342379776
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.0045045	0.22273584342379776
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0045045	0.22273584342379776
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.0045045	0.22273584342379776
COLCHICINE POISONING	0.0045045	0.22273584342379776
BATHING SUIT ICHTHYOSIS	0.0045045	0.22273584342379776
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0045045	0.22273584342379776
ALPHA-HEAVY CHAIN DISEASE	0.0045045	0.22273584342379776
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0045045	0.22273584342379776
HYPOTRICHOSIS 5; HYPT5	0.0045045	0.22273584342379776
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.0045045	0.22273584342379776
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.0045045	0.22273584342379776
CENTRIFUGAL LIPODYSTROPHY	0.0045045	0.22273584342379776
TRICHOTILLOMANIA; TTM	0.0045045	0.22273584342379776
PSEUDOPROGERIA SYNDROME	0.0045045	0.22273584342379776
OLIVER-MCFARLANE SYNDROME	0.0045045	0.22273584342379776
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0045045	0.22273584342379776
LINEAR NEVUS SEBACEUS SYNDROME	0.0045045	0.22273584342379776
CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK	0.0045045	0.22273584342379776
HALLERMANN-STREIFF SYNDROME	0.0045045	0.22273584342379776
ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6	0.0045045	0.22273584342379776
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.0045045	0.22273584342379776
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.0045045	0.22273584342379776
HYPOTRICHOSIS 11; HYPT11	0.0045045	0.22273584342379776
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.0045045	0.22273584342379776
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.0045045	0.22273584342379776
ULERYTHEMA OPHRYOGENESIS	0.0045045	0.22273584342379776
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.0045045	0.22273584342379776
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.0045045	0.22273584342379776
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.0045045	0.22273584342379776
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.0045045	0.22273584342379776
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0045045	0.22273584342379776
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0045045	0.22273584342379776
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0045045	0.22273584342379776
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.0045045	0.22273584342379776
PSEUDOPELADE OF BROCQ	0.0045045	0.22273584342379776
ALOPECIA, CONGENITAL	0.0045045	0.22273584342379776
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.0045045	0.22273584342379776
INSULIN-RESISTANCE SYNDROME TYPE B	0.0045045	0.22273584342379776
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004485620000000001	0.221802276385538
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004485620000000001	0.221802276385538
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.004485620000000001	0.221802276385538
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.004485620000000001	0.221802276385538
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004485620000000001	0.221802276385538
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004485620000000001	0.221802276385538
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.004485620000000001	0.221802276385538
IMMUNODEFICIENCY 49; IMD49	0.004485620000000001	0.221802276385538
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004485620000000001	0.221802276385538
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004485620000000001	0.221802276385538
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00447121	0.2210897392551712
AXENFELD-RIEGER SYNDROME	0.00447121	0.2210897392551712
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00447121	0.2210897392551712
ACRODYSOSTOSIS	0.00447121	0.2210897392551712
BARBER-SAY SYNDROME	0.00447121	0.2210897392551712
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.00445883	0.22047758036038012
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00445883	0.22047758036038012
VERVERI-BRADY SYNDROME; VERBRAS	0.00445883	0.22047758036038012
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00445883	0.22047758036038012
SHASHI-PENA SYNDROME; SHAPNS	0.00445883	0.22047758036038012
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00445752	0.22041280425761953
STEEL SYNDROME; STLS	0.00445752	0.22041280425761953
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00445752	0.22041280425761953
2Q24 MICRODELETION SYNDROME	0.00441755	0.21843639141232055
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00441755	0.21843639141232055
ANTLEY-BIXLER SYNDROME	0.00441755	0.21843639141232055
TRISOMY 1Q	0.00441755	0.21843639141232055
RITSCHER-SCHINZEL SYNDROME 1	0.00441755	0.21843639141232055
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.00441133	0.2181288285427243
GENITOPATELLAR SYNDROME	0.00441133	0.2181288285427243
8P23.1 DUPLICATION SYNDROME	0.00441133	0.2181288285427243
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.0043976399999999995	0.21745189354517258
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0043976399999999995	0.21745189354517258
NOONAN SYNDROME 9; NS9	0.00435912	0.2155471794395705
JOUBERT SYNDROME 14	0.00435912	0.2155471794395705
PROTEUS SYNDROME	0.00435912	0.2155471794395705
NOONAN SYNDROME 4; NS4	0.00435912	0.2155471794395705
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00435912	0.2155471794395705
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00435912	0.2155471794395705
LEGIUS SYNDROME	0.00435912	0.2155471794395705
NEUROFACIODIGITORENAL SYNDROME	0.00435912	0.2155471794395705
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00435912	0.2155471794395705
NOONAN SYNDROME 2; NS2	0.00435912	0.2155471794395705
NOONAN SYNDROME 5; NS5	0.00435912	0.2155471794395705
FRIAS SYNDROME	0.00435912	0.2155471794395705
NOONAN SYNDROME 8; NS8	0.00435912	0.2155471794395705
NOONAN SYNDROME 10; NS10	0.00435912	0.2155471794395705
MESOMELIA-SYNOSTOSES SYNDROME	0.00435912	0.2155471794395705
COSTELLO SYNDROME; CSTLO	0.00435912	0.2155471794395705
CAT-EYE SYNDROME	0.00431162	0.21319842762191474
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.00431162	0.21319842762191474
XP22.13P22.2 DUPLICATION SYNDROME	0.00431162	0.21319842762191474
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00431162	0.21319842762191474
17P11.2 MICRODUPLICATION SYNDROME	0.00431162	0.21319842762191474
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00431162	0.21319842762191474
POTOCKI-LUPSKI SYNDROME	0.00431162	0.21319842762191474
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00431034	0.21313513494135478
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00431034	0.21313513494135478
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.21313513494135478
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00431034	0.21313513494135478
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.00431034	0.21313513494135478
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.00431034	0.21313513494135478
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00431034	0.21313513494135478
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00431034	0.21313513494135478
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00431034	0.21313513494135478
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.00431034	0.21313513494135478
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.21313513494135478
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.00431034	0.21313513494135478
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.00431034	0.21313513494135478
CHÉDIAK-HIGASHI SYNDROME	0.00431034	0.21313513494135478
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00431034	0.21313513494135478
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00431034	0.21313513494135478
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.00431034	0.21313513494135478
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.00431034	0.21313513494135478
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.21313513494135478
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.00431034	0.21313513494135478
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00431034	0.21313513494135478
PANDAS	0.00431034	0.21313513494135478
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.21313513494135478
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00431034	0.21313513494135478
WHIPPLE DISEASE	0.00431034	0.21313513494135478
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.00431034	0.21313513494135478
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.00431034	0.21313513494135478
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.21313513494135478
OPTIC PATHWAY GLIOMA	0.00431034	0.21313513494135478
SCHINDLER DISEASE, TYPE I	0.00431034	0.21313513494135478
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.21313513494135478
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.00431034	0.21313513494135478
COG8-CDG	0.00431034	0.21313513494135478
INFANTILE NEUROAXONAL DYSTROPHY	0.00431034	0.21313513494135478
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.00431034	0.21313513494135478
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.00431034	0.21313513494135478
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00431034	0.21313513494135478
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.00431034	0.21313513494135478
ALPERS-HUTTENLOCHER SYNDROME	0.00431034	0.21313513494135478
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00431034	0.21313513494135478
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00431034	0.21313513494135478
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.00431034	0.21313513494135478
CARNOSINASE DEFICIENCY	0.00431034	0.21313513494135478
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00431034	0.21313513494135478
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.00431034	0.21313513494135478
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.00431034	0.21313513494135478
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.21313513494135478
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.00431034	0.21313513494135478
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00431034	0.21313513494135478
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.00431034	0.21313513494135478
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00431034	0.21313513494135478
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.00431034	0.21313513494135478
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00431034	0.21313513494135478
AICARDI-GOUTIERES SYNDROME 6	0.00431034	0.21313513494135478
ALEXANDER DISEASE	0.00431034	0.21313513494135478
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00431034	0.21313513494135478
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00431034	0.21313513494135478
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00431034	0.21313513494135478
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00431034	0.21313513494135478
RETT SYNDROME, CONGENITAL VARIANT	0.00431034	0.21313513494135478
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00429793	0.21252149262436298
DONNAI-BARROW SYNDROME	0.00429793	0.21252149262436298
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00429793	0.21252149262436298
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00417745	0.20656406906665423
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00417745	0.20656406906665423
MARDEN-WALKER SYNDROME	0.00417745	0.20656406906665423
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00417745	0.20656406906665423
SCHWARTZ-JAMPEL SYNDROME	0.00417745	0.20656406906665423
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00412995	0.20421531724899847
MOSAIC TRISOMY 8	0.00412995	0.20421531724899847
CAMPOMELIC DYSPLASIA	0.00412995	0.20421531724899847
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00412995	0.20421531724899847
CAMPOMELIC DYSPLASIA	0.00412995	0.20421531724899847
CLEIDOCRANIAL DYSPLASIA; CCD	0.00412995	0.20421531724899847
PFEIFFER SYNDROME TYPE 3	0.00412995	0.20421531724899847
DIASTROPHIC DWARFISM	0.00412995	0.20421531724899847
CLEIDOCRANIAL DYSPLASIA	0.00412995	0.20421531724899847
DUPLICATION OF THE PITUITARY GLAND	0.00412995	0.20421531724899847
SIFRIM-HITZ-WEISS SYNDROME	0.00407152	0.20132610527624847
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00407152	0.20132610527624847
CRANIOSYNOSTOSIS 6; CRS6	0.00405783	0.20064917027869672
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0038694000000000003	0.191331795436573
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0038694000000000003	0.191331795436573
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0038694000000000003	0.191331795436573
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0038694000000000003	0.191331795436573
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0038694000000000003	0.191331795436573
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0038694000000000003	0.191331795436573
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.0038694000000000003	0.191331795436573
FILIPPI SYNDROME	0.00376969	0.18640139451576337
NEONATAL MARFAN SYNDROME	0.00376969	0.18640139451576337
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00376969	0.18640139451576337
8P23.1 MICRODELETION SYNDROME	0.00376969	0.18640139451576337
POTOCKI-SHAFFER SYNDROME	0.00376969	0.18640139451576337
JOUBERT SYNDROME 10	0.00376969	0.18640139451576337
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00376969	0.18640139451576337
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00370981	0.1834404838033165
SOTOS SYNDROME 2	0.00370981	0.1834404838033165
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.00370981	0.1834404838033165
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00370981	0.1834404838033165
15Q11Q13 MICRODUPLICATION SYNDROME	0.00370981	0.1834404838033165
MAXILLOFACIAL DYSOSTOSIS	0.00370981	0.1834404838033165
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.00370981	0.1834404838033165
MEIER-GORLIN SYNDROME 3; MGORS3	0.00370981	0.1834404838033165
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00370981	0.1834404838033165
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.00370981	0.1834404838033165
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.00370981	0.1834404838033165
3Q27.3 MICRODELETION SYNDROME	0.00370981	0.1834404838033165
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.00370981	0.1834404838033165
BARDET-BIEDL SYNDROME 18; BBS18	0.00364964	0.18046523334293024
BARDET-BIEDL SYNDROME 5; BBS5	0.00364964	0.18046523334293024
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00364964	0.18046523334293024
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.00364964	0.18046523334293024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.00364964	0.18046523334293024
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00364964	0.18046523334293024
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00364964	0.18046523334293024
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00364964	0.18046523334293024
BARDET-BIEDL SYNDROME 8; BBS8	0.00364964	0.18046523334293024
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.00364964	0.18046523334293024
BARDET-BIEDL SYNDROME 10; BBS10	0.00364964	0.18046523334293024
BARDET-BIEDL SYNDROME 12; BBS12	0.00364964	0.18046523334293024
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.00364964	0.18046523334293024
BARDET-BIEDL SYNDROME 17; BBS17	0.00364964	0.18046523334293024
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00364964	0.18046523334293024
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.00364964	0.18046523334293024
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00364964	0.18046523334293024
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00364964	0.18046523334293024
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.00364964	0.18046523334293024
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.00364964	0.18046523334293024
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00364964	0.18046523334293024
ALG2-CDG	0.00364964	0.18046523334293024
ALG9-CDG	0.00364964	0.18046523334293024
ALG12-CDG	0.00364964	0.18046523334293024
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00364964	0.18046523334293024
JOUBERT SYNDROME 31; JBTS31	0.00364964	0.18046523334293024
CONGENITAL SHORT BOWEL SYNDROME	0.00364964	0.18046523334293024
MPDU1-CDG	0.00364964	0.18046523334293024
SCHIZOPHRENIA 19; SCZD19	0.00364964	0.18046523334293024
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00364964	0.18046523334293024
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00364964	0.18046523334293024
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00364964	0.18046523334293024
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.00364964	0.18046523334293024
ISOLATED CLOVERLEAF SKULL SYNDROME	0.00364964	0.18046523334293024
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00364964	0.18046523334293024
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00364964	0.18046523334293024
DYSTONIA 28, CHILDHOOD-ONSET	0.00364964	0.18046523334293024
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00364964	0.18046523334293024
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00364964	0.18046523334293024
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.00364964	0.18046523334293024
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00364964	0.18046523334293024
EPISODIC ATAXIA TYPE 7	0.00364964	0.18046523334293024
SPINOCEREBELLAR ATAXIA 42	0.00364964	0.18046523334293024
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00364964	0.18046523334293024
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.00364964	0.18046523334293024
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.18046523334293024
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00364964	0.18046523334293024
SPINOCEREBELLAR ATAXIA 5; SCA5	0.00364964	0.18046523334293024
GALACTOSEMIA	0.00364964	0.18046523334293024
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.00364964	0.18046523334293024
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00364964	0.18046523334293024
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00364964	0.18046523334293024
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00364964	0.18046523334293024
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00364964	0.18046523334293024
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00364964	0.18046523334293024
EARLY-ONSET SCHIZOPHRENIA	0.00364964	0.18046523334293024
DYSTONIA-APHONIA SYNDROME	0.00364964	0.18046523334293024
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.00364964	0.18046523334293024
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00364964	0.18046523334293024
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00364964	0.18046523334293024
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00364964	0.18046523334293024
SPINOCEREBELLAR ATAXIA TYPE 14	0.00364964	0.18046523334293024
LYSINURIC PROTEIN INTOLERANCE	0.00364964	0.18046523334293024
LEIGH SYNDROME	0.00364964	0.18046523334293024
SPINOCEREBELLAR ATAXIA 1	0.00364964	0.18046523334293024
LYMPHANGIOLEIOMYOMATOSIS	0.00364964	0.18046523334293024
ONDINE SYNDROME	0.00364964	0.18046523334293024
MALARIA	0.00364964	0.18046523334293024
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00364964	0.18046523334293024
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.00364964	0.18046523334293024
SPINOCEREBELLAR ATAXIA TYPE 32	0.00364964	0.18046523334293024
PRUNE BELLY SYNDROME	0.00364964	0.18046523334293024
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00364964	0.18046523334293024
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00364964	0.18046523334293024
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00364964	0.18046523334293024
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00364964	0.18046523334293024
PAPILLOMA OF CHOROID PLEXUS	0.00364964	0.18046523334293024
ALPHA-THALASSEMIA	0.00364964	0.18046523334293024
PHAKOMATOSIS PIGMENTOVASCULARIS	0.00364964	0.18046523334293024
REACTIVE ARTHRITIS	0.00364964	0.18046523334293024
SPINOCEREBELLAR ATAXIA 32; SCA32	0.00364964	0.18046523334293024
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.00364964	0.18046523334293024
SECKEL SYNDROME 4	0.00364964	0.18046523334293024
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00364964	0.18046523334293024
DISTAL TRISOMY 18Q	0.00364964	0.18046523334293024
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00364964	0.18046523334293024
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.00364964	0.18046523334293024
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00364964	0.18046523334293024
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00364964	0.18046523334293024
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00364964	0.18046523334293024
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00364964	0.18046523334293024
JOUBERT SYNDROME 4	0.00364964	0.18046523334293024
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00364964	0.18046523334293024
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00364964	0.18046523334293024
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00364964	0.18046523334293024
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.00364964	0.18046523334293024
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.00364964	0.18046523334293024
ATAXIA-TELANGIECTASIA	0.00364964	0.18046523334293024
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00364964	0.18046523334293024
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00364964	0.18046523334293024
BENIGN FAMILIAL NEONATAL EPILEPSY	0.00364964	0.18046523334293024
CRISPONI SYNDROME	0.00364964	0.18046523334293024
SYMMETRICAL THALAMIC CALCIFICATIONS	0.00364964	0.18046523334293024
ISOLATED ECTOPIA LENTIS	0.00364964	0.18046523334293024
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00364964	0.18046523334293024
FACIOCARDIORENAL SYNDROME	0.00358802	0.1774182841428471
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00358802	0.1774182841428471
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00358802	0.1774182841428471
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00358802	0.1774182841428471
JOUBERT SYNDROME 3; JBTS3	0.00352959	0.17452907217009708
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00352959	0.17452907217009708
608028 THAI SYMPHALANGISM SYNDROME	0.00352959	0.17452907217009708
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.00352959	0.17452907217009708
PERLMAN SYNDROME	0.00352959	0.17452907217009708
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00352959	0.17452907217009708
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00352959	0.17452907217009708
17Q12 MICRODUPLICATION SYNDROME	0.00352814	0.17445737343040024
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0034965000000000005	0.17289285748280808
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.0034965000000000005	0.17289285748280808
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.0034965000000000005	0.17289285748280808
OLIVER SYNDROME	0.0034965000000000005	0.17289285748280808
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.0034965000000000005	0.17289285748280808
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0034965000000000005	0.17289285748280808
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0034965000000000005	0.17289285748280808
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.0034965000000000005	0.17289285748280808
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.0034965000000000005	0.17289285748280808
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0034965000000000005	0.17289285748280808
JOUBERT SYNDROME 24	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.17289285748280808
PEHO-LIKE SYNDROME; PEHOL	0.0034965000000000005	0.17289285748280808
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0034965000000000005	0.17289285748280808
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0034965000000000005	0.17289285748280808
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0034965000000000005	0.17289285748280808
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0034965000000000005	0.17289285748280808
MUCOLIPIDOSIS TYPE IV	0.0034965000000000005	0.17289285748280808
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0034965000000000005	0.17289285748280808
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0034965000000000005	0.17289285748280808
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.0034965000000000005	0.17289285748280808
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.17289285748280808
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.0034965000000000005	0.17289285748280808
LISSENCEPHALY 8; LIS8	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0034965000000000005	0.17289285748280808
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.0034965000000000005	0.17289285748280808
WARBURG MICRO SYNDROME 2; WARBM2	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0034965000000000005	0.17289285748280808
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, X-LINKED 98; MRX98	0.0034965000000000005	0.17289285748280808
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0034965000000000005	0.17289285748280808
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.0034965000000000005	0.17289285748280808
XQ28 (MECP2) DUPLICATION	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0034965000000000005	0.17289285748280808
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, X-LINKED 103	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0034965000000000005	0.17289285748280808
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0034965000000000005	0.17289285748280808
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.0034965000000000005	0.17289285748280808
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0034965000000000005	0.17289285748280808
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0034965000000000005	0.17289285748280808
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0034965000000000005	0.17289285748280808
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0034965000000000005	0.17289285748280808
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0034965000000000005	0.17289285748280808
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0034965000000000005	0.17289285748280808
AL-RAQAD SYNDROME; ARS	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.0034965000000000005	0.17289285748280808
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0034965000000000005	0.17289285748280808
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0034965000000000005	0.17289285748280808
ADENYLOSUCCINATE LYASE DEFICIENCY	0.0034965000000000005	0.17289285748280808
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0034965000000000005	0.17289285748280808
SCHAAF-YANG SYNDROME; SHFYNG	0.0034965000000000005	0.17289285748280808
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.0034965000000000005	0.17289285748280808
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0034965000000000005	0.17289285748280808
COG4-CDG	0.0034965000000000005	0.17289285748280808
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0034965000000000005	0.17289285748280808
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0034965000000000005	0.17289285748280808
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0034965000000000005	0.17289285748280808
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0034965000000000005	0.17289285748280808
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0034965000000000005	0.17289285748280808
ANGELMAN SYNDROME	0.0034965000000000005	0.17289285748280808
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.0034965000000000005	0.17289285748280808
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0034965000000000005	0.17289285748280808
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.0034965000000000005	0.17289285748280808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0034965000000000005	0.17289285748280808
INFANTILE DYSTONIA-PARKINSONISM	0.0034965000000000005	0.17289285748280808
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0034965000000000005	0.17289285748280808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0034965000000000005	0.17289285748280808
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.0034965000000000005	0.17289285748280808
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.0034965000000000005	0.17289285748280808
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0034965000000000005	0.17289285748280808
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.0034965000000000005	0.17289285748280808
ZIMMERMANN-LABAND SYNDROME 1	0.00348209	0.17218032035244132
PIEBALDISM	0.00348209	0.17218032035244132
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00348209	0.17218032035244132
WAARDENBURG-SHAH SYNDROME	0.00348209	0.17218032035244132
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00348209	0.17218032035244132
FEINGOLD SYNDROME 1; FGLDS1	0.00348209	0.17218032035244132
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.00348209	0.17218032035244132
HURLER SYNDROME	0.00348209	0.17218032035244132
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.00346971	0.1715681614576502
CHROMOSOME 5Q12 DELETION SYNDROME	0.00346971	0.1715681614576502
WIEACKER-WOLFF SYNDROME	0.00346971	0.1715681614576502
JOUBERT SYNDROME 30; JBTS30	0.00346971	0.1715681614576502
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00346971	0.1715681614576502
11Q22.2Q22.3 MICRODELETION SYNDROME	0.00346971	0.1715681614576502
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00346971	0.1715681614576502
9Q21.13 MICRODELETION SYNDROME	0.00346971	0.1715681614576502
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.00346971	0.1715681614576502
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.00346971	0.1715681614576502
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00346971	0.1715681614576502
1Q21.1 MICRODELETION SYNDROME	0.0034684	0.17150338535488957
COFS SYNDROME	0.0034684	0.17150338535488957
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.0034684	0.17150338535488957
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.0034684	0.17150338535488957
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0034684	0.17150338535488957
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.0034684	0.17150338535488957
8Q12 MICRODUPLICATION SYNDROME	0.0034684	0.17150338535488957
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0034684	0.17150338535488957
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0034684	0.17150338535488957
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00342843	0.16952697250959062
MARFAN SYNDROME	0.00342843	0.16952697250959062
LOWRY-MACLEAN SYNDROME	0.00342843	0.16952697250959062
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00342843	0.16952697250959062
SECKEL SYNDROME 1; SCKL1	0.00342843	0.16952697250959062
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00342843	0.16952697250959062
16Q24.3 MICRODELETION SYNDROME	0.00342221	0.16921940963999443
13Q12.3 MICRODELETION SYNDROME	0.00342221	0.16921940963999443
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00342221	0.16921940963999443
SIALIDOSIS TYPE 2	0.00342221	0.16921940963999443
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00342221	0.16921940963999443
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00342221	0.16921940963999443
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00342221	0.16921940963999443
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00342221	0.16921940963999443
GALACTOSE EPIMERASE DEFICIENCY	0.00340852	0.16854247464244268
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00340852	0.16854247464244268
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00340852	0.16854247464244268
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00340852	0.16854247464244268
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00340852	0.16854247464244268
2P15-16.1 MICRODELETION SYNDROME	0.00337	0.1666377605368406
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00337	0.1666377605368406
SCARF SYNDROME	0.00337	0.1666377605368406
RUVALCABA SYNDROME	0.00337	0.1666377605368406
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00337	0.1666377605368406
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00337	0.1666377605368406
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00337	0.1666377605368406
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00337	0.1666377605368406
DISTAL TRISOMY 15Q	0.00337	0.1666377605368406
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.00337	0.1666377605368406
PROTEUS SYNDROME	0.00337	0.1666377605368406
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0033225	0.16428900871918484
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0033225	0.16428900871918484
THANATOPHORIC DYSPLASIA	0.0033225	0.16428900871918484
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0033225	0.16428900871918484
WAARDENBURG SYNDROME TYPE 3	0.0033225	0.16428900871918484
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0033225	0.16428900871918484
GENITOPATELLAR SYNDROME; GTPTS	0.0033225	0.16428900871918484
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0033225	0.16428900871918484
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0033225	0.16428900871918484
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00330881	0.1636120737216331
CONGENITAL HYDROCEPHALUS	0.00330881	0.1636120737216331
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00330881	0.1636120737216331
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00330881	0.1636120737216331
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.00330881	0.1636120737216331
MECKEL SYNDROME, TYPE 10; MKS10	0.00318833	0.15765465016392433
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00318833	0.15765465016392433
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00318833	0.15765465016392433
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00318833	0.15765465016392433
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00318833	0.15765465016392433
TYSHCHENKO SYNDROME	0.00318833	0.15765465016392433
JOUBERT SYNDROME WITH OCULAR DEFECT	0.00318833	0.15765465016392433
JOUBERT SYNDROME WITH RENAL DEFECT	0.00318833	0.15765465016392433
AASE-SMITH SYNDROME I	0.00318833	0.15765465016392433
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.00314083	0.15530589834626854
CHARGE-LIKE SYNDROME, X-LINKED	0.00314083	0.15530589834626854
MEIER-GORLIN SYNDROME 7	0.00314083	0.15530589834626854
MEIER-GORLIN SYNDROME 1; MGORS1	0.00314083	0.15530589834626854
TIBIAL HEMIMELIA	0.00314083	0.15530589834626854
RAPADILINO SYNDROME	0.00314083	0.15530589834626854
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00314083	0.15530589834626854
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00314083	0.15530589834626854
DIABETIC EMBRYOPATHY	0.00314083	0.15530589834626854
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00314083	0.15530589834626854
GORDON SYNDROME	0.00314083	0.15530589834626854
BOR SYNDROME	0.00314083	0.15530589834626854
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00314083	0.15530589834626854
STICKLER SYNDROME TYPE 2	0.00312714	0.15462896334871684
STICKLER SYNDROME TYPE 1	0.00312714	0.15462896334871684
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00312714	0.15462896334871684
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00312714	0.15462896334871684
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00312714	0.15462896334871684
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00312714	0.15462896334871684
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00312714	0.15462896334871684
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00312714	0.15462896334871684
SPINOCEREBELLAR ATAXIA TYPE 36	0.0030824	0.15241668637351852
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.0030824	0.15241668637351852
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0030824	0.15241668637351852
RHYNS SYNDROME	0.0030824	0.15241668637351852
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0030824	0.15241668637351852
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0030824	0.15241668637351852
MYASTHENIA GRAVIS	0.0030824	0.15241668637351852
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0030824	0.15241668637351852
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.0030824	0.15241668637351852
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00306871	0.1517397513759668
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00306871	0.1517397513759668
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00306871	0.1517397513759668
WAARDENBURG SYNDROME TYPE 2	0.00306871	0.1517397513759668
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.00306871	0.1517397513759668
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00306871	0.1517397513759668
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00306871	0.1517397513759668
JOUBERT SYNDROME 21	0.00306871	0.1517397513759668
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00306871	0.1517397513759668
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00306871	0.1517397513759668
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00306871	0.1517397513759668
CONGENITAL MYASTHENIC SYNDROME	0.00306871	0.1517397513759668
CODAS SYNDROME	0.00306871	0.1517397513759668
ISOLATED COMPLEX I DEFICIENCY	0.00306871	0.1517397513759668
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00306871	0.1517397513759668
LEIGH SYNDROME; LS	0.00306871	0.1517397513759668
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00306871	0.1517397513759668
REFSUM DISEASE	0.00306871	0.1517397513759668
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00306871	0.1517397513759668
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00306871	0.1517397513759668
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00302121	0.149390999558311
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00302121	0.149390999558311
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00302121	0.149390999558311
CHROMOSOME 18P DELETION SYNDROME	0.00295376	0.14605577197723985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00295376	0.14605577197723985
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00295376	0.14605577197723985
TETRASOMY 5P	0.00295376	0.14605577197723985
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.00295376	0.14605577197723985
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00295376	0.14605577197723985
GORLIN SYNDROME	0.00295376	0.14605577197723985
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00295376	0.14605577197723985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00295376	0.14605577197723985
600736 VELOFACIOSKELETAL SYNDROME	0.00295376	0.14605577197723985
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00295376	0.14605577197723985
OROFACIODIGITAL SYNDROME XV; OFD15	0.00295376	0.14605577197723985
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00295376	0.14605577197723985
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00295376	0.14605577197723985
PENTASOMY X	0.00295376	0.14605577197723985
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00295376	0.14605577197723985
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00295376	0.14605577197723985
3Q13 MICRODELETION SYNDROME	0.00295376	0.14605577197723985
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00295376	0.14605577197723985
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00295376	0.14605577197723985
CHROMOSOME 16Q22 DELETION SYNDROME	0.00295376	0.14605577197723985
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.00295376	0.14605577197723985
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00295376	0.14605577197723985
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00295376	0.14605577197723985
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00295376	0.14605577197723985
DIAMOND-BLACKFAN ANEMIA 8	0.00295376	0.14605577197723985
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00295376	0.14605577197723985
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00295376	0.14605577197723985
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00295376	0.14605577197723985
RING CHROMOSOME 6 SYNDROME	0.00295376	0.14605577197723985
ROIFMAN-CHITAYAT SYNDROME	0.00295376	0.14605577197723985
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00295376	0.14605577197723985
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00295376	0.14605577197723985
6Q TERMINAL DELETION SYNDROME	0.0028938799999999997	0.14309486126479293
XQ12-Q13.3 DUPLICATION SYNDROME	0.0028938799999999997	0.14309486126479293
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.0028938799999999997	0.14309486126479293
7P22.1 MICRODUPLICATION SYNDROME	0.0028938799999999997	0.14309486126479293
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.0028938799999999997	0.14309486126479293
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0028938799999999997	0.14309486126479293
SAY-BARBER-MILLER SYNDROME	0.0028938799999999997	0.14309486126479293
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.0028938799999999997	0.14309486126479293
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0028938799999999997	0.14309486126479293
CRANIOLENTICULOSUTURAL DYSPLASIA	0.0028938799999999997	0.14309486126479293
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.0028938799999999997	0.14309486126479293
12Q14 MICRODELETION SYNDROME	0.0028938799999999997	0.14309486126479293
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0028938799999999997	0.14309486126479293
6Q16 MICRODELETION SYNDROME	0.0028938799999999997	0.14309486126479293
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0028938799999999997	0.14309486126479293
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0028938799999999997	0.14309486126479293
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0028938799999999997	0.14309486126479293
47,XYY SYNDROME	0.0028938799999999997	0.14309486126479293
1Q44 MICRODELETION SYNDROME	0.0028938799999999997	0.14309486126479293
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.0028938799999999997	0.14309486126479293
CHITAYAT SYNDROME	0.0028938799999999997	0.14309486126479293
PMM2-CDG	0.0028938799999999997	0.14309486126479293
49,XYYYY SYNDROME	0.0028938799999999997	0.14309486126479293
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0028938799999999997	0.14309486126479293
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.0027941700000000003	0.13816446034398336
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0027941700000000003	0.13816446034398336
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0027941700000000003	0.13816446034398336
FRANK-TER HAAR SYNDROME; FTHS	0.0027941700000000003	0.13816446034398336
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0027941700000000003	0.13816446034398336
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0027941700000000003	0.13816446034398336
17P13.3 MICRODUPLICATION SYNDROME	0.0027941700000000003	0.13816446034398336
AUTISM, SUSCEPTIBILITY TO, 18	0.0027941700000000003	0.13816446034398336
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.0027941700000000003	0.13816446034398336
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0027941700000000003	0.13816446034398336
19P13.13 MICRODELETION SYNDROME	0.0027941700000000003	0.13816446034398336
ARTERIAL TORTUOSITY SYNDROME	0.0027941700000000003	0.13816446034398336
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.0027941700000000003	0.13816446034398336
XIA-GIBBS SYNDROME	0.0027941700000000003	0.13816446034398336
MONOSOMY 13Q34	0.0027941700000000003	0.13816446034398336
JUVENILE POLYPOSIS OF INFANCY	0.0027941700000000003	0.13816446034398336
WEAVER SYNDROME	0.0027941700000000003	0.13816446034398336
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0027941700000000003	0.13816446034398336
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.0027941700000000003	0.13816446034398336
JUVENILE POLYPOSIS SYNDROME	0.0027941700000000003	0.13816446034398336
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0027941700000000003	0.13816446034398336
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0027941700000000003	0.13816446034398336
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0027941700000000003	0.13816446034398336
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0027941700000000003	0.13816446034398336
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.0027941700000000003	0.13816446034398336
ATKIN-FLAITZ SYNDROME	0.0027941700000000003	0.13816446034398336
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.0027941700000000003	0.13816446034398336
COLE-CARPENTER SYNDROME 2; CLCRP2	0.0027941700000000003	0.13816446034398336
SMITH-KINGSMORE SYNDROME; SKS	0.0027941700000000003	0.13816446034398336
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0027941700000000003	0.13816446034398336
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.0027941700000000003	0.13816446034398336
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.0027941700000000003	0.13816446034398336
ALAGILLE SYNDROME	0.0027941700000000003	0.13816446034398336
RING CHROMOSOME 14 SYNDROME	0.0027941700000000003	0.13816446034398336
NOONAN SYNDROME 3; NS3	0.0027941700000000003	0.13816446034398336
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.0027941700000000003	0.13816446034398336
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0027941700000000003	0.13816446034398336
TEMTAMY SYNDROME; TEMTYS	0.0027941700000000003	0.13816446034398336
MOMO SYNDROME	0.0027941700000000003	0.13816446034398336
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0027941700000000003	0.13816446034398336
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0027941700000000003	0.13816446034398336
CEREBROOCULONASAL SYNDROME	0.0026125000000000002	0.1291813499710671
MELNICK-NEEDLES SYNDROME	0.0026125000000000002	0.1291813499710671
OROFACIODIGITAL SYNDROME IV; OFD4	0.0026125000000000002	0.1291813499710671
PFEIFFER SYNDROME TYPE 2	0.0026125000000000002	0.1291813499710671
ACALVARIA	0.0026125000000000002	0.1291813499710671
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0026125000000000002	0.1291813499710671
DIAPHANOSPONDYLODYSOSTOSIS	0.0026125000000000002	0.1291813499710671
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.0026125000000000002	0.1291813499710671
CRANE-HEISE SYNDROME	0.0026125000000000002	0.1291813499710671
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.0026125000000000002	0.1291813499710671
MECKEL SYNDROME	0.0026125000000000002	0.1291813499710671
KNIEST-LIKE DYSPLASIA, LETHAL	0.0026125000000000002	0.1291813499710671
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.0026125000000000002	0.1291813499710671
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0026125000000000002	0.1291813499710671
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0026125000000000002	0.1291813499710671
NEMALINE MYOPATHY 2; NEM2	0.0026125000000000002	0.1291813499710671
48,XXYY SYNDROME	0.0026125000000000002	0.1291813499710671
49,XXXXY SYNDROME	0.0026125000000000002	0.1291813499710671
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0026125000000000002	0.1291813499710671
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0026125000000000002	0.1291813499710671
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0026125000000000002	0.1291813499710671
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.0026125000000000002	0.1291813499710671
ATELOSTEOGENESIS TYPE I	0.0026125000000000002	0.1291813499710671
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0026125000000000002	0.1291813499710671
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.0026125000000000002	0.1291813499710671
MOSAIC TRISOMY 9	0.0026125000000000002	0.1291813499710671
FETAL AKINESIA DEFORMATION SEQUENCE	0.0026125000000000002	0.1291813499710671
CATEL-MANZKE SYNDROME	0.0026125000000000002	0.1291813499710671
NEU-LAXOVA SYNDROME 2; NLS2	0.0026125000000000002	0.1291813499710671
SIX2-RELATED FRONTONASAL DYSPLASIA	0.0025540700000000003	0.12629213799831707
TETRASOMY 12P	0.0025540700000000003	0.12629213799831707
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0025540700000000003	0.12629213799831707
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0025540700000000003	0.12629213799831707
MCDONOUGH SYNDROME	0.0025540700000000003	0.12629213799831707
CHAR SYNDROME	0.0025540700000000003	0.12629213799831707
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0025540700000000003	0.12629213799831707
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0025540700000000003	0.12629213799831707
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.0025540700000000003	0.12629213799831707
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.0025540700000000003	0.12629213799831707
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.0025540700000000003	0.12629213799831707
JACOBSEN SYNDROME	0.0025540700000000003	0.12629213799831707
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.0025540700000000003	0.12629213799831707
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.0025540700000000003	0.12629213799831707
COACH SYNDROME	0.0025540700000000003	0.12629213799831707
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.0025540700000000003	0.12629213799831707
ASCHER SYNDROME	0.0025540700000000003	0.12629213799831707
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0025540700000000003	0.12629213799831707
SCLEROSTEOSIS 2; SOST2	0.00250657	0.1239433861806613
MELNICK-NEEDLES SYNDROME	0.00250657	0.1239433861806613
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00250657	0.1239433861806613
CHOPS SYNDROME; CHOPS	0.00250657	0.1239433861806613
YUNIS-VARON SYNDROME	0.00250657	0.1239433861806613
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00250657	0.1239433861806613
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00250657	0.1239433861806613
YUNIS-VARON SYNDROME	0.00250657	0.1239433861806613
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00250657	0.1239433861806613
PFEIFFER SYNDROME TYPE 1	0.00250657	0.1239433861806613
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00250657	0.1239433861806613
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00250657	0.1239433861806613
ALPHA-MANNOSIDOSIS	0.00250657	0.1239433861806613
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00250657	0.1239433861806613
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00250657	0.1239433861806613
PELVISCAPULAR DYSPLASIA	0.00250657	0.1239433861806613
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00250657	0.1239433861806613
ISOLATED BRACHYCEPHALY	0.00250657	0.1239433861806613
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0024928800000000003	0.12326645118310955
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0024928800000000003	0.12326645118310955
ACROCALLOSAL SYNDROME	0.0024928800000000003	0.12326645118310955
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.0024928800000000003	0.12326645118310955
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.0024928800000000003	0.12326645118310955
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.0024928800000000003	0.12326645118310955
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0024928800000000003	0.12326645118310955
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0024928800000000003	0.12326645118310955
KEIPERT SYNDROME; KPTS	0.0024928800000000003	0.12326645118310955
VICI SYNDROME	0.0024928800000000003	0.12326645118310955
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0024928800000000003	0.12326645118310955
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0024928800000000003	0.12326645118310955
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0024928800000000003	0.12326645118310955
DUANE-RADIAL RAY SYNDROME; DRRS	0.0024928800000000003	0.12326645118310955
NASODIGITOACOUSTIC SYNDROME	0.0024928800000000003	0.12326645118310955
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0024928800000000003	0.12326645118310955
GLUTAMINE DEFICIENCY, CONGENITAL	0.00196464	0.09714635307450994
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.00196464	0.09714635307450994
MEGALENCEPHALY	0.00196464	0.09714635307450994
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00196464	0.09714635307450994
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00196464	0.09714635307450994
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.09714635307450994
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00196464	0.09714635307450994
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00196464	0.09714635307450994
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00196464	0.09714635307450994
MICRO SYNDROME	0.00196464	0.09714635307450994
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00196464	0.09714635307450994
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00196464	0.09714635307450994
TRISOMY 18P	0.00196464	0.09714635307450994
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00196464	0.09714635307450994
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.00196464	0.09714635307450994
TRISOMY 18-LIKE SYNDROME	0.00196464	0.09714635307450994
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00196464	0.09714635307450994
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00196464	0.09714635307450994
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00196464	0.09714635307450994
OMODYSPLASIA 1; OMOD1	0.00196464	0.09714635307450994
BOOMERANG DYSPLASIA	0.00196464	0.09714635307450994
MULTIPLE METAPHYSEAL DYSPLASIA	0.00196464	0.09714635307450994
CARPENTER-WAZIRI SYNDROME	0.00196464	0.09714635307450994
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.09714635307450994
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.09714635307450994
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00196464	0.09714635307450994
SHELDON-HALL SYNDROME	0.00196464	0.09714635307450994
OCULOECTODERMAL SYNDROME; OES	0.00196464	0.09714635307450994
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.09714635307450994
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.09714635307450994
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00196464	0.09714635307450994
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00196464	0.09714635307450994
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00196464	0.09714635307450994
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00196464	0.09714635307450994
C SYNDROME	0.00196464	0.09714635307450994
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.09714635307450994
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.09714635307450994
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00196464	0.09714635307450994
FILIPPI SYNDROME; FLPIS	0.00196464	0.09714635307450994
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.09714635307450994
LÉRI-WEILL DYSCHONDROSTEOSIS	0.00196464	0.09714635307450994
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00196464	0.09714635307450994
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00196464	0.09714635307450994
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.00196464	0.09714635307450994
FAMILIAL BENIGN COPPER DEFICIENCY	0.00196464	0.09714635307450994
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00196464	0.09714635307450994
MIETENS SYNDROME	0.00196464	0.09714635307450994
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00196464	0.09714635307450994
8Q24.3 MICRODELETION SYNDROME	0.00196464	0.09714635307450994
MULIBREY NANISM	0.00196464	0.09714635307450994
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00196464	0.09714635307450994
LISSENCEPHALY, X-LINKED, 2	0.00196464	0.09714635307450994
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.00196464	0.09714635307450994
BEEMER LETHAL MALFORMATION SYNDROME	0.00196464	0.09714635307450994
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00196464	0.09714635307450994
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00196464	0.09714635307450994
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00196464	0.09714635307450994
LIG4 SYNDROME	0.00196464	0.09714635307450994
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00196464	0.09714635307450994
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.09714635307450994
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00196464	0.09714635307450994
CRANIOECTODERMAL DYSPLASIA 1	0.00196464	0.09714635307450994
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00196464	0.09714635307450994
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00196464	0.09714635307450994
ISOLATED TRIGONOCEPHALY	0.00196464	0.09714635307450994
ALAZAMI SYNDROME; ALAZS	0.00196464	0.09714635307450994
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00196464	0.09714635307450994
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00196464	0.09714635307450994
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.00190476	0.09418544236206304
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.09418544236206304
7Q11.23 DUPLICATION SYNDROME	0.00190476	0.09418544236206304
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	0.09418544236206304
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00190476	0.09418544236206304
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.00190476	0.09418544236206304
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.09418544236206304
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	0.09418544236206304
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.09418544236206304
SAUL-WILSON SYNDROME; SWILS	0.00190476	0.09418544236206304
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.09418544236206304
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00190476	0.09418544236206304
MILD CANAVAN DISEASE	0.00190476	0.09418544236206304
PARTINGTON SYNDROME	0.00190476	0.09418544236206304
SALLA DISEASE	0.00190476	0.09418544236206304
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.09418544236206304
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	0.09418544236206304
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00190476	0.09418544236206304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00190476	0.09418544236206304
FG SYNDROME 2; FGS2	0.00190476	0.09418544236206304
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00190476	0.09418544236206304
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.09418544236206304
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00190476	0.09418544236206304
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00190476	0.09418544236206304
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00190476	0.09418544236206304
EPISODIC ATAXIA TYPE 1	0.00190476	0.09418544236206304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00190476	0.09418544236206304
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.00190476	0.09418544236206304
CRANIOSYNOSTOSIS 7	0.00190476	0.09418544236206304
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00190476	0.09418544236206304
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	0.09418544236206304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.09418544236206304
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00190476	0.09418544236206304
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00190476	0.09418544236206304
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00190476	0.09418544236206304
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.09418544236206304
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00190476	0.09418544236206304
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00190476	0.09418544236206304
MENTAL RETARDATION, X-LINKED 9	0.00190476	0.09418544236206304
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.00190476	0.09418544236206304
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00190476	0.09418544236206304
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00190476	0.09418544236206304
EPIDERMAL NEVUS SYNDROME	0.00190476	0.09418544236206304
LIG4 SYNDROME	0.00190476	0.09418544236206304
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.09418544236206304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.00190476	0.09418544236206304
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.09418544236206304
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	0.09418544236206304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.00190476	0.09418544236206304
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00190476	0.09418544236206304
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00190476	0.09418544236206304
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00190476	0.09418544236206304
MASA SYNDROME	0.00190476	0.09418544236206304
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00190476	0.09418544236206304
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00190476	0.09418544236206304
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00190476	0.09418544236206304
XQ25 DUPLICATION SYNDROME	0.00190476	0.09418544236206304
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00190476	0.09418544236206304
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00190476	0.09418544236206304
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.09418544236206304
HAREL-YOON SYNDROME; HAYOS	0.00190476	0.09418544236206304
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00190476	0.09418544236206304
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.00190476	0.09418544236206304
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00190476	0.09418544236206304
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.09418544236206304
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00190476	0.09418544236206304
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00190476	0.09418544236206304
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.09418544236206304
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.00190476	0.09418544236206304
PRADER-WILLI SYNDROME	0.00190476	0.09418544236206304
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00190476	0.09418544236206304
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00190476	0.09418544236206304
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.09418544236206304
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00190476	0.09418544236206304
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.00190476	0.09418544236206304
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	0.09418544236206304
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.09418544236206304
FAMILIAL MULTIPLE LIPOMATOSIS	0.00190476	0.09418544236206304
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.09418544236206304
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.09418544236206304
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00190476	0.09418544236206304
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.09418544236206304
5Q14.3 MICRODELETION SYNDROME	0.00190476	0.09418544236206304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00190476	0.09418544236206304
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.09418544236206304
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	0.09418544236206304
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00190476	0.09418544236206304
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.00190476	0.09418544236206304
TENORIO SYNDROME; TNORS	0.00190476	0.09418544236206304
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.09418544236206304
LARYNGOTRACHEAL ANGIOMA	0.00190476	0.09418544236206304
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00190476	0.09418544236206304
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00190476	0.09418544236206304
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00190476	0.09418544236206304
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.09418544236206304
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	0.09418544236206304
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00190476	0.09418544236206304
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00190476	0.09418544236206304
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.00190476	0.09418544236206304
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00190476	0.09418544236206304
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.00190476	0.09418544236206304
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00190476	0.09418544236206304
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.09418544236206304
2Q23.1 MICRODELETION SYNDROME	0.00190476	0.09418544236206304
AUTISM	0.00190476	0.09418544236206304
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.09418544236206304
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.00190476	0.09418544236206304
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00190476	0.09418544236206304
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00190476	0.09418544236206304
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.09418544236206304
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00190476	0.09418544236206304
FORSYTHE-WAKELING SYNDROME; FWS	0.00190476	0.09418544236206304
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00190476	0.09418544236206304
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.09418544236206304
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00190476	0.09418544236206304
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.09418544236206304
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.00190476	0.09418544236206304
PRADER-WILLI SYNDROME; PWS	0.00190476	0.09418544236206304
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.09418544236206304
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.00190476	0.09418544236206304
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00190476	0.09418544236206304
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00190476	0.09418544236206304
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00190476	0.09418544236206304
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.00190476	0.09418544236206304
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.00190476	0.09418544236206304
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00190476	0.09418544236206304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00190476	0.09418544236206304
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00190476	0.09418544236206304
MICROTIA	0.00190476	0.09418544236206304
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	0.09418544236206304
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00190476	0.09418544236206304
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00190476	0.09418544236206304
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.09418544236206304
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.00190476	0.09418544236206304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.00190476	0.09418544236206304
17Q11.2 MICRODUPLICATION SYNDROME	0.00190476	0.09418544236206304
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	0.09418544236206304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00190476	0.09418544236206304
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.00190476	0.09418544236206304
RETINITIS PIGMENTOSA 71; RP71	0.00190476	0.09418544236206304
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00190476	0.09418544236206304
COFFIN-SIRIS SYNDROME 2; CSS2	0.00190476	0.09418544236206304
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00180505	0.08925504144125344
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00180505	0.08925504144125344
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00180505	0.08925504144125344
TETRASOMY 18P	0.00180505	0.08925504144125344
COHEN SYNDROME	0.00180505	0.08925504144125344
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00180505	0.08925504144125344
OGDEN SYNDROME	0.00180505	0.08925504144125344
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.00180505	0.08925504144125344
MALAN OVERGROWTH SYNDROME	0.00180505	0.08925504144125344
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00180505	0.08925504144125344
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.08925504144125344
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.00180505	0.08925504144125344
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00180505	0.08925504144125344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.00180505	0.08925504144125344
MARTSOLF SYNDROME	0.00180505	0.08925504144125344
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00180505	0.08925504144125344
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00180505	0.08925504144125344
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00180505	0.08925504144125344
ROIFMAN SYNDROME; RFMN	0.00180505	0.08925504144125344
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00180505	0.08925504144125344
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00180505	0.08925504144125344
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00180505	0.08925504144125344
PROTEUS-LIKE SYNDROME	0.00180505	0.08925504144125344
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00180505	0.08925504144125344
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.08925504144125344
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00180505	0.08925504144125344
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00180505	0.08925504144125344
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00180505	0.08925504144125344
OCCIPITAL HORN SYNDROME	0.00180505	0.08925504144125344
GABA-TRANSAMINASE DEFICIENCY	0.00180505	0.08925504144125344
ACRORENAL-MANDIBULAR SYNDROME	0.00180505	0.08925504144125344
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00180505	0.08925504144125344
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00180505	0.08925504144125344
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00180505	0.08925504144125344
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00180505	0.08925504144125344
RUVALCABA SYNDROME	0.00180505	0.08925504144125344
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00180505	0.08925504144125344
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00180505	0.08925504144125344
611961 STEVENSON-CAREY SYNDROME	0.00180505	0.08925504144125344
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00180505	0.08925504144125344
MEVALONIC ACIDURIA; MEVA	0.00180505	0.08925504144125344
CHROMOSOME 16P13.3 DELETION SYNDROME	0.00180505	0.08925504144125344
MARFAN SYNDROME; MFS	0.00180505	0.08925504144125344
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00180505	0.08925504144125344
CLARK-BARAITSER SYNDROME	0.00180505	0.08925504144125344
COLE-CARPENTER SYNDROME	0.00180505	0.08925504144125344
GMS SYNDROME	0.00180505	0.08925504144125344
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00180505	0.08925504144125344
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.08925504144125344
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.00180505	0.08925504144125344
MEVALONIC ACIDURIA	0.00180505	0.08925504144125344
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00180505	0.08925504144125344
SECKEL SYNDROME 5; SCKL5	0.00180505	0.08925504144125344
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.00180505	0.08925504144125344
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00180505	0.08925504144125344
CAT-EYE SYNDROME (TYPE I)	0.00180505	0.08925504144125344
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.08925504144125344
RETINOBLASTOMA; RB1	0.00162338	0.08027193106833717
MICROPHTHALMIA, SYNDROMIC 4	0.00162338	0.08027193106833717
ISOLATED PIERRE ROBIN SYNDROME	0.00162338	0.08027193106833717
SCHNECKENBECKEN DYSPLASIA	0.00162338	0.08027193106833717
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00162338	0.08027193106833717
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00162338	0.08027193106833717
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00162338	0.08027193106833717
ACRORENAL SYNDROME	0.00162338	0.08027193106833717
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00162338	0.08027193106833717
WEAVER-WILLIAMS SYNDROME	0.00162338	0.08027193106833717
BLACKFAN-DIAMOND ANEMIA	0.00162338	0.08027193106833717
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00162338	0.08027193106833717
FAMILIAL VISCERAL MYOPATHY	0.00162338	0.08027193106833717
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00162338	0.08027193106833717
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.00162338	0.08027193106833717
ADDUCTED THUMBS SYNDROME	0.00162338	0.08027193106833717
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00162338	0.08027193106833717
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.00162338	0.08027193106833717
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00162338	0.08027193106833717
OCULO-PALATO-CEREBRAL SYNDROME	0.00162338	0.08027193106833717
ACROPECTOROVERTEBRAL DYSPLASIA	0.00162338	0.08027193106833717
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00162338	0.08027193106833717
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00162338	0.08027193106833717
XYLT1-CDG	0.00162338	0.08027193106833717
FEMORAL-FACIAL SYNDROME	0.00162338	0.08027193106833717
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.00162338	0.08027193106833717
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00162338	0.08027193106833717
METATROPIC DYSPLASIA	0.00162338	0.08027193106833717
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00162338	0.08027193106833717
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00162338	0.08027193106833717
TROCHLEA OF THE HUMERUS, APLASIA OF	0.00162338	0.08027193106833717
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00162338	0.08027193106833717
RETINOBLASTOMA	0.00162338	0.08027193106833717
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.00162338	0.08027193106833717
MAXILLONASAL DYSPLASIA	0.00162338	0.08027193106833717
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00162338	0.08027193106833717
PRIMARY PULMONARY HYPOPLASIA	0.00162338	0.08027193106833717
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00162338	0.08027193106833717
HISTIOCYTOID CARDIOMYOPATHY	0.00162338	0.08027193106833717
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.00162338	0.08027193106833717
LETHAL KNIEST-LIKE DYSPLASIA	0.00162338	0.08027193106833717
PIERRE ROBIN SYNDROME AND OLIGODACTYLY	0.00162338	0.08027193106833717
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00162338	0.08027193106833717
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00162338	0.08027193106833717
DIAPHANOSPONDYLODYSOSTOSIS	0.00162338	0.08027193106833717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.00162338	0.08027193106833717
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00162338	0.08027193106833717
LYMPHEDEMA, HEREDITARY, II	0.00162338	0.08027193106833717
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00162338	0.08027193106833717
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.00162338	0.08027193106833717
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00162338	0.08027193106833717
ATELOSTEOGENESIS, TYPE II	0.00162338	0.08027193106833717
OCULOPALATOCEREBRAL SYNDROME	0.00162338	0.08027193106833717
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00162338	0.08027193106833717
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00162338	0.08027193106833717
FIBROCHONDROGENESIS 1; FBCG1	0.00162338	0.08027193106833717
SPRENGEL DEFORMITY	0.00162338	0.08027193106833717
MESOMELIC LIMB SHORTENING AND BOWING	0.00162338	0.08027193106833717
MECKEL SYNDROME, TYPE 4; MKS4	0.00162338	0.08027193106833717
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00162338	0.08027193106833717
HOLZGREVE SYNDROME	0.00162338	0.08027193106833717
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	0.00162338	0.08027193106833717
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00162338	0.08027193106833717
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.00162338	0.08027193106833717
ATELOSTEOGENESIS, TYPE I; AO1	0.00162338	0.08027193106833717
OROFACIODIGITAL SYNDROME XI; OFD11	0.00162338	0.08027193106833717
OROFACIODIGITAL SYNDROME X	0.00162338	0.08027193106833717
ISOLATED DANDY-WALKER MALFORMATION	0.00162338	0.08027193106833717
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.00162338	0.08027193106833717
SCHNECKENBECKEN DYSPLASIA	0.00162338	0.08027193106833717
PALATOPHARYNGEAL INCOMPETENCE	0.00162338	0.08027193106833717
AASE-SMITH SYNDROME	0.00162338	0.08027193106833717
MEGAEPIPHYSEAL DWARFISM	0.00162338	0.08027193106833717
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00162338	0.08027193106833717
PELVIS-SHOULDER DYSPLASIA	0.00162338	0.08027193106833717
PHOCOMELIA, SCHINZEL TYPE	0.00162338	0.08027193106833717
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00162338	0.08027193106833717
LOWRY-MACLEAN SYNDROME	0.00162338	0.08027193106833717
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00162338	0.08027193106833717
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.00162338	0.08027193106833717
MICROFORM HOLOPROSENCEPHALY	0.00162338	0.08027193106833717
C SYNDROME	0.00162338	0.08027193106833717
MCKUSICK-KAUFMAN SYNDROME	0.00162338	0.08027193106833717
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00162338	0.08027193106833717
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00162338	0.08027193106833717
PIERRE ROBIN SYNDROME	0.00162338	0.08027193106833717
260150 PALANT CLEFT PALATE SYNDROME	0.00162338	0.08027193106833717
OROFACIODIGITAL SYNDROME TYPE 14	0.00162338	0.08027193106833717
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00162338	0.08027193106833717
TETRAPLOIDY	0.00162338	0.08027193106833717
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00162338	0.08027193106833717
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00162338	0.08027193106833717
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00162338	0.08027193106833717
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00162338	0.08027193106833717
CAMPOMELIA, CUMMING TYPE	0.00162338	0.08027193106833717
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00162338	0.08027193106833717
HYPOTONIA-CYSTINURIA SYNDROME	0.00156495	0.07738271909558715
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.00156495	0.07738271909558715
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.00156495	0.07738271909558715
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.07738271909558715
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00156495	0.07738271909558715
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.00156495	0.07738271909558715
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.00156495	0.07738271909558715
PURPURA SIMPLEX	0.00156495	0.07738271909558715
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.00156495	0.07738271909558715
MALIGNANT ATROPHIC PAPULOSIS	0.00156495	0.07738271909558715
INFANTILE SIALIC ACID STORAGE DISEASE	0.00156495	0.07738271909558715
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00156495	0.07738271909558715
X-LINKED CENTRONUCLEAR MYOPATHY	0.00156495	0.07738271909558715
GOOD SYNDROME	0.00156495	0.07738271909558715
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00156495	0.07738271909558715
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00156495	0.07738271909558715
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.07738271909558715
CLUSTER HEADACHE, FAMILIAL	0.00156495	0.07738271909558715
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.07738271909558715
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00156495	0.07738271909558715
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00156495	0.07738271909558715
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00156495	0.07738271909558715
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00156495	0.07738271909558715
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.07738271909558715
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00156495	0.07738271909558715
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.00156495	0.07738271909558715
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00156495	0.07738271909558715
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00156495	0.07738271909558715
MYASTHENIA GRAVIS; MG	0.00156495	0.07738271909558715
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00156495	0.07738271909558715
PRADER-WILLI-LIKE SYNDROME	0.00156495	0.07738271909558715
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00156495	0.07738271909558715
ARIMA SYNDROME	0.00156495	0.07738271909558715
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00156495	0.07738271909558715
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00156495	0.07738271909558715
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00156495	0.07738271909558715
TYPICAL NEMALINE MYOPATHY	0.00156495	0.07738271909558715
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.00156495	0.07738271909558715
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00156495	0.07738271909558715
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00156495	0.07738271909558715
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00156495	0.07738271909558715
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.07738271909558715
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00156495	0.07738271909558715
CENTRONUCLEAR MYOPATHY	0.00156495	0.07738271909558715
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00156495	0.07738271909558715
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00156495	0.07738271909558715
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00156495	0.07738271909558715
JOUBERT SYNDROME 7	0.00156495	0.07738271909558715
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00156495	0.07738271909558715
SALIH MYOPATHY; SALMY	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00156495	0.07738271909558715
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00156495	0.07738271909558715
FACIOCARDIOMELIC SYNDROME	0.00156495	0.07738271909558715
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00156495	0.07738271909558715
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00156495	0.07738271909558715
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00156495	0.07738271909558715
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00156495	0.07738271909558715
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00156495	0.07738271909558715
PROLACTINOMA	0.00156495	0.07738271909558715
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00156495	0.07738271909558715
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00156495	0.07738271909558715
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00156495	0.07738271909558715
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00156495	0.07738271909558715
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00156495	0.07738271909558715
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00156495	0.07738271909558715
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.00156495	0.07738271909558715
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00156495	0.07738271909558715
MEIER-GORLIN SYNDROME 8; MGORS8	0.00156495	0.07738271909558715
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00156495	0.07738271909558715
KAWASAKI DISEASE	0.00156495	0.07738271909558715
TUKEL SYNDROME	0.00156495	0.07738271909558715
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00156495	0.07738271909558715
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.00156495	0.07738271909558715
ISOLATED CONGENITAL ALACRIMA	0.00156495	0.07738271909558715
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00156495	0.07738271909558715
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.00156495	0.07738271909558715
TSH-SECRETING PITUITARY ADENOMA	0.00156495	0.07738271909558715
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00156495	0.07738271909558715
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00156495	0.07738271909558715
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00156495	0.07738271909558715
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00156495	0.07738271909558715
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.00156495	0.07738271909558715
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00156495	0.07738271909558715
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00156495	0.07738271909558715
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.00156495	0.07738271909558715
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00156495	0.07738271909558715
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00156495	0.07738271909558715
FETAL TRIMETHADIONE SYNDROME	0.00156495	0.07738271909558715
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5	0.00156495	0.07738271909558715
PROGRESSIVE HEMIFACIAL ATROPHY	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00156495	0.07738271909558715
INHALATIONAL BOTULISM	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00156495	0.07738271909558715
IATROGENIC BOTULISM	0.00156495	0.07738271909558715
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00156495	0.07738271909558715
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00156495	0.07738271909558715
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00156495	0.07738271909558715
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00156495	0.07738271909558715
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00156495	0.07738271909558715
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00156495	0.07738271909558715
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00156495	0.07738271909558715
%300245 PTOSIS, HEREDITARY CONGENITAL 2;;PTOS2;;PTOSIS, X-LINKED; PTOSX	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00156495	0.07738271909558715
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.00156495	0.07738271909558715
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00156495	0.07738271909558715
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00156495	0.07738271909558715
NON-FUNCTIONING PITUITARY ADENOMA	0.00156495	0.07738271909558715
INFANT BOTULISM	0.00156495	0.07738271909558715
WARBURG MICRO SYNDROME 1	0.00156495	0.07738271909558715
ERDHEIM-CHESTER DISEASE	0.00156495	0.07738271909558715
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00156495	0.07738271909558715
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00156495	0.07738271909558715
THYMIC TUMOR	0.00156495	0.07738271909558715
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.00156495	0.07738271909558715
PITUITARY APOPLEXY	0.00156495	0.07738271909558715
ADULT INTESTINAL BOTULISM	0.00156495	0.07738271909558715
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00156495	0.07738271909558715
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00156495	0.07738271909558715
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.00156495	0.07738271909558715
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00156495	0.07738271909558715
WOUND BOTULISM	0.00156495	0.07738271909558715
JOUBERT SYNDROME 35; JBTS35	0.00156495	0.07738271909558715
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.00156495	0.07738271909558715
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00156495	0.07738271909558715
FRONTOOCULAR SYNDROME	0.00156495	0.07738271909558715
WIDOW'S PEAK SYNDROME	0.00156495	0.07738271909558715
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00156495	0.07738271909558715
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00156495	0.07738271909558715
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00156495	0.07738271909558715
HYPOTONIA-CYSTINURIA SYNDROME	0.00156495	0.07738271909558715
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.00156495	0.07738271909558715
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00156495	0.07738271909558715
THYMIC EPITHELIAL NEOPLASM	0.00156495	0.07738271909558715
PAROXYSMAL HEMICRANIA	0.00156495	0.07738271909558715
POSTERIOR FUSION OF LUMBOSACRAL VERTEBRAE-BLEPHAROPTOSIS SYNDROME	0.00156495	0.07738271909558715
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00156495	0.07738271909558715
INTESTINAL BOTULISM	0.00156495	0.07738271909558715
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00156495	0.07738271909558715
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00156495	0.07738271909558715
FOODBORNE BOTULISM	0.00156495	0.07738271909558715
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00156495	0.07738271909558715
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00156495	0.07738271909558715
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.00156495	0.07738271909558715
BROOKE-SPIEGLER SYNDROME	0.00151745	0.07503396727793138
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.00151745	0.07503396727793138
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00151745	0.07503396727793138
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.00151745	0.07503396727793138
BETA-MANNOSIDOSIS	0.00151745	0.07503396727793138
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.07503396727793138
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00151745	0.07503396727793138
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.07503396727793138
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00151745	0.07503396727793138
OSTEOGENESIS IMPERFECTA	0.00151745	0.07503396727793138
SPINOCEREBELLAR ATAXIA TYPE 31	0.00151745	0.07503396727793138
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00151745	0.07503396727793138
AUROCEPHALOSYNDACTYLY	0.00151745	0.07503396727793138
RETINAL VENOUS BEADING	0.00151745	0.07503396727793138
NAIL-PATELLA SYNDROME	0.00151745	0.07503396727793138
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00151745	0.07503396727793138
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00151745	0.07503396727793138
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00151745	0.07503396727793138
17Q12 MICRODELETION SYNDROME	0.00151745	0.07503396727793138
TUNE DEAFNESS	0.00151745	0.07503396727793138
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00151745	0.07503396727793138
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.00151745	0.07503396727793138
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00151745	0.07503396727793138
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00151745	0.07503396727793138
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.07503396727793138
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00151745	0.07503396727793138
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00151745	0.07503396727793138
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00151745	0.07503396727793138
NEUROFIBROMATOSIS, TYPE II	0.00151745	0.07503396727793138
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.07503396727793138
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00151745	0.07503396727793138
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00151745	0.07503396727793138
LEBER CONGENITAL AMAUROSIS	0.00151745	0.07503396727793138
EAR EXOSTOSES	0.00151745	0.07503396727793138
BRANCHIOOTIC SYNDROME 2	0.00151745	0.07503396727793138
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.07503396727793138
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00151745	0.07503396727793138
COXOAURICULAR SYNDROME	0.00151745	0.07503396727793138
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00151745	0.07503396727793138
MENIERE DISEASE	0.00151745	0.07503396727793138
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00151745	0.07503396727793138
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00151745	0.07503396727793138
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00151745	0.07503396727793138
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.07503396727793138
FETAL METHYLMERCURY SYNDROME	0.00151745	0.07503396727793138
CAMURATI-ENGELMANN DISEASE	0.00151745	0.07503396727793138
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00151745	0.07503396727793138
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00151745	0.07503396727793138
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.07503396727793138
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.07503396727793138
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.07503396727793138
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00151745	0.07503396727793138
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00151745	0.07503396727793138
IVIC SYNDROME	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.07503396727793138
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.07503396727793138
IVIC SYNDROME	0.00151745	0.07503396727793138
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.00151745	0.07503396727793138
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.07503396727793138
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.07503396727793138
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00151745	0.07503396727793138
PAGET DISEASE OF BONE 3; PDB3	0.00151745	0.07503396727793138
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00151745	0.07503396727793138
TOWNES-BROCKS SYNDROME	0.00151745	0.07503396727793138
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.07503396727793138
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00151745	0.07503396727793138
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.07503396727793138
OSTEOGENESIS IMPERFECTA, TYPE I	0.00151745	0.07503396727793138
LYMPHEDEMA, HEREDITARY, III	0.00151745	0.07503396727793138
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00151745	0.07503396727793138
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.00151745	0.07503396727793138
LASSA FEVER	0.00151745	0.07503396727793138
GRACILE SYNDROME	0.00151745	0.07503396727793138
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00151745	0.07503396727793138
WYBURN-MASON SYNDROME	0.00151745	0.07503396727793138
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00151745	0.07503396727793138
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00151745	0.07503396727793138
CRANIOPHARYNGIOMA	0.00151745	0.07503396727793138
RFT1-CDG	0.00151745	0.07503396727793138
46,XX GONADAL DYSGENESIS	0.00151745	0.07503396727793138
CHIARI MALFORMATION TYPE I	0.00151745	0.07503396727793138
TURCOT SYNDROME WITH POLYPOSIS	0.00151745	0.07503396727793138
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.00151745	0.07503396727793138
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.07503396727793138
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00151745	0.07503396727793138
XYLOSIDASE DEFICIENCY	0.00151745	0.07503396727793138
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00151745	0.07503396727793138
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00151745	0.07503396727793138
THALIDOMIDE EMBRYOPATHY	0.00151745	0.07503396727793138
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00151745	0.07503396727793138
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.07503396727793138
SPINOCEREBELLAR ATAXIA 13	0.00151745	0.07503396727793138
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.00151745	0.07503396727793138
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00151745	0.07503396727793138
NATHALIE SYNDROME	0.00151745	0.07503396727793138
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.07503396727793138
COXOAURICULAR SYNDROME	0.00151745	0.07503396727793138
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.07503396727793138
RENAL COLOBOMA SYNDROME	0.00151745	0.07503396727793138
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00151745	0.07503396727793138
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00151745	0.07503396727793138
MORQUIO SYNDROME A	0.00151745	0.07503396727793138
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00151745	0.07503396727793138
OTOSCLEROSIS 3; OTSC3	0.00151745	0.07503396727793138
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00151745	0.07503396727793138
CORNEODERMATOOSSEOUS SYNDROME	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.07503396727793138
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00151745	0.07503396727793138
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00151745	0.07503396727793138
SEVERE CANAVAN DISEASE	0.00151745	0.07503396727793138
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00151745	0.07503396727793138
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00151745	0.07503396727793138
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.07503396727793138
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.00151745	0.07503396727793138
RETICULAR DYSGENESIS	0.00151745	0.07503396727793138
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00151745	0.07503396727793138
KEUTEL SYNDROME; KTLS	0.00151745	0.07503396727793138
USHER SYNDROME, TYPE ID	0.00151745	0.07503396727793138
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.00151745	0.07503396727793138
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.07503396727793138
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00151745	0.07503396727793138
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00151745	0.07503396727793138
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.00151745	0.07503396727793138
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.00151745	0.07503396727793138
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00151745	0.07503396727793138
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.07503396727793138
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00151745	0.07503396727793138
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00151745	0.07503396727793138
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00151745	0.07503396727793138
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00151745	0.07503396727793138
GALACTOSIALIDOSIS	0.00151745	0.07503396727793138
ISOLATED PLAGIOCEPHALY	0.00151745	0.07503396727793138
N SYNDROME	0.00151745	0.07503396727793138
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00151745	0.07503396727793138
SPASTIC PARAPARESIS AND DEAFNESS	0.00151745	0.07503396727793138
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.07503396727793138
WILDERVANCK SYNDROME	0.00151745	0.07503396727793138
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00151745	0.07503396727793138
RAMON SYNDROME	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.07503396727793138
VIRAL HEMORRHAGIC FEVER	0.00151745	0.07503396727793138
CARNEY-STRATAKIS SYNDROME	0.00151745	0.07503396727793138
ABCD SYNDROME	0.00151745	0.07503396727793138
CONE-ROD DYSTROPHY 1; CORD1	0.00151745	0.07503396727793138
FRIEDREICH ATAXIA	0.00151745	0.07503396727793138
TIETZ SYNDROME	0.00151745	0.07503396727793138
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.07503396727793138
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00151745	0.07503396727793138
THANATOPHORIC DYSPLASIA TYPE 1	0.00151745	0.07503396727793138
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.07503396727793138
COFFIN-SIRIS SYNDROME 4; CSS4	0.00151745	0.07503396727793138
COFFIN-SIRIS SYNDROME 3; CSS3	0.00151745	0.07503396727793138
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00151745	0.07503396727793138
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.00151745	0.07503396727793138
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00151745	0.07503396727793138
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.07503396727793138
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00151745	0.07503396727793138
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00151745	0.07503396727793138
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.00151745	0.07503396727793138
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00151745	0.07503396727793138
X-LINKED HYPOPHOSPHATEMIA	0.00151745	0.07503396727793138
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.07503396727793138
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.07503396727793138
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.07503396727793138
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00151745	0.07503396727793138
COWDEN SYNDROME 5; CWS5	0.00151745	0.07503396727793138
COWDEN SYNDROME 6; CWS6	0.00151745	0.07503396727793138
LISSENCEPHALY 5; LIS5	0.00151745	0.07503396727793138
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.07503396727793138
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00151745	0.07503396727793138
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.07503396727793138
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.00151745	0.07503396727793138
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.00151745	0.07503396727793138
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.07503396727793138
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.07503396727793138
ACQUIRED PARTIAL LIPODYSTROPHY	0.00151745	0.07503396727793138
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00151745	0.07503396727793138
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00151745	0.07503396727793138
ANUS, IMPERFORATE	0.00151745	0.07503396727793138
KEARNS-SAYRE SYNDROME	0.00151745	0.07503396727793138
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00151745	0.07503396727793138
GLYCOGEN STORAGE DISEASE II	0.00151745	0.07503396727793138
BRITTLE CORNEA SYNDROME	0.00151745	0.07503396727793138
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.07503396727793138
OTOSCLEROSIS 8; OTSC8	0.00151745	0.07503396727793138
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00151745	0.07503396727793138
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00151745	0.07503396727793138
SPINOCEREBELLAR ATAXIA TYPE 13	0.00151745	0.07503396727793138
HYDROXYKYNURENINURIA	0.00151745	0.07503396727793138
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00151745	0.07503396727793138
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00151745	0.07503396727793138
PITUITARY CARCINOMA	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.07503396727793138
SPINOCEREBELLAR ATAXIA TYPE 18	0.00151745	0.07503396727793138
WARSAW BREAKAGE SYNDROME; WABS	0.00151745	0.07503396727793138
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.00151745	0.07503396727793138
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.07503396727793138
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.07503396727793138
SLC39A8-CDG	0.00151745	0.07503396727793138
ARACHNOIDITIS	0.00151745	0.07503396727793138
FETAL IODINE DEFICIENCY DISORDER	0.00151745	0.07503396727793138
FANCONI ANEMIA	0.00151745	0.07503396727793138
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.07503396727793138
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00151745	0.07503396727793138
PANHYPOPHYSITIS	0.00150376	0.07435703228037964
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.00150376	0.07435703228037964
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.07435703228037964
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00150376	0.07435703228037964
NEUTRAL LIPID STORAGE MYOPATHY	0.00150376	0.07435703228037964
JUBERG-MARSIDI SYNDROME	0.00150376	0.07435703228037964
HADDAD SYNDROME	0.00150376	0.07435703228037964
HURLER-SCHEIE SYNDROME	0.00150376	0.07435703228037964
ADENOHYPOPHYSITIS	0.00150376	0.07435703228037964
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.07435703228037964
FAMILIAL LONG QT SYNDROME	0.00150376	0.07435703228037964
SCHEIE SYNDROME	0.00150376	0.07435703228037964
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00150376	0.07435703228037964
RENIER-GABREELS-JASPER SYNDROME	0.00150376	0.07435703228037964
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.07435703228037964
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00150376	0.07435703228037964
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.07435703228037964
STICKLER SYNDROME, TYPE V; STL5	0.00150376	0.07435703228037964
INFANTILE LIVER FAILURE SYNDROME 1	0.00150376	0.07435703228037964
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00150376	0.07435703228037964
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00150376	0.07435703228037964
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00150376	0.07435703228037964
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.07435703228037964
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00150376	0.07435703228037964
PEROXISOME BIOGENESIS DISORDER 6B	0.00150376	0.07435703228037964
PEROXISOME BIOGENESIS DISORDER 5B	0.00150376	0.07435703228037964
SPONDYLOPERIPHERAL DYSPLASIA	0.00150376	0.07435703228037964
THYROCEREBRORETINAL SYNDROME	0.00150376	0.07435703228037964
USHER SYNDROME, TYPE IIIA	0.00150376	0.07435703228037964
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00150376	0.07435703228037964
WAARDENBURG-SHAH SYNDROME	0.00150376	0.07435703228037964
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.07435703228037964
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.07435703228037964
RETINITIS PIGMENTOSA 59; RP59	0.00150376	0.07435703228037964
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.07435703228037964
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00150376	0.07435703228037964
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.07435703228037964
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.07435703228037964
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.07435703228037964
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00150376	0.07435703228037964
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.07435703228037964
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00150376	0.07435703228037964
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.07435703228037964
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00150376	0.07435703228037964
IMMUNODEFICIENCY 47	0.00150376	0.07435703228037964
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00150376	0.07435703228037964
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00150376	0.07435703228037964
JOHANSON-BLIZZARD SYNDROME; JBS	0.00150376	0.07435703228037964
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00150376	0.07435703228037964
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.07435703228037964
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.07435703228037964
NEURAMINIDASE DEFICIENCY	0.00150376	0.07435703228037964
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.07435703228037964
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.00150376	0.07435703228037964
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.07435703228037964
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.07435703228037964
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00150376	0.07435703228037964
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00150376	0.07435703228037964
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.00150376	0.07435703228037964
PEROXISOME BIOGENESIS DISORDER 3B	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.07435703228037964
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.07435703228037964
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.07435703228037964
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00150376	0.07435703228037964
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00150376	0.07435703228037964
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.07435703228037964
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00150376	0.07435703228037964
OPTIC ATROPHY 8	0.00150376	0.07435703228037964
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.07435703228037964
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00150376	0.07435703228037964
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00150376	0.07435703228037964
WOLFRAM SYNDROME 2; WFS2	0.00150376	0.07435703228037964
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.07435703228037964
USHER SYNDROME, TYPE IG	0.00150376	0.07435703228037964
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.07435703228037964
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.07435703228037964
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00150376	0.07435703228037964
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00150376	0.07435703228037964
SPONDYLOOCULAR SYNDROME; SOS	0.00150376	0.07435703228037964
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.07435703228037964
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.07435703228037964
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.07435703228037964
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.00150376	0.07435703228037964
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.07435703228037964
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.07435703228037964
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00150376	0.07435703228037964
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.07435703228037964
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.07435703228037964
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00150376	0.07435703228037964
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.07435703228037964
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00150376	0.07435703228037964
ALPORT SYNDROME, X-LINKED; ATS	0.00150376	0.07435703228037964
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00150376	0.07435703228037964
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.07435703228037964
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.00150376	0.07435703228037964
BRACHYDACTYLY, TYPE B2	0.00150376	0.07435703228037964
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00150376	0.07435703228037964
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00150376	0.07435703228037964
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.07435703228037964
DEAFNESS, X-LINKED 1	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.07435703228037964
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.07435703228037964
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.07435703228037964
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.07435703228037964
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.07435703228037964
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.07435703228037964
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.00150376	0.07435703228037964
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.07435703228037964
DEAFNESS, Y-LINKED 1	0.00150376	0.07435703228037964
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.07435703228037964
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00150376	0.07435703228037964
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00150376	0.07435703228037964
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.00150376	0.07435703228037964
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.07435703228037964
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.07435703228037964
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00150376	0.07435703228037964
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00150376	0.07435703228037964
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.00150376	0.07435703228037964
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.00150376	0.07435703228037964
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00150376	0.07435703228037964
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.07435703228037964
STIFF SKIN SYNDROME	0.00150376	0.07435703228037964
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00150376	0.07435703228037964
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00150376	0.07435703228037964
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.07435703228037964
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.07435703228037964
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.07435703228037964
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.07435703228037964
FACIOSCAPULOHUMERAL DYSTROPHY	0.00150376	0.07435703228037964
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.07435703228037964
NATHALIE SYNDROME	0.00150376	0.07435703228037964
OTODENTAL DYSPLASIA	0.00150376	0.07435703228037964
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00150376	0.07435703228037964
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.00150376	0.07435703228037964
WILLIAMS-BEUREN SYNDROME; WBS	0.00150376	0.07435703228037964
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00150376	0.07435703228037964
WT LIMB-BLOOD SYNDROME	0.00150376	0.07435703228037964
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.07435703228037964
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00150376	0.07435703228037964
LAURENCE-MOON SYNDROME	0.00150376	0.07435703228037964
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00150376	0.07435703228037964
USHER SYNDROME TYPE 3	0.00150376	0.07435703228037964
USHER SYNDROME TYPE 2	0.00150376	0.07435703228037964
USHER SYNDROME TYPE 1	0.00150376	0.07435703228037964
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.07435703228037964
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.00150376	0.07435703228037964
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00150376	0.07435703228037964
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.07435703228037964
NEUROFIBROMATOSIS TYPE 2	0.00150376	0.07435703228037964
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.00150376	0.07435703228037964
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.00150376	0.07435703228037964
ACUTE BILIRUBIN ENCEPHALOPATHY	0.00150376	0.07435703228037964
TOWNES-BROCKS SYNDROME 1; TBS1	0.00150376	0.07435703228037964
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.00150376	0.07435703228037964
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00150376	0.07435703228037964
KRABBE DISEASE	0.00150376	0.07435703228037964
FAMILIAL COLD URTICARIA	0.00150376	0.07435703228037964
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00150376	0.07435703228037964
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00150376	0.07435703228037964
HIRSCHSPRUNG DISEASE	0.00150376	0.07435703228037964
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00150376	0.07435703228037964
SPINOCEREBELLAR ATAXIA TYPE 37	0.00150376	0.07435703228037964
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.07435703228037964
SPINOCEREBELLAR ATAXIA 31	0.00150376	0.07435703228037964
SLC35A2-CDG	0.00150376	0.07435703228037964
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.07435703228037964
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00150376	0.07435703228037964
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.07435703228037964
THYROCEREBRORENAL SYNDROME	0.00150376	0.07435703228037964
PAPILLORENAL SYNDROME	0.00150376	0.07435703228037964
PROXIMAL SYMPHALANGISM	0.00150376	0.07435703228037964
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.07435703228037964
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.07435703228037964
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.00150376	0.07435703228037964
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00150376	0.07435703228037964
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00150376	0.07435703228037964
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00150376	0.07435703228037964
MICROPHTHALMIA, SYNDROMIC 3	0.00150376	0.07435703228037964
LOWE-KOHN-COHEN SYNDROME	0.00150376	0.07435703228037964
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.07435703228037964
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.07435703228037964
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.07435703228037964
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00150376	0.07435703228037964
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00150376	0.07435703228037964
ERMINE PHENOTYPE	0.00150376	0.07435703228037964
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00150376	0.07435703228037964
FOUNTAIN SYNDROME	0.00150376	0.07435703228037964
HYPERLEUCINE-ISOLEUCINEMIA	0.00150376	0.07435703228037964
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00150376	0.07435703228037964
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00150376	0.07435703228037964
COGAN SYNDROME	0.00150376	0.07435703228037964
CINCA SYNDROME	0.00150376	0.07435703228037964
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00150376	0.07435703228037964
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.07435703228037964
MADRAS MOTOR NEURON DISEASE	0.00150376	0.07435703228037964
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00150376	0.07435703228037964
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00150376	0.07435703228037964
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.00150376	0.07435703228037964
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.07435703228037964
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.07435703228037964
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.07435703228037964
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00150376	0.07435703228037964
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.07435703228037964
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.07435703228037964
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.07435703228037964
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.07435703228037964
FETAL IODINE SYNDROME	0.00150376	0.07435703228037964
MYH9-RELATED DISEASE	0.00150376	0.07435703228037964
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.07435703228037964
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.07435703228037964
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00150376	0.07435703228037964
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00150376	0.07435703228037964
GEMIGNANI SYNDROME	0.00150376	0.07435703228037964
EAST SYNDROME	0.00150376	0.07435703228037964
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.07435703228037964
BRAIN-LUNG-THYROID SYNDROME	0.00150376	0.07435703228037964
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00098912	0.04890941890272991
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00098912	0.04890941890272991
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00098912	0.04890941890272991
MENTAL RETARDATION, X-LINKED 21	0.00098912	0.04890941890272991
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00098912	0.04890941890272991
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00098912	0.04890941890272991
ALAGILLE SYNDROME 1; ALGS1	0.00098912	0.04890941890272991
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00098912	0.04890941890272991
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00098912	0.04890941890272991
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.00098912	0.04890941890272991
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00098912	0.04890941890272991
OPSISMODYSPLASIA; OPSMD	0.00098912	0.04890941890272991
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00098912	0.04890941890272991
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00098912	0.04890941890272991
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00098912	0.04890941890272991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00098912	0.04890941890272991
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00098912	0.04890941890272991
LAMBOTTE SYNDROME	0.00098912	0.04890941890272991
WHITE FORELOCK WITH MALFORMATIONS	0.00098912	0.04890941890272991
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00098912	0.04890941890272991
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.00098912	0.04890941890272991
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00098912	0.04890941890272991
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00098912	0.04890941890272991
KBG SYNDROME	0.00098912	0.04890941890272991
NEUROFIBROMATOSIS, TYPE I	0.00098912	0.04890941890272991
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.00098912	0.04890941890272991
HYPERTELORISM	0.00098912	0.04890941890272991
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00098912	0.04890941890272991
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00098912	0.04890941890272991
ROBINOW-SORAUF SYNDROME	0.00098912	0.04890941890272991
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00098912	0.04890941890272991
WIDOW'S PEAK	0.00098912	0.04890941890272991
GLYCEROL KINASE DEFICIENCY; GKD	0.00098912	0.04890941890272991
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00098912	0.04890941890272991
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.00098912	0.04890941890272991
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00098912	0.04890941890272991
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00098912	0.04890941890272991
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00098912	0.04890941890272991
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00098912	0.04890941890272991
GASTROCUTANEOUS SYNDROME	0.00098912	0.04890941890272991
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00098912	0.04890941890272991
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00098912	0.04890941890272991
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00098912	0.04890941890272991
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00098912	0.04890941890272991
X SMALL RINGS	0.00098912	0.04890941890272991
CRANIOSYNOSTOSIS 4; CRS4	0.00098912	0.04890941890272991
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.00098912	0.04890941890272991
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00098912	0.04890941890272991
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00098912	0.04890941890272991
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00098912	0.04890941890272991
LAURIN-SANDROW SYNDROME	0.00098912	0.04890941890272991
ICF SYNDROME	0.00098912	0.04890941890272991
GASTROCUTANEOUS SYNDROME	0.00098912	0.04890941890272991
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00098912	0.04890941890272991
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00098912	0.04890941890272991
FRONTAL ENCEPHALOCELE	0.00098912	0.04890941890272991
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00098912	0.04890941890272991
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00098912	0.04890941890272991
THAKKER-DONNAI SYNDROME	0.00098912	0.04890941890272991
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.00098912	0.04890941890272991
INTERMEDIATE NEMALINE MYOPATHY	0.00098912	0.04890941890272991
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00098912	0.04890941890272991
SPONDYLO-OCULAR SYNDROME	0.00098912	0.04890941890272991
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00098912	0.04890941890272991
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.00098912	0.04890941890272991
DISTAL MONOSOMY 17Q	0.00098912	0.04890941890272991
CURRY-JONES SYNDROME	0.00098912	0.04890941890272991
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00098912	0.04890941890272991
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00098912	0.04890941890272991
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00098912	0.04890941890272991
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00098912	0.04890941890272991
ATKIN-FLAITZ SYNDROME	0.00098912	0.04890941890272991
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.00098912	0.04890941890272991
ISOLATED ARRHINIA	0.00098912	0.04890941890272991
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00098912	0.04890941890272991
1Q21.1 MICRODUPLICATION SYNDROME	0.00098912	0.04890941890272991
8P11.2 DELETION SYNDROME	0.00098912	0.04890941890272991
14Q11.2 MICRODELETION SYNDROME	0.00098912	0.04890941890272991
RHOMBENCEPHALOSYNAPSIS	0.00098912	0.04890941890272991
FAMILIAL INTESTINAL MALROTATION	0.00098912	0.04890941890272991
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00098912	0.04890941890272991
CONO-SPONDYLAR DYSPLASIA	0.00098912	0.04890941890272991
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00098912	0.04890941890272991
DISTAL MONOSOMY 1Q	0.00098912	0.04890941890272991
ROIFMAN SYNDROME	0.00098912	0.04890941890272991
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00098912	0.04890941890272991
SUMMITT SYNDROME	0.00098912	0.04890941890272991
FGFR2-RELATED BENT BONE DYSPLASIA	0.00098912	0.04890941890272991
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.00098912	0.04890941890272991
DELAYED MEMBRANOUS CRANIAL OSSIFICATION	0.00098912	0.04890941890272991
RENAL TUBULAR DYSGENESIS	0.00098912	0.04890941890272991
QAZI-MARKOUIZOS SYNDROME	0.00098912	0.04890941890272991
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.00098912	0.04890941890272991
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.00098912	0.04890941890272991
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00098912	0.04890941890272991
OCULOTRICHOANAL SYNDROME	0.00098912	0.04890941890272991
BIFID NOSE	0.00098912	0.04890941890272991
OSTEOGLOSPHONIC DYSPLASIA	0.00098912	0.04890941890272991
CHST3-RELATED SKELETAL DYSPLASIA	0.00098912	0.04890941890272991
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.00098912	0.04890941890272991
XP21 MICRODELETION SYNDROME	0.00098912	0.04890941890272991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00098912	0.04890941890272991
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.00098912	0.04890941890272991
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00098912	0.04890941890272991
PACHYGYRIA, FRONTOTEMPORAL	0.00098912	0.04890941890272991
CHROMOSOME 4Q21 DELETION SYNDROME	0.00098912	0.04890941890272991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00098912	0.04890941890272991
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00098912	0.04890941890272991
AUTOSOMAL DOMINANT CUTIS LAXA	0.00098912	0.04890941890272991
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00098912	0.04890941890272991
DIAMOND-BLACKFAN ANEMIA 5	0.00098912	0.04890941890272991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00098912	0.04890941890272991
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00098912	0.04890941890272991
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.00098912	0.04890941890272991
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00098912	0.04890941890272991
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00098912	0.04890941890272991
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00098912	0.04890941890272991
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.00098912	0.04890941890272991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.00098912	0.04890941890272991
POSTERIOR URETHRAL VALVE	0.00098912	0.04890941890272991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00098912	0.04890941890272991
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00098912	0.04890941890272991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00098912	0.04890941890272991
JOUBERT SYNDROME 2	0.00098912	0.04890941890272991
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00098912	0.04890941890272991
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00098912	0.04890941890272991
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00098912	0.04890941890272991
AUTOSOMAL DOMINANT OMODYSPLASIA	0.00098912	0.04890941890272991
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00098912	0.04890941890272991
CEREBROOCULONASAL SYNDROME	0.00098912	0.04890941890272991
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00098912	0.04890941890272991
ADAMS-OLIVER SYNDROME 2; AOS2	0.00098912	0.04890941890272991
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.00098912	0.04890941890272991
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00098912	0.04890941890272991
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00098912	0.04890941890272991
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00098912	0.04890941890272991
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00098912	0.04890941890272991
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00098912	0.04890941890272991
JOUBERT SYNDROME 32; JBTS32	0.00098912	0.04890941890272991
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00098912	0.04890941890272991
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00098912	0.04890941890272991
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00098912	0.04890941890272991
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00098912	0.04890941890272991
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00098912	0.04890941890272991
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00098912	0.04890941890272991
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.00098912	0.04890941890272991
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00098912	0.04890941890272991
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00098912	0.04890941890272991
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00098912	0.04890941890272991
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00098912	0.04890941890272991
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00098912	0.04890941890272991
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00098912	0.04890941890272991
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00098912	0.04890941890272991
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00098912	0.04890941890272991
TRICHOHEPATOENTERIC SYNDROME 2	0.00098912	0.04890941890272991
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00098912	0.04890941890272991
NF1-MICRODELETION SYNDROME	0.00098912	0.04890941890272991
